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Case report
A 42 year old female with a progressive 
swelling of the nasal tip presented herself 
at the outpatient clinic. The past decade, 
her nose and outer skin got infected several 
times. At the age of 25 she had minor nose 
surgery in which ‘silicon based’ fillers were 
injected in the nose for aesthetic purposes. 
During physical examination, a solid mass in 
the infratip and tip of her nose was palpable 
and visible, causing a downward rotation of 
the tip and a ‘pseudo pollybeak deformation’ 
(Figure 1). MRI showed a subcutaneous mass 
with low signal intensity on T2 sequence. 
An external rhinoplasty procedure was 
performed for a meticulous removal of the 
mass (Figure 1).
 Microscopic evaluation with haematoxolin/
eosin showed a chronic inflammation, 
suggesting a chronic foreign body reaction 
to the filler. Since inflammatory cells such as 
T-cells and macrophages are key players in 
the foreign body reaction [2], which will be 
explained later in detail, it was decided to 
further analyse the removed tissue. The tissue 
showed fibrosis and cell infiltrates with T-cells 
and macrophages. The tissue showed many 
empty round holes, likely the place where the 
filler has been. These holes were surrounded 
by giant cells (fused macrophages). Both pro-
and anti-inflammatory macrophages were 
found close to the filler (Figure 2). 
 Biomaterials are seldom used in rhinoplasty 
due to a high complication rate as this case 
report shows. More research is needed to 
understand this reaction. The following 
chapters will give more inside in the foreign 
body reaction. 
Figure 1 | Mass on tip of the nose. MRI showed a 
subcutaneous mass. Open technique rhinoplasty 
showing the mass.
Figure 2 | Immunohistochemistry for macrophages 
and T-cells. T-cells (CD3), macrophages (CD68), 
pro-inflammatory macrophages (CD11c), anti-
inflammatory macrophages (CD206).
Arrows indicate samples of positive staining, F = filler, GC = 
giant cell.
This patient was treated by FR Datema and PJFM Lohuis. A part of this case report was published in 
the Dutch Journal of Otorhinolaryngology [1].
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A biomaterial is in the Merriam-Webster Dictionary defined as a natural or synthetic material that is 
suitable for introduction in living subjects and is often used in regenerative medicine to restore or 
replace tissue. In all fields of invasive medicine biomaterials play a role. In otorhinolaryngology, for 
example, biomaterials such as titanium are used to reconstruct the ossicular chain, cochlear implants 
to improve hearing and hyaluronic acid discs to reconstruct the tympanic membrane. Sometimes 
also biomaterials are used in rhinoplasty (nose surgery) or larynx surgery. Most biomaterials are 
implanted in vascular and general surgery where meshes are used for hernia repair, and vessels are 
repaired by vascular grafts and stents. There are many different types of biomaterials, each leading 
to a different reaction of the immune system after implantation. This wound healing reaction is 
named the foreign body reaction. The extend of this reaction depends on the type and design of 
the biomaterial [2-4]. 
STAGES OF WOUND HEALING
There are four stages in tissue response to biomaterials after implantation (foreign body reaction): 
Hemostasis, Inflammation, Proliferation and Remodelling [4,5]. Figure 3 shows a brief overview. 
 After implantation of a biomaterial, the first stage, hemostasis, immediately starts by adherence 
of proteins to the biomaterial and the formation of a blood clot. The type and design of the 
biomaterial can alter the attachment of proteins [2]. From the blood clot, all kinds of cytokines and 
chemokines are released leading to recruitment of inflammatory cells [2]. This leads to the second 
stage, inflammation, where neutrophils are the first inflammatory cells that arrive at the wound 
site [2]. They start cleaning the wound site from pathogens and dead cells. Then mast cells arrive 
releasing histamine, interleukin-4 (IL-4) and IL-13, thereby attracting monocytes which differentiate 
into macrophages [2]. Macrophages dominate the wound site after 2 days. These macrophages are 
mainly pro-inflammatory to promote more recruitment of inflammatory cells and phagocytosis of 
wound debris. After inflammation, the proliferation stage takes place, where fibroblasts or stem cells 
are attracted by cytokines produced by macrophages and T-cells. The fibroblasts proliferate and 
produce matrix creating granulation tissue. Also new blood vessels are formed (angiogenesis), which 
is stimulated by cytokines released from macrophages and T-cells. In the last stage, remodelling, 
macrophages orchestrate the breakdown and remodelling of matrix creating a new organized tissue 
[2,4-6]. 
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Figure 3 | Stages of wound healing, ©Greet Grotenhuis-Kramer.
Macrophages as key players
Macrophages orchestrate and conduct the foreign body reaction and are therefore key players. In 
our research we have focused on these cells. The word macrophage is derived from the Greek word 
for large (μακρος (makros)) and to eat (φαγειν (phagein)). This type of white blood cell is indeed a 
big eater since it engulfs dead cells, matrix, bacteria and much more, to clean up the wound site 
and to stimulate and orchestrate the immune system by secretion of factors [5]. Macrophages 
are resident in many tissues and organs and mostly derive from circulating monocytes which 
differentiate from hematopoietic stem cells in the bone marrow [5,6]. Macrophages can be roughly 
divided into two different subtypes: pro- and anti-inflammatory [5,8-10] (Figure 4). In response to the 
environment, macrophages can differentiate into these subtypes. Pro- inflammatory macrophages 
(M1 or classically activated) are the first cells to arrive at the wound site for attacking microbes, 
engulfing dead cells and thereby cleaning up the wound site. These macrophages are very 
important in host defence [5]. They recognize by pro-inflammatory factors such as interferon (IFN)
γ and lipopolysaccharide (LPS) on their Toll-like receptors [6,8-10]. M1 macrophages produce many 
pro-inflammatory cytokines such as interleukin (IL)-6, tumour necrosis factor (TNF)-α and IL-1β, 
needed for attraction of more inflammatory cells [8-10]. Alternatively activated macrophages (M2) 
are a group of tissue repair /regulatory macrophages. These macrophages morphologically appear 
more round compared to M1 macrophages. The group of M2 macrophages can be subdivided in 
three types. M2a macrophages are stimulated by IL-4 and IL-13 and recruit eosinophils, basophils 
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and Th2 cells [8-10]. M2b macrophages are stimulated by immune complexes and work as an 
immune-regulatory type of macrophage [8-10]. Exposure to IL-10 will induce M2c macrophages 
which supress the immune response and help tissue remodelling. These macrophages are known as 
wound healing macrophages [8-10]. The M2 macrophages are conductors, orchestrating the foreign 
body reaction by stimulating proliferation of fibroblasts, stimulate angiogenesis by producing 
growth factors and remodelling. They also inhibit pro-inflammatory macrophages [7-10]. 
Figure 4 | Subtypes of macrophages © Greet Grotenhuis-Kramer.
Frustrated wound healing
After implantation not always an organized tissue is formed with resolution of inflammation. 
Sometimes chronic inflammation with excessive matrix production leads to complications as 
observed in the case report, humps, shrinking of biomaterials or chronic postoperative pain by 
pressure on nerves do occur. These complications occur in 14–52% of patients [11,12]. Normally 
during wound healing M1 macrophages are present from the first day on and dominate after 
two days [2,7]. When most of the debris and pathogens are removed, the macrophages change 
towards a more M2 phenotype. After implantation, macrophages will try to phagocytose the 
biomaterial. Single macrophages can phagocytose particles up to 5 µm [2,7]. When the biomaterial 
is bigger, macrophages will fuse under the influence of IL-4 and IL-13, becoming a giant cell. If the 
giant cell cannot phagocytose the biomaterial, it forms a capsule trying to protect the body from the 
biomaterial. In this capsule, they secrete many enzymes such as matrix metalloproteineases (MMPs) 
to try to resorb and degrade the biomaterial [7]. Under the influence of IL-4 giant cells release 
pro-fibrotic factors such as transforming growth factor (TGF)β and platelet-derived growth factor 
(PDGF) [7]. Although the mechanism is not completely understood, it is assumed that this will result 
in continued fibroblast activation and production of excessive extra-cellular matrix such as collagen, 
leading to fibrosis [7]. 
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Biomaterials in a contaminated environment
A challenge for implantation of biomaterials is represented by a contaminated environment, 
such as bowel surgery or replacement of a previously infected mesh. Surgeons are reluctant to 
place biomaterials in a contaminated environment since the complication rate is higher and the 
biomaterial must sometimes be removed because of infection [13,14]. How the foreign body reaction 
differs from a sterile environment is not yet completely understood. It is expected that macrophages 
mainly are of the M1-phenotype, because the infection and bacteria need to be eliminated [9]. This 
will delay the foreign body reaction since M1-macrophages inhibit ingrowth of the biomaterial by 
producing matrix degrading enzymes [4,15]. Rhinoplasty (nose surgery) is also working in a field with 
a risk of contamination. Therefore very few biomaterials are used, and when used it often leads to 
complications as shown in the case report at the beginning of this chapter. In some cases, although, 
a biomaterial could be of great help to restore the function and cosmetics of the nose. 
Stem cells in wound healing
Next to macrophages, another important cell in wound healing is represented by the mesenchymal 
stem cell. These stem cells can help rebuild tissue after trauma by differentiating into many types 
of cells like fibroblasts, adipose cells, cartilage, bone and so on. These multipotent stem cells are 
therefore a good cell source for tissue engineering [16]. Mesenchymal stem cells can be harvested 
from for instance bone marrow and adipose tissue. In adipose (fat) tissue many stem cells can be 
found, first described by Rodbell in 1964 [17]. Fat tissue is convenient since this tissue is often easily 
to harvest and culture [18-21]. Adipose derived mesenchymal stem cells (ASCs) are believed to 
be important in wound healing since these cells can rapidly migrate to the wound site, enhance 
angiogenesis and stimulate matrix remodelling [22-25]. Furthermore, ASCs can interfere with the 
immune system (have immunomodulatory capacities) and thereby influence the foreign body 
reaction [26]. 
AIMS AND OUTLINE OF THE THESIS
The foreign body reaction differs per biomaterial and per patient. Some patients have complications 
after implantation of a biomaterial and some have none with the same biomaterial. For clinical 
practice, it would be a great benefit to have a tailor-made model with patients own cells to test 
pre-operatively which biomaterial is best thereby reducing complication rates. Since most of the 
knowledge and use of biomaterials is in general surgery, we will focus our research in this field. The 
ultimate goal of our research is to develop a tailor-made in vitro model with human macrophages. 
Towards developing this model, the following aims are formulated:
1) to develop an in vitro model to study the effect of biomaterials on human macrophage 
polarisation
2) to investigate the influence of biomaterials on macrophage phenotype in an inflammatory 
environment and whether this is biomaterial-dependent
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3) to investigate the influence of biomaterials on stem cells and macrophages together in an 
adjusted in vitro model 
In the last decade, the role of macrophages in reaction to biomaterials is more and more investigated 
in vivo and in vitro. 
 In Chapter 2 a review of the literature on polarisation of macrophages as response to biomaterials 
in vitro in a sterile environment is presented.
 In Chapter 3 a new model with human monocytes from peripheral blood in response to four 
different biomaterials and the outcome parameters of the model is described. 
Another challenging field in reconstructive surgery is a contaminated environment. However, how 
biomaterials perform in this environment is not completely known. In Chapter 4 an in vivo study is 
described in which in a contaminated environment in rats 7 different biomaterials are implanted. 
In this new model the complications like adhesions, incorporation and infection (Chapter 4a) and 
polarisation of macrophages (Chapter 4b) by immunohistochemistry is analysed. 
 In Chapter 5 an adaptation of the in vitro model is reported. With pro-inflammatory cytokines a 
contaminated environment is mimicked to investigate the reaction of macrophages to biomaterials 
in more detail. 
 Another important factor in wound healing is the production of matrix. In Chapter 6 the in vitro 
model is extended to a co-culture system with adipose tissue derived stem cells (ASCs) to investigate 
the influence of biomaterials on the interaction of stem cells and macrophages. 
 In Chapter 7 the overarching themes of this thesis and proposed future research topics are 
discussed.
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ABSTRACT
Activation of macrophages is critical in the acute phase of wound healing after implantation of 
surgical biomaterials. To understand the response of macrophages, they are often cultured in vitro 
on biomaterials. Since a wide range of biomaterials is currently used in the clinics, we undertook a 
systematic review of the macrophage polarization in response to these different surgical biomaterials 
in vitro. Beside the chemistry, material characteristics such as dimension, pore size, and surface 
topography are of great influence on the response of macrophages. The macrophage response also 
appears to depend on the differences in sterilization techniques that induce lasting biochemical 
changes or residues of chemicals and their byproducts used for sterilization. Regarding tissue-based 
biomaterials, macrophages on human or porcine dermis, strongly cross-linked by chemicals elicit in 
general a pro-inflammatory response with higher amounts of pro-inflammatory cytokines. Synthetic 
biomaterials such as polyethylene, polyethylene terephthalate (PET) + polyacrylamide (PAAm), 
PET + sodium salt of poly(acrylic acid) (PAANa), perfluoropolyether (PFPE) with large fibers, PEG-g-
PA, and polydioxanone (PDO) always appear to elicit an anti-inflammatory response in macrophages, 
irrespective of origin of the macrophages, for example, buffy coats or full blood. In conclusion, in 
general in vitro models contribute to evaluate the foreign body reaction on surgical biomaterials. 
Although it is difficult to simulate complexity of host response elicited by biomaterials, after their 
surgical implantation, an in vitro model gives indications of the initial foreign body response and 
allows the comparison of this response between biomaterials.
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INTRODUCTION
A wide range of biomaterials are used as implantable medical devices, notably for soft tissue repair. 
These materials have their own characteristics with regards to composition, mechanical strength, 
topography, porosity, and chemistry. Implantation of biomaterials is always associated with tissue 
damage, more or less important, according to the invasiveness of the surgical procedure, that is, 
surgical treatment of the disease and biomaterial delivery. Initially, the body response most often 
starts with blood coagulation followed by wound healing. This process is characterized by protein 
adsorption to the biomaterial, followed by recruitment of cells including macrophages already 
60 min after implantation of the material. In response to the cytokines and chemokines produced 
by the macrophages, cells involved in wound healing are attracted [1]. The inflammatory response 
is very important following surgical tissue damage and material implantation, also called foreign 
body reaction.
 Activation of macrophages is critical in the acute phase of wound healing [2,3]. Macrophages 
can be roughly divided into pro-inflammatory macrophages, also called M1 macrophages, and 
anti-inflammatory macrophages, also called M2 macrophages [4,5]. The balance between M1 and 
M2 plays a critical role in the phagocytosis of pathogens, the clearance of apoptotic cells and the 
healing and remodelling of injured tissues [6].
 Almost immediately after implantation, macrophages are recruited to biomaterials. Depending 
on the biomaterial specific characteristics, these macrophages will determine the type and intensity 
of the host response [6,7]. The eventual success of an implantable medical device strongly depends 
on this response. The host response after implantation is inter alia guided by soluble factors such as 
cytokines and growth factors, as communication agents between cells, active in the wound healing 
process. Several studies point out the cytokine classification according to their role in the foreign 
body response [8-10]. These soluble factors are, among other cell types, produced by macrophages 
and play pivotal roles in wound healing and serve as useful markers of M1/M2 activation [7,10-12].
 The pivotal role of macrophages in the wound healing process, including tissue repair or 
regeneration supported by biomaterials, is a strong incentive to interrogate the macrophage 
response, elicited by biomaterials, in well-defined in vitro conditions, with reasonable prediction 
of the complex foreign body reaction by using simplified single cell approaches. For this purpose, 
human monocyte-derived macrophages, human monocyte cell lines, mouse bone marrow-derived 
macrophages, and murine macrophage cell lines are used as culture models. In these models, it is 
examined whether biomaterials elicit a pro-inflammatory, anti-inflammatory, pro-wound healing, 
or an anti-wound healing response by macrophages. These models support the first step to analyse 
materials before use in the clinic. As nicely reviewed by Sridharan et al. [1] many different properties 
of the material influence the polarization of the macrophage, among others the mechanical 
properties, topography, and surface chemistry. Since many types of biomaterials are used in many 
different culture models with a large variety of read-out parameters, the purpose of this review was 
to provide an overview of which biomaterial leads to which response, in particular regarding the 
differentiation and activation of the macrophages and the associated production of soluble factors.
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MATERIALS AND METHODS
Search methods
This systematic review was conducted in accordance to the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses (PRISMA) guidelines.
Search strategy and study selection
On the 29th of June 2015 a systematic literature search was performed using Medline, EMBASE, 
Cochrane, PUBMED, Google Scholar, and Web-of-Science libraries (Supplementary Appendix 
S1). There were no restrictions used during the search based on the publication year, publication 
language, and type of study. Two researchers (G.S.A.B. and N.G.) screened all titles and abstracts 
of the identified articles independently for their relevance. From all articles that possibly met the 
inclusion criteria, the full-text version was retrieved and assessed for inclusion. Disagreement was 
resolved by discussion or requesting advice from a third author (Y.M.B.J.).
 An article was eligible for inclusion when it reported on macrophages and their response to 
biomaterials in an in vitro model. Presentations, reviews, and letters to the editor were not included. 
All references from the selected articles were screened for further possible inclusions.
Data extraction and analysis
The extracted data are presented in separate tables. The following information was retrieved from 
each study: first author, year of publication, culture model, biomaterial, and cytokine expression. 
A meta-analysis could not be performed due to the lack of sufficient comparative studies and the 
important variability of the in vitro macrophage models (e.g., cell origin and isolation procedure, 
culture conditions, markers).
RESULTS
Search
After the exclusion of 2904 duplicates we identified 4275 references. After screening the titles and 
abstracts, we excluded another 4169 articles. The other 106 articles were regarded relevant and 
evaluated as full text. After careful reviewing the full text, another 90 were excluded. In addition 
seven articles were included via references, resulting in 23 included articles (Figure 1).
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Figure 1 | Study selection for relevant articles.
Culture models/experimental conditions
All included studies cultured monocytes or macrophages on biomaterials. However, substantial 
differences were found in cell culture conditions between the studies. Monocytes isolated from a 
human buffy coat or human peripheral blood were used in 19/23 of the studies [7,8,11,13-28]. In the 
other four studies, one used monocytes derived from mouse bone marrow [4], one used the RAW 
264.7 cell line (mouse leukaemia monocyte macrophage cell line) [9] and the other two used the 
THP-1 human monocyte cell line [10,29] (Table 1). 
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Table 1 | Included Studies Cultured Monocytes or Macrophages on Biomaterials, aTHP human leukemic 
monocyte. bRAW/J744 murine macrophage cell line.
Author Year Cells
Almeida et al. [13] 2014 Human buffy coat
Ballotta et al. [28] 2014 Human buffy coat
Bartneck et al.[14] 2010 Human peripheral blood
Bartneck et al. [15] 2012 Human peripheral blood
Bhardwaj et al. [16] 2001 Human buffy coat
Bhattacharjee et al. [17] 2013 Human peripheral blood
Bota et al. [18] 2010 Human peripheral blood
Brodbeck et al. [8] 2002 Human peripheral blood
DeFife et al. [19] 1995 Human peripheral blood
Fearing et al. [29] 2014 THP-1 cell linea
Garg et al. [4] 2013 Mouse bone marrow-derived Mφ
Gretzer et al. [20] 2003 Human buffy coat
Grotenhuis et al. [7] 2013 Human buffy coat
Jones et al. [21,31] 2007 Human peripheral blood
Oliveira et al. [22] 2012 Human buffy coat
Orenstein et al. [23] 2009 Human peripheral blood
Orenstein et al. [24,25] 2010 Human peripheral blood
Schachtrupp et al. [11] 2003 Human buffy coat
Schutte et al. [10] 2009 THP-1 cell linea
Spiller et al. [26] 2014 Human buffy coat
Van den Beucken et al. [9] 2007 RAW 264.7 & J744A.1b
Wagner et al. [27] 2003 Human peripheral blood
In most of the studies, no additional factors were added to the culture medium. However, some also 
added soluble factors to the media. Medium with lipopolysaccharides (LPS) was the most common, 
but media also contained LPS/interferon gamma (IFN-γ), interleukin (IL)-4, IL-4/IL-13, or monocyte 
chemotactic protein (MCP)-1/IL-6/IFN-γ. The culture time varied from 2 h to 14 days, but the majority 
cultured for 1, 3, 7, and/or 10 days.
Biomaterials
Biomaterials can be divided into three groups namely the nonbiodegradable polymers (synthetic), 
biodegradable polymers (synthetic), and biologic materials [30]. In total 35 different materials were 
used in the included articles (Table 2).
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Table 2 | Reviewed Biomaterials and Their Predominant Reaction. This table shows results coming from 
different macrophage models, not necessarily equivalents. The results are adapted generally from one study.
Biomaterial Predominant reaction of macrophages 
in contact with biomaterial
Low/high cytokine 
production
Refs.
PTFE Mainly pro-inflammatory High 10,15
ePTFE Pro- and anti-inflammatory High/high 9,17,25
PET Mainly pro-inflammatory High 6,7,20
PET + BDEDTC Mainly pro-inflammatory High 7,20
PET + BDEDTC + PAAm Mainly anti-inflammatory High 7,20
PET + BDEDTC + PAANa Mainly anti-inflammatory High 7,20
PET + BDEDTC + DMAPAAmMeI Mainly pro-inflammatory High 7,20
Parietex™ Composite Pro- and anti-inflammatory High/high 6
Polyethylene Mainly anti-inflammatory Low 9,18
Polyurethane Pro- and anti-inflammatory High/high 9,15,18
PFPE (small fibers) Mainly pro-inflammatory High 13
PFPE (large fibers) Mainly anti-inflammatory High 13
PP Pro- and anti-inflammatory Low/low 6,26
PP + polyglactin Mainly pro-inflammatory High 10
Poly(ethylene glycol):poly(acrylate) Mainly anti-inflammatory Low 27
Poly-d-lysine-PAH Mainly pro-inflammatory Low 8
Silicone Pro- and anti-inflammatory High/high 15
Polylactic acid Pro- and anti-inflammatory High/high 12
Poly(ethylene oxide) Mainly pro-inflammatory High 14
Bio-A Mainly pro-inflammatory Low 23
Polydioxanone Mainly anti-inflammatory High 3
Poly-e-caprolactone bisurea Mainly anti-inflammatory High 27
Poly(urethane urea) Pro- and anti-inflammatory Low/low 19
Collamend™ Mainly pro-inflammatory High 24
Permacol™ Mainly pro-inflammatory/ 
pro- and anti-inflammatory
High/low 6,24
Allomax Mainly pro-inflammatory High 22,23
FlexHD Mainly pro-inflammatory High 22,23
Alloderm Mainly pro-inflammatory Low 22,23
Strattice™ Mainly pro-inflammatory Low 24
Surgisis® Mainly pro-inflammatory Low 24
Collagen coating Mainly pro-inflammatory High 28
Ultrafoam Mainly pro-inflammatory Low 16,25
Silk Mainly pro-inflammatory High 16
Keratin Pro- and anti-inflammatory Low/high 28
Chitosan Pro- and anti-inflammatory Low/high 12,21
BDEDTC=poly(styrene-co-benzyl N,N-diethyldithiocarbamate); DMAPAAmMeI=methyl iodide of poly[3-(dimethylamino)propyl]
acrylamide; ePTFE=expanded polytetrafluoroethylene; PAAm=polyacrylamide; PAANa=sodium salt of poly(acrylic acid); PFPE= 
perfluoropolyether; PET=polyethylene terephthalate; PP=polypropylene; PTFE=polytetrafluoroethylene. 
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Nonbiodegradable synthetic polymers
Expanded polytetrafluoroethylene (ePTFE) and polytetrafluoroethylene (PTFE) are commonly 
applied hernia mesh and vascular grafts materials. PTFE, also known as Teflon®, is naturally hydro-
phobic and nonporous. ePTFE is stretched and nano-porous and was introduced under the trademark 
GORE-TEX®, in 1969. Monocytes (precursors of macrophages) on PTFE produced low amounts of 
IL-1β and high amounts of tumor necrosis factor (TNF)-α and IL-6 in the first days of culture. IL-10 
levels increased during culture time, it was mainly produced between culture day 2 and 6 [11,16]. 
After a culture time for 8–10 days the production of TNF-α and IL-10 decreased, while IL-8 increased 
after 8 days of culture [16]. Granulocyte-macrophage colony-stimulating factor (GM-CSF) was 
secreted during the whole culture time (1–10 days) [11,16,18]. Macrophages on PTFE also produced 
platelet-derived growth factor-BB, and matrix metalloproteinase 9 but vascular endothelial growth 
factor (VEGF) was undetectable [26]. Macrophages on ePTFE produced more pro-inflammatory 
cytokines (IL-1α, IL-1β, IL-6, and TNF-α) and chemokines (MCP-1, MIP1-β, and MCP-3) in association 
with an increase of the pore size of the material [18]. In contrast, immortalized human monocyte 
cell line (THP-1) cultured on ePTFE induced an anti-inflammatory and pro-wound healing profile 
characterized by a high IL-10 production in another study [10].
 Current surgical applications of polyethylene terephthalate (PET) are surgical meshes, vascular 
grafts, heart valves, and sutures. Macrophages on PET produce predominantly pro-inflammatory 
cytokines, MCP-3, TNF-α, IL-6, IL-1β, MIP-1α,7,8,31 and pro-inflammatory chemokine IL-8 [31].
 PET is also used in combination with different “coatings.” These coatings affect biomaterial adherent 
monocyte/macrophage cytokine expression through modification of surface chemistry. Different 
coatings are used: PET + poly(styrene-co-benzyl N,N-diethyldithiocarbamate) (BDEDTC; hydrophobic), 
PET + BDEDTC + polyacrylamide (PAAm; hydrophilic and neutral), PET + BDEDTC + sodium salt 
of poly(acrylic acid) (PAANa; hydrophilic and anionic), PET + BDEDTC + methyl iodide of poly[3-
(dimethylamino)propyl]acrylamide (DMAPAAmMeI; hydrophilic and cationic), and PET + absorbable, 
continuous and hydrophilic collagen film (Parietex™ Composite). Macrophages on PAAm and 
PAANa surfaces reacted anti-inflammatory with a higher IL-10 production and lower IL-8 production 
than when cultured in PET without coating during the culture time from day 3 till day 10 [8,31]. 
Monocytes adherent to PAAm produced the most IL-6, IL-1β, IL-10, IL-8, and MIP-1β at all time 
points, compared to the other coatings in combination with PET [31]. Macrophages cultured for 
3 to 7 days, produced the highest concentrations of IL-1β on PAAm and least on BDEDTC. MIP-1β 
concentrations were greatest with PAANa at day 3. DMAPAAmMeI promoted a decrease of IL-10 and 
IL-1RA in macrophages, but it did not influence the expression levels of IL-1β, TNF-α, and IL-6 [7,29]. 
BDEDTC, PAAm, PAANa, and DMAPAAmMeI let the IL-1β, TNF-α, and IL-6 expression levels relatively 
unchanged at the end of culture time [8,31]. Parietex Composite (Covidien) induced high levels of 
pro-inflammatory and anti-inflammatory proteins [7].
 Macrophages cultured on polyethylene (PE), with versatile use such as catheters and joint 
prosthesis, produced low amounts of cytokines in general but the balance was more toward 
anti-inflammatory and pro-wound healing cytokines [10,19]. Both THP-1 cell line monocytes/
macrophages and macrophages isolated from human buffy coats cultured on polyurethane (PU), 
often used in blood contact applications, produced high levels of anti-inflammatory and pro-wound 
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healing cytokines [10,16]. Perfluoropolyether (PFPE) is a nondegradable homopolymer that shows 
chemical inertness, lipophobicity, and has very low surface energy [14]. This material was tested 
with different micro topographies and the effect on the response of macrophages. Different surface 
topographies resulted in different cytokine production by macrophages. An M1 surface marker, 
27E10, had an enhanced expression in response to closely packed small fibers, comparable to when 
macrophages were stimulated with LPS. In contrast, macrophages cultured on PFPE with large fibers 
expressed the M2 surface marker CD163 the most. Large fibers also resulted in significantly the 
highest M2-M1 index based on macrophages surface markers [14].
 Poly(propylene) (PP) is also commonly used mesh and suture materials in surgery. Both an anti-
inflammatory reaction characterized by high levels of CCL-18 and IL1-RA among others and a pro-
inflammatory reaction characterized by production of IL-8, IL-6, and IL-1β by macrophages seeded 
both for 24 h or 3 days on PP were observed [7,27]. When combined with polyglactin 910 materials 
(Vypro II®; Ethicon), monocyte/macrophages also released high amounts of TNF-α, IL-6, and low 
amounts of IL-10 after 5 days of culture, which indicates a pro-inflammatory response [11].
 Poly(ethylene glycol):poly(acrylate) PEG-g-PA is also modified with cell adhesion promoting 
peptides (YRGDS and YEILDV, peptides recognized by integrins) to modulate the host cell response 
[27]. Culturing macrophages on PEG alone resulted in low production of TNF-α, IL-1β, IL-6, and IL-8. 
Macrophages on peptide modified PEG-g-PA produced even lower levels of TNF-α and IL-6 [27].
 Poly-d-lysine (PDL) and poly(allylamine hydrochloride) (PAH), both synthetic polymers, were 
coated with DNA and seeded with two different cell line macrophages. All experiments showed 
decreased levels of TNF-α compared with the cultured polymers with LPS-stimulated murine 
macrophages (density of 1 × 105 cells/cm2) [9]. The cytokine secretion of IL-1β, IL-10, and TGF-β1 
was not different between macrophages cultured on PDL and PAH with or without LPS stimulation 
[9]. Monocytes on silicone cultured for 10 days produced high GM-CSF and IL-8 [16]. TNF-α and IL-10 
were produced at high levels the first 2–6 days, where after the production decreased [16].
Biodegradable synthetic polymers
Synthetic biodegradable polymers were first used as biodegradable sutures in the 1960s. Synthetic 
biodegradable implants are mostly used in the clinic as soft/hard tissue reinforcement materials 
or temporary barriers/wound supports. Their purpose is to avoid a chronic foreign body reaction 
[32]. These polymeric biomaterials are based on lactic acid and glycolic acid, and other monomers, 
including dioxanone and trimethylene carbonate e-caprolactone as homopolymers and copolymers.
 Polylactic acid (PLA) induces production of IL-6, IL-12/23, and IL-10, these cytokines are both pro-
inflammatory and anti-inflammatory, it appeared like human monocytes cultured on PLA exhibited 
a heterogeneous profile [13].
 Poly(D,L-lactide-co-glycolide) (PLGA) represents a major class of materials widely used in surgical 
applications and tissue engineering [15]. Bartneck et al. generated 3D nano-fibrous meshes in 
different porosities PLGA/sP(EO-stat-PO) and a 2D NCO-sP(EO-stat-PO) hydrogel. NCO-sP(EO-stat-
PO) and sP(EO-stat-PO) are ethylene oxide-derived polymers, used for preventing unspecific protein 
adsorption and cell adhesion [15].
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Macrophages on the 2D materials formed clusters with an elevated release of IL-1β and TNF-α. 
Macrophages produced more IL-8 and CCL-4 (proangiogenic chemokines) on the more covered 3D 
nanofibers PLGA/sP(EO-stat-PO) [15].
 Macrophages seeded on a copolymer of glycolic acid and trimethylene carbonate, also known as 
GORE® BIO-A® Tissue Reinforcement (WL Gore Assoc), produced very low pro-inflammatory cytokine 
levels [24]. Polydioxanone (PDO) polymer is developed for biodegradable wound closure sutures. 
Bone marrow-derived macrophages were cultured on different PDO diameter fibers and pore sizes. 
An increase of the fiber/pore size resulted in an increased expression of anti-inflammatory and 
angiogenic markers as VEGF, TGF-β, and FGF2 [4].
 The impact of mechanical cues on adherent monocytes on poly-e-caprolactone bisurea (PCL-U4U) 
was investigated. It has been demonstrated that strain affects macrophage response in terms of 
signaling and differentiation. Moderate strain (7%) elicits polarization toward a reparative M2 profile 
and enhance the expression of genes participating in the immune response [28].
 Poly(urethane urea) elicited very small amounts of TNF-α and IL-10 [20].
Biologic materials
Biologic materials are either decellularized tissues such as human or porcine skin or porcine small 
intestine submucosa (SIS), or fabricated scaffolds or meshes made of natural molecules such as 
collagen, chitosan, silk, or keratin. The decellularized tissues can have additional chemical cross-links 
to alter the degradation speed [33].
 After 7 days of culture CollaMend™ FM Implant (Bard/Davol), a moderately chemically cross-linked 
porcine dermis, mostly elicited a pro-inflammatory response in macrophages with high IL-1β, IL-6, 
IL-8, and VEGF production [25]. Macrophages on Permacol™ (Covidien), a slightly chemically cross-
linked porcine dermal matrix, produced high IL-1β, IL-6, IL-8, and VEGF levels after 7 days of culture 
[25]. But in other settings, low levels of both pro-inflammatory and anti-inflammatory proteins 
after 3 days of culture, were released by macrophages, in the presence of Permacol [7]. There were 
no differences in culture method between the two studies. AlloMax™ Surgical Graft (Bard/Davol) 
and FlexHD® (Ethicon), nonchemically cross-linked decellularized dermis but of human instead 
of porcine origin, also induced mainly pro-inflammatory reactions with high IL-1β, IL-6, IL-8, and 
VEGF cytokine production [23,24]. AlloDerm® Regenerative Tissue Matrix (LifeCell) (nonchemically 
cross-linked decellularized human dermis) induced a lower pro-inflammatory response than the 
other decellularized human dermis, characterized by lower expression of IL-1β, IL-6, IL-8, and VEGF 
[23,24]. Macrophages seeded on the noncross-linked porcine dermis, Strattice™ (LifeCell), or on the 
noncross-linked porcine SIS, Cook® Biodesign® Surgisis® (Cook), produced low levels of IL-1β, IL-6, 
IL-8, and VEGF [25].
 Macrophages cultured on collagen coatings expressed mostly M1 surface markers (CD86+) and 
express both M1 and M2 markers [29,34]. These macrophages produced also high levels of pro-
inflammatory cytokines. Another collagen-based biomaterial is Avitene™ UltraFoam™ Collagen 
Sponge (Bard/Davol; bovine source collagen sponge). Macrophages cultured on this gel did 
not produce IL-1β, and IL-6 production was only seen at day 1 and was lower produced at day 3, 
indicating that the response of the macrophages was not pro-inflammatory [17].
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Other noncommercial biopolymers have been investigated. Bhattacharjee et al. studied the 
macrophage responses against silk-fibroin and silk-sericin-based 2D films, and 3D silk-fibroin 
scaffolds [17]. These scaffolds are used for tissue engineering and drug delivery. The 3D fibroin 
scaffold induced gene expression of pro-inflammatory genes and accordingly the production of 
IL-1β and IL-6. Silk-sericin films also induced IL1-β gene expression [17].
 Two other biologic biomaterials are keratin and chitosan. Keratin has been described for 
applications such as tissue regeneration, hemostasis, and wound healing. A low foreign body reaction 
against keratin was described characterized with predominantly M2 (CD206+) macrophages, high 
levels of IL-10, and low levels of IL-1β and IL-6 [29]. Chitosan (a natural polysaccharide composed 
of randomly distributed β-(1–4)-linked d-glucosamine and N-acetyl-d-glucosamine) induced an M2 
phenotype in one study based on low TNF-α that decreased with time and high IL-10 and TGF-β1 
levels cytokines [22]. In another study chitosan induces a predominant M1 response based on high 
production of TNF-α and IL-12/IL-23 and low expression of IL-6, especially in the 3D geometry [13]. 
Oliveira et al. cultured on chitosan films instead of 3D geometry [13].
DISCUSSION
Macrophages are key components of tissue repair and remodeling in wound healing. Their 
polarization appears to depend on the type of biomaterial and their characteristics. The release of 
a variety of cytokines and chemokines is decisive for the differentiation and activity of monocytes 
[35]. Here, we reviewed the macrophage response on different materials in vitro used in tissue repair 
and regeneration and provided an overview of commonly seen macrophage responses to these 
biomaterials.
 Based on the literature review, we have shown that the dimensions of the cultured material is 
of great influence on the response of macrophages. This was (mostly) investigated in PFPE, ePTFE, 
chitosan, and PDO. The association was, however, different between increasing fiber/pore size and 
the polarization or release profile of macrophages. Two synthetic biomaterials showed the opposite 
effect of pore size. Bartneck et al. showed a higher pro-inflammatory effect when the pore size was 
smaller in PFPE [14]. Bota et al. saw a higher pro-inflammatory effect of macrophages cultured on 
ePTFE when the pores are larger [18]. Almeida et al. saw the same effect, on scaffolds based on 
chitosan, a biologic material [13]. In contrast, Garg et al. cultured macrophages on PDO, a synthetic 
biodegradable material, and they showed that large pores induced M2 phenotype and a decreased 
M1-marker expression. However, in this study, mouse bone marrow-derived macrophages were 
used instead of human macrophages. In an in vivo study with biodegradable pHEMA (2-hydroxyethyl 
methacrylate) hydrogel scaffolds it was also shown that pore size affect macrophage response. 
Pore size of 34 μm was shown to reduce fibrous encapsulation, however, more M1 cells were found 
than at those scaffolds with a larger pore size of 160 μm, this indicate that the initial M1 response is 
necessary [36].
 As expected, macrophages on moderately chemically cross-linked human or porcine dermis 
responded in general pro-inflammatory with higher amounts of pro-inflammatory cytokines 
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than the macrophages cultured on nonchemically cross-linked or slightly chemically cross-linked 
materials. This was also seen in in vivo studies were Collamend™ FM Implant (Bard/Davol) induced a 
chronic foreign body response and downstream encapsulation [37,38]. This mainly pro-inflammatory 
response lead to chronic fibrosis [39]. Unfortunately, in all in vitro studies on these biologic materials, 
only investigated IL-1β, IL-6, IL-8, and VEGF, known for their mainly pro-inflammatory response, no 
anti-inflammatory cytokines were measured. A recent review presented that moderately to strongly 
cross-linked collagen materials can alter normal wound healing. In particular, residues of chemical 
cross-links in the material were associated with a M1 macrophage response, and inhibition of M2 
macrophage polarization [33].
 Chitosan, another biopolymer, showed a predominant M1 response with a very low IL-6 
production [13]. The same effect was seen on the collagen gel; mainly pro-inflammatory cytokines 
were produced, but no production of IL-1β [17]. This can be considered a pleiotropic function of IL-6 
and IL-1β. It is known that IL-6 can act either pro-inflammatory or anti-inflammatory, depending 
on the environment [40]. IL1-β is a key cytokine that is important for wound healing, activating 
and recruiting fibroblasts, resulting in expression of extracellular matrix components like collagen, 
elastin, and glycosaminoglycans [41-43].
 Some materials induced different responses in different experiments such as acellular human 
dermis from different companies. This could be due to the differences in sterilization techniques 
that induce lasting biochemical changes or residues of the chemical used for sterilization; gamma 
radiation is used for AlloMax Surgical Graft (Bard Davol); FlexHD (Ethicon) is sterilized by detergents, 
disinfectants, and ethanol; and the sterilization process of AlloDerm Regenerative Tissue Matrix 
is proprietary. AlloDerm induced the least of the pro-inflammatory cytokines. Also, the methods 
of decellularization and processing of the materials were different, which can be an additional 
explanation for the different foreign body responses, notably explained by chemical residues, used 
for decellularization and fat removal.
 Comparing all the responses of the different materials, it appears that polyethylene, PET + PAAm, 
PET + PAANa, PFPE (large fibers), PEG-g-PA, and PDO always elicited an anti-inflammatory response 
in macrophages, irrespective of origin of the macrophages.
 In vitro testing of macrophage response to biomaterial can be an initial means of assaying 
biocompatibility. Macrophages are certainly great drivers of the acute inflammation reaction. 
Neutrophils (polymorphonuclear leukocytes [PMNs]) also characterize acute inflammatory response. 
Mast cell degranulation with histamine release and fibrinogen adsorption is also known to mediate 
acute inflammatory responses to implanted biomaterials [44,45]. For a complete in vitro model, 
these factors should also be taken into account. For example, Surgisis is known to strongly activate 
PMNs, particularly neutrophils [46]. Bryan et al. show a strong release of Reactive Oxygen Species by 
Surgisis versus Alloderm and Permacol, in animal models [47].
 In general, in vitro models are useful in the first step to evaluate the foreign body reaction on 
surgical biomaterials. Although it is difficult to simulate the environment during a surgical procedure, 
an in vitro model gives an indication of the initial foreign body response even in an environment that 
simulates an infection by, for instance, addition of LPS. Grotenhuis et al. proved this by simulating 
a bacterial infection in their in vitro model, but the macrophage response remained biomaterial 
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dependent [48]. In this perspective it will be useful to test, for example, other surgical biomaterials 
like tissue adhesives that are used in the clinic.
 Because of the complexity of host response to foreign body material it is difficult to predict the in 
vivo outcome from in vitro assays. Wolf et al. developed an in silico analysis by using an in vitro assay 
that characterized the dynamic inflammatory response of human monocyte-derived macrophages 
to biomaterials in combination with quasi-mechanistic analysis [49]. This approach can be used 
to better predict the in vivo response. More sophisticated systems, like multicellular approaches 
combining macrophages with fibroblasts, endothelial cells, and stem cells, aiming at recreating a 
better mimicking system, should certainly be useful for the in-depth investigation of the behavior of 
materials in vivo [50].
 Simple models as single cell approaches should be used for screening approaches, enabling the 
direct comparison of materials. Macrophage models can gain even higher interest by including 
monocytes from specific patient groups, like obesity, which may react differently to materials.
CONCLUSION
With this review, we provided an overview of in vitro responses of macrophages to many different 
biomaterials. Some materials performed comparable in different studies and it appears clear which 
response these biomaterials elicit in macrophages. Other materials behaved differently in different 
culture setups. Therefore, all physical properties (e.g., stiffness, pore size, strain, topography, and 
surface chemistry) of the biomaterial must be announced, because these features can induce 
different macrophage behaviour [1,39]. Each step in cell culture is critical, the macrophage isolation, 
activation of the macrophage before culture or not, time duration of cell culture since it conditions 
the phenotype/differentiation of cells, and the type of culture medium, minimal changes in culture 
methods can cause the different outcome [2,35,51,52]. In vitro culture models using macrophages on 
biomaterials are a valuable addition to the development of new biomaterials. Based on this review 
there is, however, a need for standardized culture models and a systematic comparison to the in vivo 
response.
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SUPPLEMENTARY MATERIAL
We used the following search strategy in the Embase, and the searching strategy was modified in 
other databases accordingly. (‘tissue adhesive’/exp OR ‘adhesive agent’/de OR ‘surgical mesh’/de 
OR ‘surgical equipment’/de OR ‘tissue scaffold’/de OR biomaterial/de OR (adhesive* OR glue* OR 
bioglue* OR tachocomb* OR bucrilate* OR enbucrilate* OR cyanoacryl* OR mesh* OR 4DDOME
OR AIGISRx OR AlloDerm OR AlloMax OR ‘Bard Composix EX patch’ OR ‘BIO-A Tissue Reinforcement
prosthesis’ OR CollaMend OR DermaMatrix OR Dual-Mesh OR ‘Evolution P3EM’ OR FasLata OR FlexHD 
OR FortaGen OR ‘IntePro Lite’ OR InteXen OR NEOVEIL OR ‘Optilene Mesh LP’ OR ‘Parietex composite’ 
OR Pelvicol OR Pelvisoft OR Pelvitex OR PerFix OR ‘Peri-Strips Dry’ OR PeriGuard OR Permacol OR 
Physiomesh OR Strattice OR Surgisis OR TIGR OR Timesh OR ‘TiMESH light’ OR Tutomesh OR 
Tutopatch OR Ultrapro OR Ventralex OR Veritas OR Vivosorb OR Vypro OR X-Repair OR XenMatrix 
OR scaffold* OR biomaterial* OR biocompatib* OR Hemocompatib* OR Haemocompatib* OR 
resorbable OR (implant* NEAR/3 integrat*)):ab,ti) AND (‘macrophage culture’/de OR ‘monocyte 
culture’/de OR ((macrophage/exp OR ‘macrophage activation’/de OR monocyte/de OR (macrophag* 
OR monocyte*):ab,ti) AND (‘in vitro study’/exp OR monoculture/de OR (‘in vitro’ OR culture* OR 
monocultur*):ab,ti))) NOT ([Conference Abstract]/lim OR [Conference Paper]/lim OR [Review]/lim OR 
[Conference Review]/lim OR [Letter]/lim OR [Note]/lim OR [Editorial]/lim) AND [english]/lim
ABBREVIATIONS USED
BDEDTC poly(styrene-co-benzyl N,N-diethyldithiocarbamate)
DMAPAAmMeI methyl iodide of poly[3-(dimethylamino)propyl]acrylamide
ePTFE expanded polytetrafluoroethylene
GM-CSF granulocyte-macrophage colony-stimulating factor
IFN-γ interferon gamma
IL interleukin
LPS lipopolysaccharides
MCP monocyte chemotactic protein
PAAm polyacrylamide
PAANa sodium salt of poly(acrylic acid)
PAH poly(allylamine hydrochloride)
PDL poly-d-lysine
PDO polydioxanone
PFPE perfluoropolyether
PLA polylactic acid
PLGA poly(D,L-lactide-co-glycolide)
PMNs polymorphonuclear leukocytes
PP polypropylene
PTFE polytetrafluoroethylene
SIS small intestine submucosa
TNF tumor necrosis factor
VEGF vascular endothelial growth factor
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3CHAPTER
A culture model to analyze the 
acute biomaterial-dependent reaction 
of uman primary ma rophages
Grotenhuis N, Bayon Y, Lange JF, Van Osch GJ, Bastiaansen-Jenniskens YM. 
A culture model to analyze the acute biomaterial-dependent reaction of 
human primary macrophages. Biochem Biophys Res Commun. 2013 Mar 
29;433(1):115-20. doi: 10.1016/j.bbrc.2013.02.054. Epub 2013 Feb 26.
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ABSTRACT
Macrophages are important in foreign body reactions. We devised a culture model with human 
primary macrophages to evaluate the acute response of macrophages to biomaterials. First we 
selected proteins representative for pro-inflammatory (M1) or anti-inflammatory/repair (M2) 
response of monocytes isolated from blood of healthy human donors by exposing them to 
LPS+IFNγ or IL-4. A relative M1/M2 index was calculated using IL-1β, IL-6, tumor necrosis factor (TNF)
α, monocyte chemotactic protein (MCP)-3 and macrophage inflammatory protein (MIP)-1α as M1 
markers, and IL-1 receptor antagonist (IL-1RA), CCL18, regulated and normal T-cell expressed and 
secreted (RANTES), and macrophage-derived chemokine (MDC) as M2 markers. Then monocytes were 
cultured for 3 days on 4 materials selected for known different foreign body reactions: Permacol™, 
Parietex™ Composite, multifilament polyethylene terephthalate and multifilament polypropylene. 
Macrophages on polypropylene produced high levels of anti-inflammatory proteins with a low M1/
M2 index. Macrophages on Parietex™ Composite produced high levels of inflammatory and anti-
inflammatory proteins, with a high M1/M2 index. Macrophages on polyethylene terephthalate also 
resulted in a high M1/M2 index. Macrophages on Permacol™ produced a low amount of all proteins, 
with a low M1/M2 index. This model with human primary macrophages and the panel of read-out 
parameters can be used to evaluate the acute reaction of macrophages to biomaterials in vitro to get 
more insight in the foreign body reaction.
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INTRODUCTION
Biomaterials are widely used in regenerative medicine. Worldwide there are over 100 different 
commercially available biomaterial-based medical devices, with different composition and 
formulation for clinical use. All biomaterials elicit a reaction of the body, the foreign body reaction, 
more or less marked according to the nature of biomaterials. This reaction differs between patients 
[1-3]; in hernia surgery, for example, 14–52% of the patients have complaints, usually of pain, seroma 
(wound fluid production), or excessive production of scar tissue [4,5]. 
 Macrophages play a pivotal role in the foreign body reaction [6,7]. Their subtype can change 
in response to environmental factors, giving rise to different populations of macrophages with 
distinct functions. Classically activated macrophages, or M1 macrophages, are the most thoroughly 
characterized and well-described activated macrophages. They propagate pro-inflammatory 
responses by producing cytokines such as interleukin (IL)-1β, tumor necrosis factor (TNF)α and 
interleukin (IL)-6 [8-10]. Another subtype of macrophages is represented by the alternatively 
activated macrophages, also referred to as M2 macrophages. These cells can arise when exposed 
to, for example, IL-4 or immune complexes. M2 macrophages produce among others IL-10 and 
chemokines CCL18 and CCL22 (macrophage derived chemokine, MDC) and are able to produce 
growth factors, promoting angiogenesis and extracellular matrix production [8-10].
 After implantation, biomaterials are immediately coated with serum proteins and extracellular 
matrix proteins that activate the immune system [11,12]. These proteins drive the very first steps 
of the foreign body reaction, in particular, in stimulating neutrophils and activating monocytes 
to become macrophages. Neutrophils and macrophages then release different cytokines and 
chemokines to attract more cells to the wound site [13].
 The foreign body reaction to biomaterials is mostly examined with animal experiments. Although 
studies have also been performed in vitro, most of these involve cell-lines or non-human cells. 
We devised an in vitro model based on human primary macrophages and designed an M1/M2 
index to evaluate the involvement of macrophages in the foreign body reaction to a biomaterial. 
Four different biomaterials were chosen based on a different host response in vivo; polyethylene 
therephthalate with a fast resorbing coating made from purified pepsinized porcine collagen 
(Parietex™ Composite), porcine acellular dermis matrix, mainly composed of ‘natural’ collagen 
(Permacol™), polypropylene (mPP) and a polyethylene therephthalate (mPET) biomaterial. All the 
selected materials are representative of a large palette of surgical materials. For example, mPP 
and mPET based biomaterials are widely used as prostheses for vascular, abdominal, orthopedic 
surgeries and as permanent suture materials [14]. Acellular dermis matrices are reported to be used 
in surgical reconstructions of soft tissues such as head and neck soft tissues, breast and abdominal 
wall [15].
 The synthetic biomaterials, especially polypropylene, are described to give a predominantly 
fibrotic response and naturally derived biomaterials firstly elicit an M1 response [16]. For our in vitro 
model we used primary human macrophages and selected a panel of genes and proteins based on 
literature and own experiments that can be used to discriminate between pro-inflammatory and 
anti-inflammatory macrophages.
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MATERIALS AND METHODS
Monocyte isolation
Ficoll density gradient (Ficoll-Paque™ PLUS, GE Healthcare) was used to isolate monocytes from 
7 buffy coats of healthy donors (men and women aged 21–63), obtained from the blood bank 
(Sanquin Bloodbank, Rotterdam, the Netherlands) Thirty milliliter of diluted buffy coat (1:5 ratio with 
PBS/BSA 0.1%) was layered on 15 mL of Ficoll. After 15 min centrifugation at 1000g without brake, 
the interphase band containing peripheral blood mononuclear cells was removed and washed in 
PBS/BSA 0.5% 2 mM EDTA and labeled with 100 μL of anti-CD14+ magnetic beads (CD14 microbeads 
human, MACS Separation columns LS and MidiMACS™ Separator; all Miltenyi Biotec), and isolated 
according to the manufacturer’s guidelines. This positive selection of monocytes will not activate 
the cells [17]. To measure purity of the isolation, 1 × 106 monocytes were incubated for 15 min at 
room temperature with the following antibodies: FITC-conjugated CD14 and PerCP-conjugated 
CD45 (all BD Pharmingen, Franklin Lakes, NJ, USA). After incubation, cells were washed in PBS/BSA 
0.1%. FACS analysis was performed with cellquest Pro (BD) on a FACSCalibur (BD).
Macrophage stimulation towards an M1 and M2 subtype
To validate the read out parameters, monocytes were cultured in monolayer non-stimulated 
and stimulated to M1 or M2 using cytokines as described previously [11,18-21]. The monocytes 
were plated in 6-well plates (polystyrene, Costar, Corning Inc. NY, USA) in a concentration of 
100,000 monocytes per cm2 and cultured in X-vivo 15 medium (Lonza, Verviers, Belgium) with 0.6% 
fungizone (Amphotericine, Gibco, Carlsbad) and 0.1% gentamycine (Gibco). Different media were 
tested for culture of human monocytes; on the basis of cell attachment and cell survival, X-vivo 15 
was considered the optimal medium (data not shown). Directly after plating, monocytes were either 
not stimulated or stimulated with 100 ng/mL LPS (Lipopolysaccharide, Sigma–Aldrich, St. Louis, 
MO, USA) and 10 ng/mL IFNγ (recombinant human interferon-γ, PeproTech, Rocky Hill, NJ, USA) to 
obtain an M1 subtype or 10 ng/mL IL-4 (recombinant human interleukin 4 PeproTech) to obtain 
an M2 subtype [11,18-21]. Attached monocytes will be referred to as macrophages. Macrophages 
were cultured in a humidified incubator at 37 °C, 5% CO2 (Binder, Tuttlingen, Germany) for a total of 
3 days. The monolayer cultures were harvested after 1 day of culture for gene expression and after 
3 days for protein production.
Culturing macrophages on biomaterials
To evaluate the effect of biomaterials on macrophages, the monocytes were seeded on four different 
materials immediately after isolation from the buffy coat. The following materials were chosen 
because they initiate a different reaction in vivo: multifilament polypropylene (mPP), multifilament 
polyethylene terephthalate (mPET), Permacol™ (collagen derived from porcine skin, crosslinked) and 
Parietex™ Composite (multifilament polyethylene terephthalate with an absorbable, continuous and 
hydrophilic collagen film on one of its sides) (all Covidien–Sofradim Production, Trevoux, France). The 
materials were cut into pieces of 1.5 by 1.5 cm with a sterile scalpel. Before cell seeding, to provide 
protein attachment, materials were incubated in 100% non-heat inactivated fetal bovine serum 
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(Lonza, Verviers, Belgium) for 2 h. Freshly isolated monocytes were adjusted to a concentration of 
700,000/mL in a total volume of 25 mL in a 50 mL tube (Falcon, polypropylene conical tube, Becton 
Dickinson, Franklin Lakes, NJ, USA). Twelve samples were incubated per 25 mL for 2 h at 37 °C. 
Afterwards, samples were placed in a 24-well non-adherent plate (NUNC, non-treated multiplate, 
Rochester, NY, USA) and cultured for a total of 3 days in serum free X-vivo 15 medium. The samples 
were harvested after 1 day of culture for gene expression and after 3 days for protein production 
and DNA analysis.
RNA isolation and qPCR
Monolayer samples were harvested in 1 mL RLT-buffer (Qiagen, Hilden, Germany). Seeded 
biomaterials were harvested in 350 μL RLT-buffer. Samples were kept at -80 °C until further RNA 
isolation was performed using the RNeasy Microkit (Qiagen) according to the manufacturer’s 
instructions with on column DNA digestion. RNA concentration was measured using a 
spectrophotometer (NanoDrop ND1000 UV–VIS, Isogen Life Science B.V., the Netherlands). cDNA 
was prepared using RevertAid First Strand cDNA Synthesis Kit (MBI Fermentas, Germany) according 
to the manufacturer’s instructions. qPCR was performed on an ABPrism 7000 system (Applied 
Biosystems, Foster City, CA, USA) using either Taqman Universal PCR mastermix (Applied Biosystems) 
or SybrGreen (Eurogentec, Seraing, Belgium). After testing several housekeeping genes, we found 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Fw:GTCAACGGATTTGGTCGTATTGGG; 
Rev:TGCCATGGGTGGAATCATATTGG; probe:Fam-TGGCGCCCCAACCAGCC-Tamra) to be the most 
suitable for our experiments. For analysis, the following distinctive genes were used chosen 
based on literature and pilot experiments [8,10,22,23]: tnfα and il-6 as M1 genes, cd206 and 
ccl18 as M2 genes. CCL18 FW GCACCATGGCCCTCTGCTCC, Rev GGGCACTGGGGGCTGGTTTC; 
IL-6 FW TCGAGCCCACCGGGAACGAA, Rev GCAGGGAAGGCAGCAGGCAA; CD206 FW TGGCCGTA 
TGCCGGTCACTGTTA, Rev ACTTGTGAGGTCACCGCCTTCCT; TNFα Fw GCCGCATCGCCGTCTCCTAC, 
Rev AGCGCTGAGTCGGTCACCCT (all Eurogentec). Relative gene expression was calculated using 
the 2−ΔCT method [24].
Protein analysis
Proteins of interest were based on literature [8,10,22,23] and on a pilot experiment where production 
of 42 cytokines was measured in 25 μL cell-culture supernatants after 1 and 3 days of culture using 
Milliplex (Millipore, MPXHCYTO-60K, Billerica, MA, USA) according to manufacturer’s recommendation 
to search for discriminating proteins (EGF, Eotaxin, FGF-2, FLt-3L, Fractalkine, G-CSF, GM-CSF, GRO, 
IFNα2, IFNγ, IL-1α, IL-1β, IL-1RA, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12(p40), IL-12(p70), IL-
13, IL-15, IL-17, IP-10, MCP-1, MCP-3, MDC, MIP-1α, MIP-1β, PDGF-AA, PGGF-AB/BB, RANTES, sCD40L, 
sIL-2Ra, TGFα, TNFα, TNFβ, VEGF). CCL18 was measured in addition using a CCL18 DuoSet ELISA (R&D 
systems, Minneapolis, MN, USA) in 100 μL cell-culture supernatants according to the manufacturer’s 
recommendation. From this pilot experiment the most discriminative 9 cyto-kines and the time 
point day 3 were chosen (data not shown) and measured in the subsequent experiments using 
an eight-plex Milliplex (Millipore) and a CCL18 DuoSet ELISA (R&D), namely: interleukin (IL)-1β, 
IL-6, tumor necrosis factor (TNF)α, monocyte chemotactic protein (MCP)-3, and macrophage 
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inflammatory protein (MIP)-1α, IL-1 receptor antagonist (IL-1RA), regulated upon activation normal 
T-cell expressed and secreted (RANTES or CCL5), macrophage derived chemokine (MDC), and 
CCL18. The data were corrected for number of cells by measuring DNA. Macrophages were lysed 
in 0.1%Triton/PBS (Sigma–Aldrich, St. Louis, MO, USA) and frozen at -80 °C before analyzing with 
CyQUANT© cell proliferation assay kit (Invitrogen, Carlsbad, CA, USA). DNA was measured according 
to the manufacturer’s recommendation.
Statistics
The monolayer experiments were performed with four donors for 1 day of culture, three overlapping 
donors for the 3 days of culture, with for each donor three monolayers per condition. The biomaterial 
experiments were performed with three different donors, each donor in triplicate. All data are 
presented as scatter dot plots with each dot representing one single measurement with the mean of 
the different donors. To compare the effect of the four materials on macrophage subtype, a relative 
M1/M2 index was calculated. The percentage of the mean production per cytokine was calculated, 
followed by dividing the mean percentage of M1 cytokines (MIP-1α, TNFα, MCP-3, IL-1β, IL-6) by 
the mean percentage of M2 cytokines (MDC, RANTES, IL-1RA and CCL18) per sample. Groups were 
compared in SPSS (20.0, IBM Corporation, Armonk, New York, USA) using a Kruskal–Wallis test 
(independent samples median test) and a Mann–Whitney test because the data were not normally 
distributed. Differences were considered statistically significant when p < 0.05.
RESULTS
Determination of read-out parameters for M1/M2 subtype
Purity of freshly isolated CD14+ monocytes was always > 95%, as measured by FACS analysis (data 
not shown). To determine read out parameters for the M1 and M2 subtypes we first confirmed 
the subtypes using qPCR. After one day of culture in monolayer, expression of tnfα and il-6, genes 
specific for M1 macrophages, was significantly higher in the LPS+IFNγ-stimulated cells than in the 
IL-4 stimulated cells. In addition, LPS+IFNγ resulted in a decrease relative to the unstimulated cells 
of cd206, a gene characteristic for M2 macrophages. The genes specific for M2 macrophages, ccl18 
and cd206, were significantly higher expressed in the IL-4 stimulated cells than in the LPS+IFNγ-
stimulated cells (Figure 1).
 After this confirmation of the pro-inflammatory (M1) and anti-inflammatory/repair (M2) subtype 
of macrophages we analysed the production of the proteins MIP-1α, TNFα, MCP-3, IL-1β, IL-6, MDC, 
RANTES, IL-1RA and CCL18. The medium of LPS+IFNγ-stimulated cells contained significantly more 
IL-6 than the medium of IL-4 stimulated cells (Figure 2A). The culture medium of IL-4 stimulated cells 
contained significantly more CCL18, IL-1RA, RANTES and MDC than medium of LPS+IFNγ stimulated 
cells (Figure 2B).
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Figure 1 |  Gene expression by stimulated macrophages. Macrophages were stimulated with LPS+IFNγ or 
IL-4 cultured for 1 day, n = 4 donors with samples in triplicate for each donor. tnfα and il-6 were used as M1 
markers; ccl18 and cd206 as M2 markers. Gene expression was normalized for GAPDH.
Figure 2 | Protein production of stimulated macrophages. Protein production of A | pro-inflammatory 
markers B | anti-inflammatory markers by macrophages in response to LPS+IFNγ or IL-4 stimulation after 3 
days, n = 3 donors with samples in triplicate for each donor.
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Response of macrophages to biomaterials
Interaction of macrophages with different biomaterials resulted in differences in gene expression. 
For the inflammatory cytokines no significant differences were found, however gene expression of 
ccl18 was significantly lower for macrophages seeded on Parietex™ Composite than the other three 
biomaterials. Gene expression of cd206 was significantly higher in macrophages on Permacol™ and 
mPET than in macrophages on Parietex™ Composite (Figure 3).
Figure 3 | Gene expression of macrophages seeded on biomaterials. Gene expression of macrophages 
seeded on biomaterials cultured for 1 day. n = 3 different donors, samples in triplicate. Gene expression was 
normalized for GAPDH. 
ParieC = Parietex™ Composite; Pcol = Permacol™; mPET = multifilament polyethylene terephthalate; mPP = multifilament 
polypropylene.
All proteins, besides CCL18, were produced in higher amounts by macrophages on Parietex™ 
Composite than macrophages on the other materials. CCL18 secretion was significantly higher by 
macrophages on mPP than by macrophages on the other biomaterials. The lowest amounts of all 
proteins were secreted by macrophages on Permacol™ (Figure 4A and B).
 To facilitate comparison of the different biomaterials a relative M1/M2 index was calculated for each 
biomaterial. Macrophages on Parietex™ Composite and mPET have a high M1/M2 index, meaning a 
more pro-inflammatory subtype in comparison to mPP and Permacol based on our protein panel. 
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Macrophages on Permacol™ and mPP had a low M1/M2 index, meaning a more anti-inflammatory 
subtype than the other two materials (Figure 4C).
Figure 4 | Protein production by macrophages seeded on biomaterials. Protein production by macrophages 
seeded on biomaterials cultured for 3  days corrected for DNA. A | Pro-inflammatory markers B | anti-
inflammatory markers C | M1/M2 index, n = 3 different donors, samples in triplicate. The percentage of the 
mean production per cytokine was calculated, followed by dividing the mean percentage of M1 cytokines 
(MIP-1α, TNFα, MCP-3, IL-1β, IL-6) by the mean percentage of M2 cytokines (MDC, RANTES, IL-1RA and CCL18) 
per sample. 
ParieC  =  Parietex™ Composite; Pcol  =  Permacol™; mPET  =  multifilament polyethylene terephthalate; mPP  =  multifilament 
polypropylene.
DISCUSSION
A well-characterized in vitro model can be of great value to study the mechanisms of foreign body 
reactions. In this study, we presented an in vitro model of healthy human primary macrophages 
with an M1/M2 index as one of the read-out parameters. With this model we could show that the 
acute inflammation reaction of macrophages is different in response to different biomaterials. 
We determined a panel of proteins and genes to define several distinguishing markers for 
pro-inflammatory and anti-inflammatory macrophages using LPS+IFNγ and IL-4 stimulated 
macrophages. We measured protein production for nine proteins, all except for MCP-3, were 
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described in literature related to M1 or M2 macrophages; MIP-1α (or CCL3), TNFα, IL-1β and IL-6 are 
described as pro-inflammatory M1 markers, MDC (CCL22), RANTES (CCL5), IL-1RA and CCL18 are 
described as anti-inflammatory M2 markers [10,12,18,19,25]. Although IL-6 and RANTES are known 
to be able to act either pro-inflammatory or anti-inflammatory, depending on the environment 
[8,20,21,26], in our monolayer experiments with stimulated macrophages il-6 gene expression was 
higher in LPS+IFNγ stimulated macrophages than in IL-4 stimulated macrophages. Therefore IL-6 
was selected as pro-inflammatory marker. RANTES protein levels on the other hand were higher in 
IL-4 stimulated cells than in LPS+IFNγ stimulated cells and therefore selected in our model as an anti-
inflammatory marker. When we measured the above nine proteins in all experiments, we detected 
donor differences, some proteins appeared discriminative in some, but not in other donors. This 
represents the human in vivo situation, where the macrophage reaction to a foreign material is also 
dependent on the recipient. 
  Taking together using gene expression of tnfα, il-6, ccl18 and cd206, and the protein panel with MIP-
1α, TNFα, MCP-3, IL-1β, IL-6, MDC, RANTES, IL-1RA and CCL18, we believe that we have a good read-
out panel to determine the acute reaction of macrophages to biomaterials, based on the monolayer 
experiments. Not only can these parameters be used as positive marker for a pro-inflammatory 
or an anti-inflammatory/repair reaction, also as negative markers as for instance cd206 that was 
downregulated by addition of LPS+IFNγ or il-6 that was downregulated by addition of IL-4. 
 The differences found when investigating the response of macrophages on different biomaterials 
indicated that biomaterials can directly influence the differentiation of macrophages. Macrophages 
cultured on mPP produced high levels of CCL18 protein, and their overall M1/M2 index was low in 
comparison to the other biomaterials tested, suggesting that mPP induces an anti-inflammatory/
repair subtype of macrophages. High levels of CCL18 are associated with fibrotic reactions [23,27]. 
From the in vivo situation, multifilament polypropylene is indeed known to generate a significant 
fibrotic reaction [28,29,30]. Macrophages on Permacol™ produce a low amount of both pro-
inflammatory and anti-inflammatory/repair proteins, suggesting a mild reaction to the biomaterial. 
The M1/M2 index is low, meaning that the mild reaction is mostly anti-inflammatory. Indeed 
Permacol™ is known to induce a very low foreign body reaction in vivo [31,32]. Macrophages on mPET 
have a high M1/M2 index, meaning a predominantly pro-inflammatory subtype of macrophages 
on this biomaterial. Macrophages on Parietex™ Composite produced high levels of both types of 
proteins, with a relatively high M1/M2 index. This marked acute reaction may be generated by 
soluble collagen fragments released from the collagen film directly after seeding of the monocytes, 
which is also seen in vivo [33,34]. The M1/M2 index in favour of M1 also corresponds to the less 
fibrotic reaction seen in vivo [34,35]. This association of macrophage phenotype in vitro and in vivo 
data of foreign body reaction indicates that our in vitro model based on human macrophages is 
representative. 
  To our knowledge, this is the first model with human primary macrophages that is well characterized 
and provides the possibility to study the differentiation of macrophages into different subtypes as 
a response to biomaterials. This in vitro model has two particular advantages over those previously 
used: it is an easy and fast way to evaluate the response of macrophages to different biomaterials 
compared to animal models and it uses human freshly isolated macrophages making the results 
translatable to the human in vivo situation.
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To conclude, for analysis of the reaction of human primary macrophages to biomaterials, we 
selected a panel of genes and proteins based on literature and own experiments that can be 
applied to discriminate between pro-inflammatory and anti-inflammatory/repair macrophages. 
Indeed, different biomaterials, widely used in surgeries with their specific responses, resulted 
in different inflammatory responses in vitro. This indicates that this culture model is suitable to 
evaluate macrophage responses to biomaterials. It can provide more insight in the interaction of 
macrophages with other cells such as fibroblasts, neutrophils and lymphocytes, and helps to find 
ways to interfere with the foreign body reaction.
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ABSTRACT
Background
Implantation of meshes in a contaminated environment can be complicated by mesh infection and 
adhesion formation.
Methods
The caecal ligation and puncture model was used to induce peritonitis in 144 rats. Seven commercially 
available meshes were implanted intraperitoneally: six non-absorbable meshes, of which three had 
an absorbable coating, and one biological mesh. Mesh infection, intra-abdominal abscess formation, 
adhesion formation, incorporation and shrinkage were evaluated after 28 and 90 days. Histological 
examination with haematoxylin and eosin and picrosirius red staining was performed.
Results
No mesh infections occurred in Sepramesh®, Omyramesh® and Strattice®. One mesh infection 
occurred in Parietene® and Parietene Composite®. Significantly more mesh infections were found 
in C-Qur® (15 of 16; P ≤ 0.006) and Dualmesh® (7 of 15; P ≤ 0.035). Sepramesh® showed a significant 
increase in adhesion coverage from 12.5 per cent at 28 days to 60.0 per cent at 90 days (P = 0.010). 
At 90 days there was no significant difference between median adhesion coverage of Parietene 
Composite® (35.0 per cent), Omyramesh® (42.5 per cent), Sepramesh® (60.0 per cent) and Parietene® 
(72.5 per cent). After 90 days the adhesion coverage of Strattice® was 5.0 per cent, and incorporation 
(13.4 per cent) was significantly poorer than for other non-infected meshes (P ≤ 0.009). Dualmesh® 
showed shrinkage of 63 per cent after 90 days.
Conclusion
Parietene Composite® and Omyramesh® performed well in a contaminated environment. Strattice® 
had little adhesion formation and no mesh infection, but poor incorporation. Some synthetic 
meshes can be as resistant to infection as biological meshes. 
Surgical relevance
Surgeons are reluctant to use synthetic materials in contaminated environments owing to the risk of 
mesh infection. Mesh infection often necessitates removal of the mesh, leaving an abdominal wall 
deficit larger than the original hernia. Recently developed biological meshes are suggested to allow 
implantation in a contaminated environment. This experiment shows promising results regarding 
infection rate, incorporation and adhesion formation of certain synthetic meshes in a contaminated 
environment. Biological meshes showed no mesh infection and little adhesion formation. However, 
incorporation of biological meshes was poor, making the biomechanical strength of the repair 
questionable. In contaminated abdominal wall surgery one-stage repair might be performed with 
implantation of certain types of synthetic mesh.
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INTRODUCTION
Mesh reinforcement during ventral hernia repair drastically reduces 10-year recurrence rates 
[1,2]. Non-absorbable synthetic materials are currently the most commonly used prosthesis for 
reinforcement of ventral hernias. Advantages of synthetic meshes are low recurrence rates, ease 
of use and relatively low costs. However, implantation of synthetic meshes can be complicated by 
mesh infection and adhesion formation. Mesh infection is a feared complication and reported in up 
to 16 per cent of patients after abdominal wall repair [3]. The risk of mesh infection is increased in a 
contaminated environment, which makes the use of synthetic mesh debatable [4]. Mesh infection 
after implantation often necessitates its removal, which leaves the patient with a contaminated field 
and an abdominal wall deficit that is often larger than the original hernia.
 Macroporous meshes have been preferred because large pores permit infiltration of macrophages 
and allow rapid fibroplasia and angiogenesis, with reduced infiltration and growth of bacteria [5, 
6]. The drawback of macroporous meshes is the increased risk of visceral adhesions to the site of 
the repair, with associated small bowel obstruction, pain, infertility and enterocutaneous fistula 
formation [5,7,8]. These adhesions arise as a result of fibrin deposition in the abdominal cavity, with 
subsequent formation of adhesions. The presence of contamination increases fibrin deposition, 
leading to an increased amount and tenacity of adhesions intra-abdominally and to the mesh 
[9]. In a clean environment antiadhesive coatings have proved to reduce adhesion formation to 
macroporous meshes [8,10,11].
 The aim of the study was to compare commercially available synthetic and biological meshes in 
terms of infection rate, adhesion formation, incorporation and shrinkage after implantation in a 
contaminated environment.
METHODS
One hundred and forty-four male Wistar rats weighing 250–350 g were obtained from a licensed 
breeder (Harlan Laboratories, Boxmeer, The Netherlands). They were bred under specific pathogen-
free conditions, kept under standard laboratory conditions in individually ventilated cages, and fed 
freely with standard rat chow and water throughout the experiment. The protocol of the experiment 
was approved by the Ethical Committee on Animal Experimentation of Erasmus University 
Rotterdam.
Peritonitis model
Rats were anaesthetized by isoflurane/oxygen inhalation and received buprenorphine analgesia 
(0,05 mg/kg subcutaneously). The abdomen was shaved and the skin disinfected with 70 per cent 
alcohol, after which the abdominal cavity was opened through a 3-cm midline incision. To induce 
peritonitis, a caecal ligation and puncture (CLP) model was used [12]. The caecum was carefully 
manipulated outside the abdominal cavity and ligated just distal to the ileocaecal valve with a 
monofilament non-absorbable suture (4/0 Ethilon®; Ethicon, Johnson & Johnson, Somerville, New 
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Jersey, USA), maintaining the continuity of the bowel. The caecum was punctured distally to the 
ligation with an 18-G needle. The fascia and skin were closed with a running absorbable suture 
(5/0 Safil®; B. Braun, Melsungen, Germany). After 24 h the abdomen was reopened, a culture swab 
was taken to confirm peritonitis, the necrotic caecum was resected and the abdominal cavity was 
rinsed with at least 20 ml phosphate-buffered saline at 37 °C. A sterile mesh, measuring 2·5 × 3 cm, 
was implanted intraperitoneally with three transmuscular non-absorbable sutures (5/0 Ethilon®) on 
both sides of the incision in all mesh groups. No mesh was implanted in the control group. After 
administration of gentamicin (6 mg/kg intramuscularly) the abdominal wall and skin were closed 
separately with a running absorbable suture (5/0 Safil®).
Implanted meshes
The rats were divided into eight groups, a control group that received no mesh and groups in 
which one of the following seven meshes was implanted intraperitoneally: non-cross-linked 
collagen (Strattice®; LifeCell, Branchburg, New Jersey, USA), polypropylene (Parietene®; Sofradim, 
Trevoux, France; part of Covidien, North Haven, Connecticut, USA), collagen–polyethyleneglycol–
glycerol-coated polypropylene (Parietene Composite®; Sofradim), omega-3-fatty acid-coated 
polypropylene (C-Qur®; Atrium, Hudson, New York, USA), carboxymethylcellulose–sodium 
hyaluronate-coated polypropylene (Sepramesh®; Bard, New Providence, New Jersey, USA), 
expanded polytetrafluoroethylene (PTFE) (Dualmesh®; Gore, Flagstaff, Arizona, USA) and condensed 
PTFE (Omyramesh®; B. Braun).
Measurements
Half of the surviving animals were euthanised after 28 days and half after 90 days. The abdomen 
was shaved, disinfected and opened through a equation image-shaped incision extending laterally 
and caudally to the mesh. Directly after opening the abdomen, a swab of the abdominal cavity 
was taken for culture. Mesh infection was defined as the presence of abscesses of the mesh, and 
parts of the mesh were cultured for microbiological evaluation. Adhesions were scored using 
a grid placed over the mesh, dividing it into 30 equal squares. The tenacity of the adhesions was 
graded using the Zühlke score, a four-degree classification of adhesions based on histological and 
morphological criteria [13]. Pictures of the abdominal wall with mesh and any adhesions were 
taken with a 5.0-megapixel digital camera. The abdominal cavity was inspected for abscesses; 
when present, these were scored and cultured at four sites: the liver, abdominal wall, bowel and 
omentum [14]. Mesh incorporation was defined as the percentage of the mesh edge incorporated 
into the abdominal wall, taking into account any shrinkage. Shrinkage was defined as the relative 
loss of surface compared with the original size of the mesh, measured with a calliper. The animals 
were killed by cardiac cut. All measurements were carried out by two independent observers and 
disagreements reconciled by discussion.
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Histological evaluation
At least two representative samples of macroscopically non-infected meshes with adjacent 
abdominal wall were excised by full-thickness (mesh and abdominal wall muscle) biopsy punches of 
5 mm diameter. The samples were embedded in Tissue-Tek© (Sakura, Alphen, Rijn, The Netherlands) 
and immediately frozen in liquid nitrogen. Frozen sections of 6 µm were made using a cryostat (Leica; 
Davis Instruments, Vernon Hills, Illinois, USA). Sections were stained with either haematoxylin and 
eosin or picrosirius red (Direct Red 80; Fluka Chemie, Zwijndrecht, The Netherlands) [15]. Samples 
were assigned a random number before evaluation and scored by two observers blinded to the 
specific type of mesh. Fibrosis, lymphocyte infiltration and angiogenesis were scored macroscopically 
at 200× magnification using a light microscope (Olympus, Center Valley, Pennsylvania, USA). The 
following grading scale was used: 0, none present; 1, little; 2, moderate; and 3, extensive. The 
picrosirius red-stained sections were analysed for collagen and scored by means of the same scale 
for the presence of collagen around the mesh and abdominal wall.
Statistical analysis
Results are presented as median (interquartile range). Mesh infection, tenacity and percentage of 
adhesions, histological score, abscess formation, survival and weight were compared using Kruskal–
Wallis, Mann–Whitney U, χ2 and Fisher’s exact tests as the data did not show a normal distribution. 
If the overall test showed differences, pairwise tests were done to determine the groups causing the 
overall significance. Exact methods for significance were used when computational limits allowed 
these. All reported P values are two-sided and P < 0.05 was considered statistically significant. In view 
of the numbers, it was not possible to adjust the P values using Bonferroni’s correction. Statistical 
analysis was performed using PSAW® statistical software package version 17 (IBM, Armonk, New 
York, USA).
RESULTS
During the first 2 days of the experiment 22 (15.3 per cent) of the 144 rats died. Necropsy was 
performed and septicaemia was found to be the cause of death in all rats (Table 1). On day 13 one 
rat in the C-Qur® group died from intestinal obstruction due to severe adherence of the bowel to 
the infected mesh. Abdominal cultures on day 1 confirmed bacterial contamination in all animals 
with Gram-positive (Enterococcus, Staphylococcus, Streptococcus) and Gram-negative (Escherichia 
coli and Proteus) micro-organisms. All animals exhibited symptoms of sepsis including apathetic 
behaviour, ocular exudates, piloerection, diarrhoea and weight loss. The maximum percentage 
weight loss varied between 11.1 and 14.2 per cent, and was more pronounced in the C-Qur® group 
(P ≤ 0.048 compared with other groups).
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Table 1 | Postoperative mortality and number of animals analysed at 28 and 90 days after surgery.
Group Mesh material No. of 
animals
Postoperative 
death
No. analysed 
28 days
No. analysed 
90 days
Control No mesh 18 2 8 8
Strattice® Non-cross-linked collagen 18 4 7 7
Parietene® Polypropylene 18 2 8 8
Parietene 
Composite®
Collagen–polyethyleneglycol–glycerol-
coated polypropylene
18 4 7 7
Sepramesh® Carboxymethylcellulose–sodium 
hyaluronate-coated polypropylene
18 2 8 8
C-Qur® Omega-3-fatty acid-coated polypropylene 18 2 8* 8
Dualmesh® Expanded polytetrafluoroethylene 18 3 7 8
Omyramesh® Condensed polytetrafluoroethylene 18 3 7 8
Total   144 22 60 62
* One rat in the C-Qur® group died after 13 days. The results for this rat were analysed together with those for rats killed after 28 days 
in the C-Qur® group.
Mesh infection
At the time of death macroscopic infection of the mesh was present in 24 (22.6 per cent) of 106 
animals. The infection rate among C-Qur® meshes was high (15 of 16 rats) compared with all other 
meshes (P ≤ 0.006) (Figure 1). Dualmesh® also showed a high infection rate (7 of 15 rats), significantly 
higher than all other groups apart from C-Qur® (P ≤ 0.035). All infected meshes became large fibrotic 
pseudotumours. No additional mesh infection was discovered by microbiological culture of the 
meshes.
Figure 1 | Comparison of mesh infection rates 
(combined 28 and 90 days). Values are percentage of 
macroscopically infected meshes among surviving 
animals.
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Abscesses
Intra-abdominal abscesses were found in 37 rats (62 per cent) after 28 days and 27 (44 per cent) after 
90 days (P = 0.049). The majority of abscesses were located at the caecum or abdominal wall. There 
was no significant difference between groups in intra-abdominal abscesses (P = 0.482).
Adhesions
After 28 and 90 days the surfaces of all infected meshes were completely covered with adhesions. 
Owing to the high infection rate in C-Qur® and Dualmesh® the median adhesion coverage was 
90–100 per cent (Figure 2). After 28 days significantly less adhesion to the mesh surface was found 
for Strattice® (median 10.0 (5.0–10.0) per cent) and Sepramesh® (12.5 (6.3–22.5) per cent) compared 
with all other meshes (P ≤ 0.004 and P ≤ 0.017 respectively). Median adhesion coverage was 45.0 
per cent for Parietene Composite®, 52.5 per cent for Parietene® and 55.0 per cent for Omyramesh®.
Figure 2 | Comparison of percentage of mesh adhesions at 28 and 90 days’ follow-up. Values are median 
(interquartile range). 
*P < 0·050 versus Parietene®, Parietene Composite®, C-Qur®, Dualmesh® and Omyramesh® at 28 days; †P < 0·050 versus Parietene® 
and Omyramesh® at 28 days; ‡P < 0·050 versus all other meshes at 90 days; §P < 0·050 versus Parietene®, Parietene Composite®, 
Sepramesh® and Omyramesh® at 90 days; ¶P = 0·010 versus Sepramesh® at 28 days (Mann–Whitney U test)
Sepramesh® showed an increase in adhesion formation from a median 12.5 of per cent at 
28 days to 60.0 per cent at 90 days (P = 0.010). After 90 days Strattice® (5.0 (5.0–10.0) per cent) had 
significantly less adhesion coverage than the other meshes (P ≤ 0.003). At 90 days there was no 
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significant difference between median adhesion coverage of Parietene Composite® (35.0 per cent), 
Omyramesh® (42.5 per cent), Sepramesh® (60.0 per cent) and Parietene® (72.5 per cent).
Incorporation
After 28 and 90 days C-Qur® showed no or very little incorporation into the abdominal wall owing 
to the high rate of mesh infection (Figure 3). Strattice® showed a poor incorporation of 22.7 per cent 
at 28 days, which was lower than for Omyramesh® (47.1 per cent; P = 0.004), Parietene Composite® 
(42.5 per cent; P = 0.004) and Sepramesh® (35.6 per cent; P = 0.004).
Figure 3 | Mesh edge incorporation at 28 and 90 days’ follow-up. Values are median (interquartile range). 
*P < 0·050 versus Parietene Composite®, Sepramesh®, C-Qur® and Omyramesh® at 28 days; †P < 0·050 versus Parietene®, Parietene 
Composite®, Sepramesh® and Omyramesh® at 28 days; ‡P < 0·050 versus Parietene Composite® and Omyramesh® at 28 days; §P < 
0·050 versus Parietene®, Parietene Composite®, Sepramesh®, C-Qur® and Omyramesh® at 90 days; ¶P < 0·050 versus all other meshes 
at 90 days; #P < 0·050 versus Parietene®, Parietene Composite®, C-Qur® and Omyramesh® at 90 days (Mann–Whitney U test)
The incorporation of Strattice® was not improved after 90 days (median 13.4 per cent). This was 
significantly worse than the incorporation of Parietene Composite® (54.5 per cent; P = 0.003), 
Omyramesh® (50.4 per cent; P < 0.001), Parietene® (48.4 per cent; P = 0.009) and Sepramesh® 
(40.9 per cent; P = 0.002). At 90 days, Dualmesh® (29.4 per cent) was incorporated more poorly than 
Parietene® (P = 0.020), Parietene Composite® (P = 0.009) and Omyramesh® (P = 0.002).
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Shrinkage
The shrinkage of C-Qur® could not be determined owing to the formation of large fibrotic 
pseudotumours in all but one of the meshes. The non-infected Dualmesh® showed the highest 
percentage loss of mesh surface, of 63 per cent after 90 days (P ≤ 0.012 compared with other meshes). 
All other meshes had a median loss of mesh surface of between 0 and 10 per cent after 28 days. 
Strattice® showed a progressive median loss of surface from 0 per cent at 28 days to 23 per cent at 90 
days (P = 0.003). After 90 days the purely synthetic Dualmesh®, Omyramesh® and Parietene® showed 
shrinkage of between 0 and 15 per cent. Parietene Composite® and Sepramesh® did not shrink after 
90 days (P ≤ 0.026 and P ≤ 0.014 respectively compared with all other meshes).
Histology
Fibrosis was observed in all mesh-surrounding tissues. This was especially pronounced for the four 
polypropylene-based meshes and Omyramesh® (Figure S1, supporting information). Dualmesh® 
showed a clear encapsulation of the mesh, almost without cellular infiltration into it. A large number 
of vessels could be seen in the tissue surrounding Parietene Composite® and Omyramesh®. Because 
of wide intra-animal variation, no statistically difference was found for fibrosis, influx of lymphocytes, 
angiogenesis and collagen deposition (data not shown).
DISCUSSION
In this experimental contaminated environment, the collagen-coated polypropylene mesh Parietene 
Composite® and the condensed PTFE Omyramesh® had a low risk of infection, moderate adhesion 
formation and good incorporation. The biological Strattice® mesh did not become infected and 
showed remarkably little adhesion formation, but poor incorporation.
  If a mesh is used in a contaminated environment, consensus exists that a biological collagen 
mesh or a synthetic macroporous, monofilament mesh may be advantageous [5,16-18]. Biological 
collagen meshes have been developed specifically for a contaminated environment and Strattice® 
did not show any mesh infection in this experiment. Biological meshes, particularly Strattice®, have 
shown improved clearance of bacteria, which decreases the possibility of infection and formation of 
adhesions [19]. A prospective multicentre study of contaminated ventral hernia repair with Strattice® 
reported a similar low infection rate with little need to remove the mesh [20].
  The macroporous Parietene®, Parietene Composite®, Sepramesh® and Omyramesh® had a low 
risk of infection. Large pores allow admission of macrophages, fibroplasia and angiogenesis, which 
improves the ability to clear infection [5,6]. In this study, however, the macroporous C-Qur® mesh 
showed a high infection rate. This polypropylene mesh is coated with anti-inflammatory omega-3 
fatty acids. In an experimental clean environment macrophages were scarcely present in the mesh 
after implantation [11,21]. It might be hypothesized that the anti-inflammatory properties of the 
omega-3 fatty acid coating have prevented macrophage penetration, although no clinical or 
experimental literature on the characteristics of omega-3 fatty acids in the presence of bacteria has 
yet been published.
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Figure S1 | Histological samples after 90 days: 
a,c,e,g,i haematoxylin and eosin staining and b,d,f,h,j 
picrosirius red staining of histological samples 
after 90 days (original magnification ×40). a,b | 
Polypropylene (Parietene®; Sofradim, Trevoux, France; 
part of Covidien, North Haven, Connecticut, USA); 
c,d | collagen–polyethyleneglycol–glycerol-coated 
polypropylene (Parietene Composite®; Sofradim); 
e,f | carboxymethylcellulose–sodium hyaluronate-
coated polypropylene (Sepramesh®; Bard, New 
Providence, New Jersey, USA); g,h  | expanded poly-
tetrafluoroethylene (Dualmesh®; Gore, Flagstaff, 
Arizona, USA); i,j | condensed polytetrafluoroethylene 
(Omyramesh®; B. Braun, Melsungen, Germany); and 
k,l | non-cross-linked collagen mesh (Strattice®; LifeCell, 
Branchburg, New Jersey, USA). The purple and pink 
cells in the haematoxylin and eosin-stained sections 
are fibroblasts and lymphocytes. The synthetic fibres 
of the Parietene® a,b | Parietene Composite® c,d | 
Sepramesh® e,f | and Omyramesh® i,j | are surrounded 
with fibrotic tissue with newly formed collagen. 
Around Dualmesh® g,h | a cellular layer is observed, 
forming a capsule; cellular infiltration into the mesh 
is minimal. In the picrosirius red-stained section of 
the Strattice® mesh l | it is impossible to differentiate 
between the collagen of the mesh and newly formed 
collagen (C/F). M | abdominal wall muscle; F | mesh 
fibres, C | newly formed collagen layer
Dualmesh® showed a high infection rate, probably because of its partially microporous structure 
(smaller than 10 µm). The increased risk of infection after surgery with Dualmesh®, and the need 
to remove the prosthesis in case of infection, is notorious in the clinical situation [22-24]. Mesh 
infection is caused by infiltration and proliferation of bacteria within the pores and interstices of 
synthetic materials. Small pores prevent infiltration of immune cells and make microporous meshes 
more susceptible to infection [5,25]. Additionally, the hydrophobic visceral surface of Dualmesh® 
decreases adhesion of tissue cells, allowing bacteria a free passage to the implant surface [16].
  Intra-abdominal adhesion and abscess formation are important causes of morbidity and mortality 
following contaminated abdominal surgery. During peritonitis fibrin is deposited in the abdominal 
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cavity, inducing adhesion formation and providing possible niduses for abscess formation9. 
Biological Strattice® mesh showed low adhesion formation after 90 days, confirming previous 
experimental results [26-28]. Sepramesh® showed a significant increase in adhesion formation 
between 28 and 90 days, implying that the cellulose–hyaluronate coating is absorbed before a 
neoperitoneal layer is formed. These results confirm that adhesion formation in the presence of mesh 
is not complete after 7 days [8,11]. The surface of Parietene Composite® and Omyramesh® were least 
covered with adhesions after 90 days. Low adhesion formation on the collagen-coated Parietene 
Composite® has been described in a clean environment [8,11]. The present results suggest that 
the collagen coating remains present until a neoperitoneum has formed, even in a contaminated 
environment. The low adhesion formation on Omyramesh® confirms experimental findings with this 
relatively new mesh in a clean environment [29,30]. The low adhesion formation might be explained 
by its smooth, monolayer, non-fibrous, macroporous structure. The plain polypropylene Parietene® 
mesh was largely covered with adhesions. Clinically, uncoated polypropylene meshes are known 
to induce severe adhesion formation with attachment of intestine to the mesh when implanted 
intraperitoneally [7,31]. In 21 per cent of patients with an intraperitoneal uncoated polypropylene 
mesh, adhesions made bowel resection necessary during re-exploration in one study [7]. 
  The non-infected, partially microporous, expanded PTFE Dualmesh® had an alarmingly high 
shrinkage rate (median 63 per cent after 90 days). Such shrinkage has frequently been reported 
experimentally, but this does not seem to be correlated with a higher recurrence rate clinically 
[8,23,32]. A fibrous capsule surrounding the mesh was observed, almost without cellular infiltration 
into the mesh. Contraction of this capsule was probably the cause of shrinkage, which might have 
been more pronounced in the small meshes used in the present experiment compared with the 
much larger meshes used clinically. Of the macroporous meshes, the plain polypropylene Parietene® 
showed the most shrinkage (15 per cent after 90 days), confirming experimental results [32,33].
  The biological Strattice® mesh had a 23 per cent loss of surface after 90 days, probably caused 
by collagenase activity. Premature weakening of the biomechanical properties of the scaffold 
combined with insufficient incorporation can possibly result in loss of the prosthesis and hernia 
recurrence [34]. Until evidence of biomechanical strength after hernia repair with biological meshes 
has been provided, synthetic meshes are preferred for primary repair. 
  Translation of experimental results to the clinical situation should be done with caution. 
However, the CLP model is suitable for studying the behaviour of synthetic and biological meshes 
experimentally in a contaminated environment. In this model, as in clinical infections, peritonitis 
arises from a complex interaction of the immune system with inflammatory, haemodynamic and 
biochemical alterations similar to human sepsis, with a consistent increase in cytokine levels [35-
38]. Another advantage of this experimental model is the use of rats of the same age and sex, and 
specified pathogen-free bacterial status. This minimizes biological and microbiological variability, 
and makes it suitable for comparing characteristics of different meshes in a similar contaminated 
environment [38]. A limitation of the model is the size of the mesh and mesh pores in relation to the 
abdominal wall, which is different between rats and humans. This might lead to an overestimation 
of shrinkage. The meshes in this experiment were fixated with six sutures. In humans the number 
of fixation points in relation to the mesh size would be much higher. This might have influenced 
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incorporation, as described in previous experimental mesh studies [8,11]. Finally, the concentration 
of the antiadhesive coatings and its systemic effects during breakdown in this model might be 
different from the human situation. 
  The experimental results of synthetic mesh implantation in a contaminated environment 
make strict contraindication in humans questionable. Although there are no meshes without 
disadvantages, certain permanent synthetic meshes might be somewhat infection-resistant and 
therefore useful for permanent hernia repair in a contaminated environment.
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Mesh-specific inflammatory cell response 
in a contaminated environment
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ABSTRACT
Background
The use of meshes for abdominal hernia surgery in a contaminated environment is compromised due 
to a high risk of complications. Little is known about differences in the foreign body reaction between 
materials in contaminated environments. Therefore we compared the presence of macrophages 
and their attractors after implantation of different meshes in a contaminated environment in vivo.
Methods
28 and 90 days after implantation, biopsies of the abdominal wall with implanted meshes (ParieteneTM, 
Parietene CompositeTM, C-QurTM, SeprameshTM, Dualmesh® and Omyramesh®) were harvested from a 
peritonitis rat model. Biopsies were analysed with immunohistochemistry for macrophage markers 
CD68, iNOS, and CD206, and for T-cells with CD3. Toluidine-staining was used for mast cells. 
Results
More CD3- and CD68-positive cells were found in samples with meshes than in the control group 
without a mesh. After 90 days, Parietene CompositeTM and SeprameshTM were surrounded by more 
iNOS-positive cells than the control group. C-QurTM and Dualmesh® were surrounded by more 
CD206-positive cells than the control group at day 28. The M1/M2 ratio was low for all meshes. 
Conclusions
Mesh-specific cellular responses are evident in a contaminated environment and therefore these 
data can help the surgeon to select suitable meshes for implantation. 
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INTRODUCTION
Meshes are occasionally used in a clean-contaminated or even in a contaminated environment, like 
fascial defects after bowel resection, near stomas or after removal of an infected mesh. Generally 
spoken, in clinical application the risk of complications like infection of the mesh is higher in 
a contaminated field and therefore surgeons are hesitant to use meshes in these cases [1,2]. The 
extent of the inflammatory response of the body, also known as foreign body reaction, depends 
on the type and consistency of the mesh [3-5]. Using an in vitro model, we have recently described 
mesh-dependent reactions of macrophages in a contaminated environment [6].
 Many researchers investigate the foreign body reaction in a sterile environment. After implantation, 
all types of meshes used for abdominal wall hernia surgery induce a foreign body reaction. 
After implantation of the mesh, inflammatory cells, starting with neutrophils and mast cells are 
attracted to the wound site [3]. Mast cells attract macrophages to the wound site and the number 
and degranulation of mast cells is important for the extend of the foreign body reaction [3,4,7,8]. 
Besides mast cells, T-cells are also important attractors of macrophages [3 4,9]. After being recruited, 
macrophages will dominate the wound site [3,5]. Macrophage phenotypes can range between pro-
inflammatory (M1) and repair/anti-inflammatory (M2). M1-macrophages produce pro-inflammatory 
factors such as interleukin (IL)-6, tumor necrosis factor (TNF)α and express inducible nitric oxide 
synthase (iNOS) [10]. M2-macrophages produce anti-inflammatory factors such as IL-1 receptor 
antagonist (IL-1RA), chemokines such as CCL18, and growth factors such as vascular endothelial 
growth factor (VEGF). M2-macrophages express among others the surface protein CD206, which is 
the mannose receptor important for recognition of pathogens [10]. 
 How the foreign body reaction in a contaminated environment will depend on the type of material 
is not yet completely understood. In a contaminated environment, macrophages are expected to 
change mainly into the M1-phenotype because the infection and presence of bacteria needs to 
be eliminated [11]. M1-macrophages negatively influence incorporation of the mesh, by producing 
matrix degrading enzymes and inhibitors of extracellular matrix [5]. Van Putten et al. [12] found 
that the foreign body reaction against collagen discs is delayed in the presence of bacterial cell 
wall components. Whether the presence of bacterial components also delays the foreign body 
reaction against synthetic meshes is not known. Using an in vitro model, we have confirmed mesh-
dependent reactions of macrophages in a contaminated environment [6]. Previously we studied 
the in vivo behavior of seven commercially available meshes (1 biological and 6 synthetic meshes) 
in a contaminated environment in rats and found differences in mesh infection, adhesions and 
incorporation of the biomaterial [13]. In this experiment polypropylene was used, a mesh often 
used in patients and also polypropylene-based meshes with a hydrophilic collagen-coating, omega 
3-fatty acid-coating, and a hyaluronate-carboxymethylcellulose coating, which are described to 
have a lower complication rate in a clean environment [14]. Expanded (microporous) and condensed 
(macroporous) expanded polytetrafluoroethylene (PTFE) meshes were also included. Expanded 
PTFE has a high infection risk due to the small micropores whereas condensed PTFE is believed to 
have a good outcome in a contaminated environment due to its macroporous structure [15,16].
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In this study, the cellular immune responses to different synthetic meshes in a contaminated 
environment in vivo are compared in more detail. As macrophages are the key players in the foreign 
body reaction, the presence of T-cells and mast cells as macrophage attractors and the phenotypes 
of macrophages with immunohistochemistry are investigated. This knowledge can help the surgeon 
to choose the best materials to use in an environment with high risk of contamination.
 
MATERIALS AND METHODS
Contaminated model in vivo
The rat experiment protocol is according to the Animal Research: Reporting In Vivo (ARRIVE) 
guidelines and was approved by the Ethical Committee on Animal Experimentation of Erasmus 
University Rotterdam, the Netherlands (EMC 2075-105-10-03). We used samples of an earlier 
presented study in which in 144 (8 groups, 9 rats per group, two time points) male Wistar rats (Harlan 
Laboratories, Boxmeer, the Netherlands) weighing 250–350 grams a contaminated environment 
was created by caecum ligation and puncture [13]. Briefly, the caecum was ligated just distally to 
the ileocaecal valve maintaining the continuity of the bowel and punctured distally to the ligation 
with an 18-G needle leading to leakage of fecal fluids with bacteria into the abdominal cavity to 
induce peritonitis. After 24 hours the abdomen was re-opened and peritonitis was confirmed by 
microbiological culture, resulting in a contaminated wound. One of the following meshes (2.5 x 3 cm) 
was implanted intraperitoneally with 6 transmuscular nonabsorbable sutures (5/0 Ethilon, Johnson 
& Johnson: New Brunswick, New Jersey, United States): ParieteneTM (polypropylene (PP), Covidien- 
Sofradim Production, Trevoux, France), Parietene CompositeTM (PP with an one-sided absorbable, 
hydrophilic collagen-coating, Covidien- Sofradim Production, Trevoux, France), C-QurTM, (PP with 
omega 3-fatty acid-coating and triglycerides, Atrium, Hudson, New York, USA), SeprameshTM (PP, 
with a hyaluronate-carboxymethylcellulose coating, Bard, New Providence, New Jersey, USA), 
Dualmesh® (expanded polytetrafluoroethylene (PTFE), Gore, Flagstaff, Arizona, USA), Omyramesh® 
(condensed PTFE, B Braun, Melsungen, Germany) or StratticeTM (collagen derived from porcine skin, 
LifeCell, Branchburg, New Jersey, USA). A control group was included following completely the same 
protocol, only no mesh was implanted after re-opening the abdomen. After implantation, all rats 
received one dose of gentamicin (6 mg/kg) intramuscularly. Two to four rats per group died from 
sepsis [13]. 
Harvesting
At 28 days and 90 days after implantation of the materials, the animals were euthanized by cardiac 
cut and a swab was taken to culture bacteria; C-QurTM resulted in 95% (15 out of 16) of the samples 
positive for bacteria, Dualmesh® 50% (7 out of 15) and ParieteneTM and Parietene CompositeTM both 
5% (1 out of 15), in the other groups no infections were found [13]. One biopsy per animal was taken 
from the incorporated mesh with surrounding tissue. In the rats without a biomaterial a biopsy of 
the abdominal wall was taken at the same place where in the other rats the mesh was implanted. 
In some animals, incorporation of the material was insufficient and because there was no adjacent 
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tissue, no biopsy could be taken. For StratticeTM at both time points, SeprameshTM at day 28 and 
C-QurTM and Omyramesh® at day 90 only 1 or 2 samples could be taken because of insufficient 
incorporation and therefore these conditions were excluded for analysis. Biopsies were snap-frozen 
in Tissue-Tek© (Sakura, Alphen, Rijn, The Netherlands) with liquid nitrogen and stored at -80 °C till 
sectioning. Sections of 6 μm were cut on a cryostat (Leica; Davis Instruments, Vernon Hills, Illinois, 
USA) and stored at -80 °C. 
Staining
Immunohistochemistry
Frozen sections were defrosted and fixed in acetone. After fixation sections were washed in PBS and 
incubated with 10% normal goat serum (Sigma-Aldrich, St Louis, MO, USA) to block non-specific 
binding. After incubation sections were washed with phosphate buffered saline and incubated 
with primary antibodies against CD206 (2.5 µg/mL, Abcam, 64693, Cambridge, UK), iNOS (2 µg/mL, 
Abcam, 15323), CD3 (1:100, Abcam, 16669), CD68 (5 ug/ml, Acris Antibodies GmbH, BM 4000, 
Herford, Germany). We choose the antibiodies based on literature [4,10,22]. Irrelevant IgG was used 
as a negative control. Link biotinylated goat-anti-mouse (Biogenex, HK-325-UM, Fremont, CA, USA) 
was used at a second antibody, Label streptavidin-AP (Biogenex, HK-321-UK) as a tertiary antibody 
with neu-fuchsin as substrate. Sections were counterstained with hematoxylin (Sigma). Lung and 
spleen tissue were used as a positive controls. Sections were mounted with vectamount (Vector 
Laboratories, Burlingame, CA). 
Toluidine blue (mast cells) 
Sections were defrosted and fixated in acetone. After washing in demineralised water the sections 
were placed in a toluidine blue solution (1% Toluidin blue (Fluka (Sigma), 89640) in 50% isopropanol 
and 50% demineralised water) for 30 minutes at 37 °C. Sections were washed for 1 minute in pure 
isopropanol. Sections were air-dried and mounted with vectamount (Vector Laboratories). 
Analyses
Stained sections were analysed by light microscopy (Olympus, Tokyo, Japan). Per staining, sections 
were blinded and the number of cells in 5 areas at the interface of the mesh and tissue was ranked. 
In the case of the control group, cells were counted subcutaneously, at the place where in the other 
groups the mesh was implanted. Samples were ranked based on the number of positive cells, ranks 
were ranging from 1 to 58 (due to a total of 58 analysed samples). Control group day 28: 8 samples, 
day 90: 7 samples. ParieteneTM 8 and 5 samples respectively, Parietene CompositeTM 5 and 4 samples, 
C-qurTM day 28: 5 samples, SeprameshTM day 90: 4 samples, Dualmesh© day 28: 3 samples, day 90: 4 
samples, Omyramesh© day 28: 5 samples. Ranking was performed by two independent observers 
(NG and NK). The ranking of one observer was compared with the ranking of the other observer. 
If there was a difference in ranking per sample of more than 15, the samples were analysed again. 
After that, the mean ranking per sample was calculated from the ranking of one observer and the 
other observer. Then the samples were unblinded and were used for further analysis. The number 
of iNOS-positive cells was divided by the number of CD206-positive cells leading to an M1/M2 ratio. 
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The natural logarithm of this ratio was calculated for visualization. Data is presented as box plots 
with medians and whiskers showing the interquartile range.
Statistics
The medians of the groups were compared with a Kruskal-Wallis test (independent samples median 
test) and Mann-Whitney in SPSS (IBM Corp. Released 2011. IBM SPSS Statistics for Windows, Version 
20.0. Armonk, NY: IBM Corp.) False Discovery Rate was used for mathematical correction by multiple 
comparisons. P < 0.05 was considered statistically significant.
 
RESULTS
The number of mast cells and T-cells were analysed in the tissue adjacent to the meshes, since 
these two cells are the main attractors of macrophages. We found no significant differences in the 
numbers of mast cells between the biomaterials or compared to the control group (Figure 1A). 
All meshes had more CD3-positive T-cells at day 28 than the control group (P = or < 0.03). There 
were also mesh-dependent differences: ParieteneTM was surrounded by less CD3-positive cells than 
Dualmesh® (P = 0.03) and Parietene CompositeTM was surrounded by less CD3-positive cells than 
Omyramesh® (P = 0.03). After 90 days still all samples with meshes contained more CD3-positive 
cells than the control group (P = 0.03) (Figure 1B).
 To investigate the total number of attracted macrophages, samples were stained for CD68 as a 
general macrophage marker. After 28 days more macrophages were found adjacent in the groups 
with a mesh than in the control group (P = or < 0.015). The same finding was still observed after 
90 days, but this was only statistically significant for SeprameshTM (P = 0.02) and Dualmesh© (P = 0.02) 
(Figure 2). 
 To investigate how the different meshes influence the macrophage phenotype, we stained the 
samples with antibodies against iNOS for M1-macrophages and with antibodies against CD206 for 
M2-macrophages. At day 28 we did not find significant differences between the conditions, however 
after 90 days, Parietene CompositeTM and SeprameshTM were surrounded by significantly more iNOS-
positive cells than the control group (P = 0.03). There were no statistically significant differences 
between the meshes (Figure 3a). After 28 days we found more CD206-positive cells surrounding 
C-QurTM and Dualmesh® than in the control group (P = 0.045). After 90 days, no significant differences 
were observed (Figure 3b). To determine for each mesh whether it induces a more pro- or anti-
inflammatory reaction the M1/M2 ratio was calculated based on iNOS positive and CD206-positive 
cells (Figure 3c). All meshes except Parietene CompositeTM after 90 days, had a negative mean ratio, 
indicative for a predominant M2, or anti-inflammatory, reaction. However no statistically significant 
differences in M1/M2 ratios were observed between the meshes.
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Figure 1 A | Analysis of the presence of mast cells at day 28 and day 90 after implantation of a mesh. Graphs 
show the mean rank per type of mesh, numbers behind the groups indicate sample size. An example of the 
toluidine staining is shown in which positive cells are indicated by arrows. M indicates mesh. B | Analysis of 
the presence of T-cells with antibodies against CD3 after 28 and 90 days. An example of the CD3 staining is 
shown in which positive cells are indicated by arrows. M indicates mesh. Graphs show the mean rank per type 
of mesh, P-values are indicated in the graphs, numbers behind the groups indicate sample size
Figure 2 | Analysis and ranking for the presence of CD68-positive macrophages 28 and 90 days after 
implantation of a mesh. An example of CD68-positive cells is shown in which positive cells are indicated by 
arrows. M indicates mesh. Graphs show the mean rank per type of mesh, P-values are indicated in the graphs, 
numbers behind the groups indicate sample size
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Figure 3 A | Analysis and ranking for the presence of iNOS-positive M1 macrophages 28 and 90 days after 
implantation of a mesh. An example of iNOS-positive cells is shown in which positive cells are indicated by 
arrows. M indicates mesh. Graphs show the mean rank per type of mesh, P-values are indicated in the graphs, 
numbers behind the groups indicate sample size. B | Analysis and ranking for the presence of CD206-positive 
macrophages 28 and 90 days after implantation of a mesh. An example of CD206-positive cells is shown in 
which positive cells are indicated by arrows. M indicates mesh. Graphs show the mean rank per type of mesh, 
P-values are indicated in the graphs, numbers behind the groups indicate sample size. C | The M1/M2 ratio 
based on the number of iNOS- positive cells divided by the CD206- positive cells, the natural logarithm of 
this ratio was calculated for visualisation. P-values are indicated in the graph, numbers behind the groups 
indicate sample size
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DISCUSSION
Surgeons often hesitate to use biomaterials in a contaminated environment, like fascial defects 
after bowel resection, near stomas or after removal of an infected mesh. Nowadays, most used 
biomaterials in this environment are biologic materials, which are very expensive compared to 
synthetic biomaterials. However, a critical review describes that there is not enough evidence to 
state that biologic biomaterials perform better than synthetic biomaterials [1]. Therefore a close look 
to synthetic biomaterials in a contaminated environment is needed. 
 Little is known about the mesh-specific phenotypes and presence of macrophages after 
implantation of a mesh in a contaminated environment. In this study, different meshes were 
implanted in a rat model in a contaminated environment. The attractors of macrophages, namely 
T-cells and mast cells, and the different phenotypes of macrophages were analysed. In these 
experiments mesh-specific cellular responses were seen. All meshes induced the influx of T-cells 
and macrophages, still present after 90 days compared with the control group without a mesh. 
High levels of T-cells and macrophages indicate a chronic inflammatory reaction when meshes were 
implanted in a contaminated environment [3,4]. 
 Both PTFE-meshes were surrounded by the most T-cells whereas the polypropylene biomaterials 
ParieteneTM and Parietene CompositeTM had the lowest number of T-cells. The latter is indicative for 
resolution of the inflammatory reaction, possibly leading to a fibrotic reaction for ParieteneTM which 
is often seen in vivo. This macroscopically represents in a firm incorporation and shrinking of this 
mesh suggesting fibrosis [3,13,17,18]. Parietene CompositeTM performed well macroscopically with 
a low amount of adhesions and a low percentage of infection in a contaminated environment [13], 
most likely due to the collagen layer which is known to reduce adhesions [14]. 
 We found high numbers of CD206-positive and iNOS-positive macrophages around C-QurTM-
and Dualmesh®-samples after 28 days, indicative for a chronic inflammation reaction. Indeed 
macroscopically these meshes had the highest infection rate and a bad incorporation in the 
abdominal wall [13]. This might be explained by the presence of endotoxins released by bacteria 
during the infection, which are known to delay the foreign body reaction [12]. Dualmesh® is a 
partially microporous mesh with a higher risk of infection than PP and polyethylene [15,19]. This 
can be explained by the small pore size allowing bacteria to infiltrate when macrophages cannot 
[20]. Also small pores induce a M1 pro-inflammatory reaction, known to induce tissue turnover 
and thereby negatively influencing incorporation of meshes in the abdominal wall [5,21]. This was 
macroscopically confirmed [13]. Higher numbers of M2 macrophages are associated with a better 
outcome in wound healing than with a predominant M1-reaction [22,23]. We found high levels 
of CD206(M2)- positive cells around Parietene CompositeTM and SeprameshTM which are meshes 
known for a good biocompatibility in vivo with low adhesion formation [14]. C-QurTM is coated 
with triglycerides and Omega 3-fatty acids. Cardiovascular research showed that triglycerides can 
enhance an inflammatory response in endothelial cells. Whether this is also the case in the foreign 
body reaction is not investigated, however this can be a possible explanation for the found chronic 
inflammation reaction [24]. 
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We expected more distinguished differences between the meshes regarding the M1/M2 ratio, 
however macrophages are a heterogeneous population of cells, M1 and M2 being two extremes in the 
spectrum [25,26]. Subtle differences in this ratio might have been missed. Due to poor incorporation 
of some of the meshes we did not have equal group sizes leading to a lower probability of finding 
significant differences. SeprameshTM at day 28, C-QurTM and Omyramesh® at day 90, and StratticeTM 
at both timepoints had a very low sample size due to no ingrowth in the surrounding tissues which 
made it impossible to draw conclusions. Therefore these meshes for these time points were not 
included in our analysis. No differences were found for mast cells. This is likely due to the time point 
of analysis for we did our first analysis 28 days after implantation. The amount and presence of mast 
cells is indicative for an acute inflammatory reaction [7,27] and therefore differences could not be 
detected in these experiments. Future studies with increased sample numbers and time points 
are needed to obtain more insight in the precise foreign body reaction and thereby the different 
performances of meshes in a contaminated environment. 
 For surgery in an environment at risk of contamination, the choice of a specific mesh is important. 
More insight in mesh-dependent cellular immune responses can help surgeons choose between the 
various commercially available meshes for implantation in a contaminated environment.
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In vitro model to study the biomaterial-
dependent reaction of macrophages in 
an inflammatory environment
Grotenhuis N, Vd Toom HF, Kops N, Bayon Y, Deerenberg EB, Mulder IM, 
van Osch GJ, Lange JF, Bastiaansen-Jenniskens YM. In vitro model to study 
the biomaterial-dependent reaction of macrophages in an inflammatory 
environment. Br J Surg. 2014 Jul;101(8):983-92. doi: 10.1002/bjs.9523. 
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ABSTRACT
Background
Macrophages play an important role in the reaction to biomaterials, which sometimes have to 
be used in a surgical field at risk of contamination. The macrophage phenotype in reaction to 
biomaterials in an inflammatory environment was evaluated in both an in vivo and in vitro setting.
Methods
In the in vivo setting, polypropylene (PP) biomaterial was implanted for 28 days in the 
contaminated abdominal wall of rats, and upon removal analysed by routine histology as well as 
immunohistochemistry for CD68 (marker for macrophages), inducible nitric oxide synthase (iNOS 
– a marker for pro-inflammatory M1 macrophages) and CD206 (marker for anti-inflammatory M2 
macrophages). For the in vitro model, human peripheral blood monocytes were cultured for 3 days 
on biomaterials made from PP, collagen (COL), polyethylene terephthalate (PET) and PET coated with 
collagen (PET+COL). These experiments were performed both with and without lipopolysaccharide 
and interferon γ stimulation. Secretion of both M1- and M2-related proteins was measured, and a 
relative M1/M2 index was calculated.
Results
In vivo, iNOS- and CD206-positive cells were found around the fibres of the implanted PP 
biomaterial. In vitro, macrophages on both PP and COL biomaterial had a relatively low M1/M2 
index. Macrophages on the PET biomaterial had a high M1/M2 index, with the highest increase of 
M1 cytokines in an inflammatory environment. Macrophages on the PET+COL biomaterial also had 
a high M1/M2 index.
Conclusion
Macrophages in an inflammatory environment in vitro still react in a biomaterial-dependent manner. 
This model can help to select biomaterials that are tolerated best in a surgical environment at risk 
of contamination.
Surgical relevance
Biomaterials in an environment at risk of contamination are often not tolerated owing to a high 
risk of postoperative infection, which may ultimately lead to removal of the biomaterial. An in vitro 
model with primary human macrophages was used to provide insight into the acute reaction of 
macrophages to a biomaterial in an inflammatory environment simulated with lipopolysaccharide 
and interferon γ. The reaction of macrophages in such an inflammatory environment was still 
biomaterial-dependent. This in vitro model can be used to study the reaction of macrophages to 
different biomaterials in an inflammatory environment in more detail, and thereby help to select 
biomaterials that are tolerated best in a surgical environment at risk of contamination.
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INTRODUCTION
Biomaterials are used widely in reparative and regenerative medicine. However, in an environment 
at risk of contamination, surgeons are reluctant to use biomaterials owing to a higher risk of 
complications. A feared postoperative complication of biomaterial implantation is infection of the 
biomaterial and surrounding tissue by bacteria, reported in up to 16 per cent of patients [1]. The risk 
of infection is even higher in some circumstances, such as in surgery of the gastrointestinal tract or 
nasal cavity, as well as in the presence of peritonitis. The risk of infection also depends on the type 
of biomaterial, such as its configuration, hydrophobicity and whether it is made from monofilament 
or multifilament [1-3]. All biomaterials elicit a foreign body reaction, and the degree of this reaction 
varies depending on the nature of the biomaterials. At present, the foreign body reaction in an 
environment with a high risk of contamination is not well characterized.
 Macrophages play a pivotal role in the foreign body reaction [1,4,5]. The phenotype of the 
macrophages can change in response to environmental factors, giving rise to different populations 
of macrophages with distinct functions, which can force the foreign body reaction into tolerance 
of the biomaterial or into a state of inflammation. Classically activated macrophages, or M1 
macrophages, have been characterized and described most thoroughly. They propagate pro-
inflammatory responses by producing cytokines such as interleukin (IL) 1β, tumour necrosis factor 
(TNF) α and IL-6 [6-8]. Another macrophage phenotype is represented by the alternatively activated 
macrophages, referred to as M2 macrophages. These cells can arise when exposed to IL-4 or immune 
complexes. They express scavenger receptors and IL-1 receptor antagonist (IL-1RA). M2 macrophages 
also produce IL-10 and chemokines, such as CCL18 and macrophage-derived chemokine (MDC, or 
CCL22) [6-8], and are able to produce growth factors, thus promoting angiogenesis and tissue repair 
[6]. During wound healing, M1 macrophages are normally present from day 1, and accumulate 
and dominate the wound site after 2–3 days. After cleaning the wound site by phagocytosis, 
macrophages change towards an M2 phenotype. Persistent inflammation can cause an imbalance 
of M1 to M2 macrophages and lead to fibrosis. Synthetic biomaterials can induce the formation of 
fibrous wound healing tissue within 2–4 weeks. Macrophages cannot phagocytose this synthetic 
biomaterial, leading to the formation of giant cells situated at the biomaterial surface [9].
 In a contaminated environment macrophages adapt to an M1 phenotype [10], needed for control 
of the acute infection by phagocytosis. However, prolonged M1 phenotype of macrophages can lead 
to tissue damage, and may compromise the integration of the material in the body by the release 
of inflammatory cytokines [9]. Therefore, the foreign body reaction is altered in a contaminated 
environment.
 New biomaterials should be developed for use in an environment where the risk of contamination 
of the biomaterial is high. Biological materials, such as collagen-based biomaterials processed 
from human or porcine dermis, are thought to be tolerated in an environment at high risk of 
contamination and have a low postoperative complication rate [11,12]. Biomaterials with low actual 
surface area, such as monofilament biomaterials, were well tolerated in a contaminated field in an 
experimental study [2], and in several clinical studies have been associated with fewer postoperative 
infections [13,14]. However, there is no consensus yet, and only a few comparative studies [13, 
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14] are available. In a recent study [15] employing an experimental rat model, the foreign body 
reaction in rats was biomaterial-dependent in a contaminated environment. Some biomaterials 
had poor incorporation into the abdominal wall with a high infection rate, whereas others, such as 
monofilament polypropylene (PP) biomaterials, had good incorporation into the abdominal wall 
and a low inflammatory reaction [15].
 The aim of this study was to investigate the reaction of macrophages to biomaterials in an 
environment at risk of contamination. First, the phenotype of macrophages surrounding a 
monofilament polypropylene biomaterial was analysed in vivo, as this material has been shown 
previously to induce the mildest foreign body reaction [15]. Second, the macrophage phenotype and 
reaction were characterized in more detail in an in vitro model. In this model bacterial contamination 
was simulated, thereby permitting comparison of the macrophage reaction in a contaminated and a 
clean environment. Contamination was simulated using a combination of lipopolysaccharide (LPS) 
and interferon (IFN) γ, and the macrophage reaction was studied by measuring a panel of proteins 
indicative of the macrophage phenotype.
METHODS
Rat peritonitis model and tissue collection
The protocol of the rat experiment was approved by the Ethical Committee on Animal Experimentation 
of Erasmus University Rotterdam, The Netherlands, and is in accordance with the Animal Research: 
Reporting In Vivo Experiments (ARRIVE) guidelines. A contaminated environment was created 
by the caecal ligature puncture model, in which the caecum is punctured to provide leakage of 
faecal fluid into the abdominal cavity, thus causing peritonitis. After 24 h the abdominal cavity was 
reopened, peritonitis was confirmed by microbiological culture, and a monofilament PP biomaterial 
(Parietene™; Covidien – Sofradim Production, Trévoux, France) was placed intraperitoneally in 
four rats [15]. 28 days after implantation, a sample of the abdominal wall with the incorporated 
biomaterial was harvested using biopsy punches (5 mm diameter). As controls, abdominal walls 
from rats with peritonitis, but with no biomaterial, were collected. All tissue samples were fixed in 
4 per cent formalin and embedded in paraffin.
Histology and immunohistochemistry
Tissue sections were cut and stained with haematoxylin and eosin in accordance with standard 
procedures. To identify macrophage types, immunohistochemical staining was carried out with the 
following antibodies: CD68, a general macrophage marker; CD206, a marker for M2 macrophages 
[8], and inducible nitric oxide synthase (iNOS) as a marker for M1 macrophages [9]. Briefly, paraffin 
sections were dewaxed and, to block the sections for aspecific binding, the sections were pretreated 
with heat-mediated antigen retrieval solution (Target Retrieval Solution; Dako, Glostrup, Denmark) 
at 90 °C for 20 min. Sections were incubated with CD68 (1 : 100; Acris, Herford, Germany), CD206 
(1 : 100) or iNOS (1 : 50) (both Abcam, Cambridge, UK) antibodies for 60 min, and subsequently 
incubated with link and label (Concentrated MultiLink® and Concentrated HRP Label (peroxidase-
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conjugated streptavidin); BioGenex, Fremont, California, USA); 3,3’-diaminobenzidine was used as 
substrate. Sections were dried overnight and mounted with VectaMount™ (Vector Laboratories, 
Burlingame, California, USA). Matching irrelevant isotype antibodies were used as negative controls, 
and tissues known to contain the specific markers were employed as positive controls. Sections 
were also Gram-stained to visualize potential bacteria. All slides were analysed with an Olympus 
BX50 light microscope (Olympus, Tokyo, Japan).
Monocyte isolation
Ficoll density gradient (Ficoll-Paque™ PLUS; GE Healthcare, St Giles, UK) was used to isolate 
monocytes from the buffy coat of four healthy donors (men and women aged 25–65 years). All buffy 
coats were obtained from the blood bank (Sanquin, Rotterdam, The Netherlands). Some 30 ml of 
buffy coat diluted 1 : 5 with 0.1 per cent bovine serum albumin (BSA) in phosphate-buffered saline 
(PBS) was layered on 15 ml Ficoll. After 15 min centrifugation at 1000g with no brake, the interphase 
band containing peripheral blood mononuclear cells was aspirated and washed in PBS/BSA 
0·5 per cent 2 mmol/l EDTA and labelled with 100 µl anti-CD14+ magnetic beads (CD14 microbeads 
human, MACS Separation columns LS and MidiMACS™ Separator; all from Miltenyi Biotec, Bergisch 
Gladbach, Germany), and isolated according to the manufacturer’s guidelines. This positive selection 
of monocytes will not activate the cells [16]. Purity of the isolation was assessed by fluorescence-
activated cell sorting (FACS) analysis, in which 1 × 106 monocytes were incubated for 15 min at 
room temperature with the following antibodies: FITC-conjugated CD14 and peridinin chlorophyll 
protein complex (PerCP)-conjugated CD45 (all BD Biosciences, Franklin Lakes, New Jersey, USA). 
After incubation, cells were washed in PBS/BSA 0.1 per cent and FACS analysis was performed with 
CellQuest™ Pro on a FACSCalibur™ (both BD Biosciences); the purity of the freshly isolated CD14+ 
monocytes was above 95 per cent (data not shown). In the case of donors 1, 2 and 4, the yield of 
monocytes was not sufficient to allow testing of all four biomaterials in the experiments.
Culturing macrophages on biomaterials
Four different biomaterials were chosen to study macrophage response in relation to the biomaterial 
(all from Covidien – Sofradim Production): a multifilament PP biomaterial (Parietene™), hydrophobic 
with a contact angle of 95°; a collagen-based material (COL) (Permacol™), processed from porcine 
skin and cross-linked with hexamethylene di-isocyanate; a multifilament polyethylene terephthalate 
(PET) biomaterial, hydrophilic with a contact angle of 80.9°; and a multifilament PET biomaterial with 
an absorbable, continuous and hydrophilic collagen film on one of its sides (PET + COL) (Parietex™ 
Composite). The PET and PP biomaterials have a similar weave (Figure S1, supporting information).
 The materials were cut into 1.5 × 1.5-cm pieces with a sterile scalpel. Before cell seeding, materials 
were incubated in 100 per cent non-heat-inactivated fetal calf serum (FCS) (Lonza, Verviers, Belgium) 
for 2 h to provide protein attachment. Freshly isolated monocytes were adjusted to a concentration 
of 0.7 × 10 6 cells/ml in a total volume of 25 ml in a 50-ml PP tube (Falcon™; Becton, Dickinson, Franklin 
Lakes, New Jersey, USA). Twelve samples were incubated per 25 ml for 2 h at 37°C. Subsequently, 
samples were placed in a 24-well non-adherent plate (NUNC™, non-treated multiplate; Thermo 
Scientific, Rochester, New York, USA) and cultured for 3 days in serum-free X-VIVO™ 15 medium with 
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20 per cent FCS (Lonza). To simulate an inflammatory environment caused by bacterial infection, 
macrophages on biomaterials were cultured with 10 ng/ml LPS (Sigma-Aldrich, St Louis, Missouri, 
USA) and 1 ng/ml recombinant human IFN-γ (PeproTech, Rocky Hill, New Jersey, USA), and compared 
with macrophages on the same materials without simulation. The medium was refreshed after 48 h 
of culturing, and after a further 24 h in culture the supernatant was harvested for protein analysis.
Supplementary Figure 1 | Detailed picture of wave pattern of PET and PP. 
Left: polypropylene multifilament. Right polyethylene multifilament.
Analysis of the production of inflammatory and anti-inflammatory cytokines
Proteins were measured in 25 µl cell culture supernatant using a multiplex system (Millipore, Billerica, 
Massachusetts, USA) [17]. IL-1β, IL-6, TNF-α, monocyte chemotactic protein (MCP) 3 and macrophage 
inflammatory protein (MIP) 1α, IL-1RA, RANTES (regulated on activation, normal T cell expressed and 
secreted, or CCL5), and MDC (CCL22) were measured according to manufacturer recommendations. 
The CCL18 DuoSet® enzyme-linked immunosorbent assay (R&D Systems, Minneapolis, Minnesota, 
USA) was used to analyse CCL18 in 100 µl cell culture supernatant according to the manufacturer’s 
instructions. These nine proteins were selected based on previous experiments, where the read-out 
parameters were chosen after stimulation of macrophages towards either the M1 or M2 phenotype 
[17].
 To correct for the numbers of macrophages on the different biomaterials, the cells were lysed in 
0.1 per cent Triton in PBS (Sigma-Aldrich) and samples were frozen at -80 °C before being analysed 
with a CyQUANT® cell proliferation assay kit (Invitrogen, Carlsbad, California, USA). DNA content was 
measured according to the manufacturer’s recommendation.
Statistical analysis
The in vitro experiments were performed in triplicate with four different monocyte donors. All data 
are presented as scatterdot plots, with each dot representing an individual sample. The mean of 
the four donors is indicated by a line in the graphs. When evaluating the effect of an inflammatory 
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environment, the data are presented as the ratio of the LPS/IFN-γ-stimulated condition versus 
the non-stimulated condition for each biomaterial. To calculate the ratio between LPS/IFN-γ-
stimulated samples and non-stimulated samples, the stimulated samples were divided by the mean 
of the non-stimulated samples per donor. To compare the effect of the four biomaterials on the 
macrophage phenotype in an inflammatory environment, a relative M1/M2 index for each material 
was determined by calculating for each cytokine the percentage of production relative to the mean 
production on the four materials. This was followed by taking the mean of the percentages of the M1 
cytokines (MIP-1α, TNF-α, MCP-3, IL-1β, IL-6) divided by the mean percentages of the M2 cytokines 
(MDC, RANTES, IL-1RA and CCL18) per sample. Groups were compared in SPSS® for Windows® version 
20.0 (IBM, Armonk, New York, USA) using the Kruskal–Wallis test (independent samples median test) 
and Mann–Whitney U test, because the data were not normally distributed. Correlation between 
proteins was analysed by Spearman correlation. The Bonferroni correction was used. Differences 
were considered statistically significant when P < 0.050.
RESULTS
Macrophage phenotype in vivo
The PP biomaterial was well integrated in the surrounding tissues 28 days after implantation into 
the contaminated abdominal wall of rats. On histological examination, all samples displayed dense 
tissue surrounding the fibres of the biomaterial, with many multinucleated CD206-positive giant 
cells. iNOS- and CD206-positive cells were also observed in this dense layer. In addition, many 
blood vessels were observed in the connective tissue surrounding the biomaterial (Figure 1). To 
investigate the influence of a biomaterial, samples of abdominal wall tissue from control rats with 
contamination but without implanted biomaterial were also stained with haematoxylin and eosin, 
and for CD68, CD206 and iNOS, at 28 days. These samples had no infiltration of lymphocytes and 
only a few macrophages, some of which were iNOS- or CD206-positive (Figure 1).
Biomaterial-dependent effect on macrophage phenotype in an in vitro model
LPS and IFN-γ were chosen to simulate bacterial infection in the in vitro model. LPS is a bacterial wall 
fragment and IFN-γ is known to activate the immune system and macrophages following bacterial 
infection [18]. To investigate how macrophages react on biomaterials in this simulated inflammatory 
environment in vitro, production of IL-1β, IL-6, TNF-α, MCP-3, MIP-1α, IL-1RA, RANTES, MDC and CCL18 
was measured. The production of these proteins in an inflammatory environment was compared 
with that in a non-stimulated environment. Although the inflammatory environment increased 
the production of most pro-inflammatory proteins by macrophages, there were still differences in 
relation to the tested biomaterials. Macrophages on PET biomaterial induced the biggest increase in 
pro-inflammatory proteins (Figure 2). 
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Figure 1 a,d | Haematoxylin and eosin (CD68 shown in inset), b,e inducible nitric oxide synthase (iNOS) 
and c,f | CD206 staining 28 days after implantation of polypropylene (PP) in a contaminated environment 
in the rat. CD68-, iNOS- and CD206-positive macrophages can be seen surrounding the PP fibres. a–c | PP 
biomaterial from a contaminated abdominal wall. d–f | Abdominal wall without biomaterial from the same 
model. Representative sections and samples are shown. Brown colour represents positive staining; arrows 
indicate positive cells. GC, giant cell; V, vessels. (Original magnification ×200)
The stimulated versus non-stimulated ratio for anti-inflammatory proteins was approximately 1, 
indicating no increase in the production of these proteins in an inflammatory environment, except 
for RANTES, which was produced in greater amounts by macrophages on PET biomaterial in an 
inflammatory environment (Figure 3).
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Figure 2 | Production of pro-inflammatory cytokines by macrophages seeded on different biomaterials in an 
inflammatory (as induced by lipopolysaccharide/interferon γ) compared with a non-stimulated environment 
after 3 days of culture. a | Tumour necrosis factor (TNF) α, b | interleukin (IL) 1β, c | monocyte chemotactic 
protein (MCP) 3; d | IL-6, e | macrophage inflammatory protein (MIP) 1α. The dotted line indicates the basal 
level of expression, where there is no difference between stimulated and non-stimulated environments, 
and the bars denote the mean value. Monocytes from a total of four donors were divided over the different 
biomaterials in triplicate samples. Cells from all donors could not be tested on every biomaterial owing to 
a low yield of monocytes. Protein production was corrected for DNA before comparison of stimulated and 
non-stimulated environments. 
PET+COL = polyethylene terephthalate with a collagen coating; COL = collagen; PET = polyethylene terephthalate; PP = polypropylene. 
*P < 0·001, †P < 0·050 (Kruskal–Wallis and Mann–Whitney U tests), indicating a significant increase in pro-inflammatory cytokines 
compared with baseline values
To compare the reaction of macrophages on the four different biomaterials in an inflammatory 
environment, the total amount of protein corrected for DNA is shown (Figure 4 and Figure S2, 
supporting information). The greatest induction of pro-inflammatory cytokines TNF-α, IL-1β, 
MCP-3 and MIP-1α was induced by macrophages on PET + COL biomaterial in the inflammatory 
environment. The lowest induction of pro-inflammatory and anti-inflammatory cytokine production 
was seen on the COL biomaterial (Figure 4). 
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Figure 3 | Production of anti-inflammatory cytokines by macrophages seeded on different biomaterials in an 
inflammatory environment (as induced by lipopolysaccharide/interferon γ) compared with a non-stimulated 
environment after 3 days of culture. a | CCL18, b | interleukin 1 receptor antagonist (IL-1RA), c | RANTES 
(regulated on activation, normal T cell expressed and secreted), d | macrophage-derived chemokine (MDC). 
The dotted line indicates the basal level of expression, where there is no difference between stimulated and 
non-stimulated environments, and the bars denote the mean value. Monocytes from a total of four donors 
were divided over the different biomaterials in triplicate samples. Cells from all donors could not be tested 
on every biomaterial owing to a low yield of monocytes. Protein production was corrected for DNA before 
comparison of stimulated and non-stimulated environments. 
PET+COL = polyethylene terephthalate with a collagen coating; COL = collagen; PET = polyethylene terephthalate; PP = 
polypropylene. *P <  0·050 (Kruskal–Wallis and Mann–Whitney U tests), indicating a significant increase in anti-inflammatory 
cytokines compared with baseline values.
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Figure 4 | Comparison of secretion of pro-inflammatory cytokines by macrophages seeded on different 
biomaterials on the third day of culture with lipopolysaccharide/interferon γ, corrected for DNA. a | 
Tumour necrosis factor (TNF) α, b | interleukin (IL) 1β, c | monocyte chemotactic protein (MCP) 3; d | IL-6, 
e | macrophage inflammatory protein (MIP) 1α. Monocytes from a total of four donors were divided over the 
different biomaterials in triplicate samples. Cells from all donors could not be tested on every biomaterial 
owing to a low yield of monocytes. 
PET+COL = polyethylene terephthalate with a collagen coating; COL = collagen; PET, polyethylene terephthalate; PP = polypropylene. 
a *P < 0·001 (PET+COL versus COL), †P < 0·050 (PET+COL versus PET), ‡P < 0.050 (COL versus PP); b †P < 0·050 (PET+COL versus COL 
and PET), ‡P < 0·050 (COL versus PET and PP); c *P < 0·001 (COL versus PET+COL and PET), †P < 0·050 (COL versus PP); d †P < 0·050 
(COL versus PET and PP); e *P < 0·001 (COL versus PET+COL and PP) (Kruskal–Wallis and Mann–Whitney U tests)
Supplementary Figure 2 | DNA of macrophages cultured on biomaterials. DNA (ng) of macrophages seeded 
on different biomaterials at day 3 of culture with LPS/IFNγ. n = 4 monocyte donors with samples in triplicate. 
Due to the yield of the monocytes not all biomaterials could be seeded except for donor 3. 
PET+COL = polyethylene terephthalate with a collagen coating; COL = collagen; PET = polyethylene terephthalate; PP = polypropylene
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Macrophages on PP biomaterial produced significantly more CCL18 and MDC than macrophages on 
other biomaterials, with the exception of MDC on PET + COL biomaterial. Macrophages on PET + COL 
biomaterial induced a significantly higher RANTES production compared with macrophages on 
COL (Figure 5). Macrophages on PP and COL biomaterial had the lowest M1/M2 index, whereas 
macrophages on PET and PET + COL biomaterials had the highest M1/M2 index in the inflammatory 
environment (Figure 5).
Figure 5 | Comparison of secretion of anti-inflammatory cytokines by macrophages seeded on different 
biomaterials at the third day of culture with lipopolysaccharide/interferon γ, corrected for DNA. a | CCL18, 
b | interleukin 1 receptor antagonist (IL-1RA), c | RANTES (regulated on activation, normal T cell expressed and 
secreted), d | macrophage-derived chemokine (MDC); e | M1/M2 macrophage index. Monocytes from a total 
of four donors were divided over the different biomaterials in triplicate samples. Cells from all donors could 
not be tested on every biomaterial owing to a low yield of monocytes. The M1/M2 index for each sample 
was calculated as the percentage of the mean for each cytokine. The mean of M1 cytokines (macrophage 
inflammatory protein 1α, tumour necrosis factor α, monocyte chemotactic protein 3, interleukin (IL) 1β, IL-6) 
was divided by the mean of M2 cytokines (MDC, RANTES, IL-1RA and CCL18). 
PET+COL = polyethylene terephthalate with a collagen coating; COL = collagen; PET, polyethylene terephthalate; PP = polypropylene. 
a | †P < 0·050 (PP versus all other biomaterials); c | †P < 0·050 (PET+COL versus COL); d | *P < 0·001 (PP versus PET), †P < 0·050 (PP versus 
COL); e | *P < 0·001 (PP versus PET+COL and PET), †P < 0·050 (COL versus PET+COL and PET) (Kruskal–Wallis and Mann–Whitney U 
tests)
Taking all the samples together, after correction for multiple testing, significant correlations with 
P < 0.050 were found between MCP-3 and MDC (rs = 0.80), IL-6 and IL-1β (rs = 0.59), MIP-1α and MCP-3 
(rs = 0.64), MIP-1α and IL-1β (rs = 0.60), TNF-α and IL-1β (rs = 0.59), and MIP-1α and RANTES (rs = 0.72).
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DISCUSSION
As tolerance to biomaterials in surgical areas at risk of postoperative contamination is not understood 
completely, surgeons are reluctant to use biomaterials in these circumstances. Biomaterials should 
be explored for safer use in surgical environments prone to the development of postoperative 
infection. Macrophages are key players in the foreign body reaction, thus influencing the fate of 
biomaterials. In the present study the effect of biomaterials on macrophage phenotypes in an 
experimental model of postoperative contamination in rats, and in an in vitro model of inflammation, 
were studied.
 Implantation of the monofilament PP biomaterial in a contaminated environment in the rat 
in vivo [15] revealed that PP fibres became surrounded by a small layer of dense tissue with many 
macrophages and other leucocytes. Compared with a contaminated abdominal wall without PP, 
which by day 28 displayed only a few inflammatory cells, the implanted PP mesh appeared to extend 
the postoperative inflammatory reaction. No residual bacteria were observed on Gram staining 
(data not shown), in agreement with previous results of negative microbiological cultures of the 
biomaterial 28 days after implantation [15]. This means that the extended inflammatory reaction 
is not caused by the presence of bacteria. The macrophages surrounding the PP mesh displayed 
mainly an M2 phenotype, which is associated with tissue repair and angiogenesis, thus indicating a 
remodelling phase of wound healing [10]. In earlier in vivo rat studies, monofilament PP biomaterial 
evoked an anti-inflammatory/fibrotic reaction with formation of fibrotic tissue around the mesh 
fibres, a low infection rate, and good incorporation into the abdominal wall, in both a contaminated 
[15] and a sterile [19-21] environment.
 For the in vitro analysis, the M1/M2 index was calculated to summarize the effects of a biomaterial 
on macrophages. However, it should be appreciated that dividing macrophages into either M1 or M2 
phenotypes is a simplification, as several intermediate states exist [22]. In the in vitro inflammatory 
environment, macrophages on the multifilament PP biomaterial induced the expression of anti-
inflammatory proteins at a higher rate than the other biomaterials tested, thus resulting in a low 
M1/M2 index. The low M1/M2 index in the case of PP is caused mainly by a high protein production 
of CCL18, which is known for its association with fibrosis [23].
 Macrophages on the COL biomaterial produced a relatively low amount of pro-inflammatory and 
anti-inflammatory cytokines, indicative of a mild reaction to the biomaterial. A mild foreign body 
reaction against collagen-based biomaterial has also been observed in vivo by others [11,12,14,24].
 Macrophages on the PET biomaterial had a relatively high M1/M2 index in the in vitro model, 
indicating a predominantly pro-inflammatory reaction of macrophages. PET and PP biomaterials 
are knitted according to similar weaves, resulting in comparable surfaces (Figure S1, supporting 
information). The difference in vitro is thus mainly in the contact angle/hydrophobicity, and therefore 
the pro-inflammatory reaction; thus the high M1/M2 index can be caused partly by the polymer 
type itself.
 The PET + COL composite biomaterial tested is the mesh type generally preferred for intraperitoneal 
hernia surgery, as it minimizes the formation of postoperative tissue adhesions [25,26]. A high 
M1/M2 index was found for PET + COL biomaterial, indicating a high pro-inflammatory reaction 
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in an inflammatory environment. In fact, this material evoked the highest absolute production 
of pro-inflammatory cytokines. This acute reaction can be explained by phagocytic activity of 
macrophages, trying to break down and digest the thin collagen layer [27]. A pro-inflammatory 
reaction was induced by the macrophages on PET + COL, even in a non-stimulated environment. 
When this environment was compared with an inflammatory environment in vitro, only a slight 
further increase in pro-inflammatory protein production was observed. This indicates that the 
PET + COL material itself has a great influence on the reaction of macrophages.
 In a previous study [17], the M1/M2 index in a sterile environment was analysed in vitro. Most 
interestingly, the present data indicate that the macrophage response remains biomaterial-specific 
even in an environment with simulated contamination. When comparing sterile and contaminated 
environments, the largest differences were observed for TNF-α production. TNF-α is an acute-phase 
protein, and reacts quickly in the present in vitro system. However, this does not indicate that the 
fourfold increases in MCP-3 or the threefold increases in IL-6 are less relevant, as these factors might 
have a different potency or kinetics.
 In vivo there is a great difference between multifilament and monofilament biomaterials, as the 
former allow more cells to attach and fill the biomaterial. Monofilament biomaterials are less prone 
to infection because they provide fewer niches for bacterial infiltration [2,3]. In the present study, 
monofilament biomaterials were not tested in the in vitro system owing to the low number of 
macrophages attaching to these in comparison with multifilament biomaterials.
 The variation between macrophages isolated from different donors is not unexpected because it 
is known from clinical practice that patients respond differently to biomaterials. However, variations 
between the samples from one donor were also observed, which can be explained by the fact that 
monocytes are a heterogeneous population with different sensitivities to biomaterials or cytokines. 
However, taken together, distinct differences in macrophage reactions to biomaterials were 
observed.
 The present study describes the very acute reaction to biomaterials, with analysis after 3 days of 
culture. The acute reaction is indicative of the subsequent outcome. It is obvious that the in vivo 
conditions are more complex than the in vitro situation. Most importantly, this study shows that 
an in vitro model system can be used to evaluate and simulate the foreign body reaction in an 
inflammatory environment, which can aid in selecting and developing new biomaterials that are 
well tolerated under conditions with a high risk of postoperative biomaterial infection.
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ABSTRACT
Background
Macrophages and mesenchymal stem cells (MSCs) are important cells in wound healing. We 
hypothesized that the cross-talk between macrophages and adipose tissue-derived MSCs (ASCs) is 
biomaterial dependent, thereby influencing processes involved in wound healing.
Materials and Methods
The effect of macrophages cultured on polypropylene (PP) or polyethylene terephthalate coated 
with a collagen film (PET/Col) on ASCs in monolayer or on the same material was examined either 
through conditioned medium (CM) or in a direct coculture. ASC proliferation, collagen production, 
and gene expression were examined. As comparison, the effect of macrophages stimulated with 
lipopolysaccharide (LPS) and interferon gamma (IFNγ) [M(LPS/IFNγ)] or interleukin (IL) 4 [M(IL-4)] on 
ASCs was examined.
Results
Macrophage-CM increased collagen deposition, proliferation, and gene expression of MMP1, PLOD2, 
and PTGS2 in ASCs, irrespective of the material. Culturing ASCs and macrophages in coculture when 
only macrophages were on the materials induced the same effects on gene expression. When both 
ASCs and macrophages were cultured on biomaterials, PP induced COL1A1 and MMP1 more than 
PET/Col. M(LPS/IFNγ) CM increased PLOD2, MMP1, and PTGS2 and decreased TGFB in ASCs more 
than the M(IL-4) CM.
Conclusion
Biomaterials influence wound healing by influencing the interaction between macrophages and 
ASCs. We provided more insight into the behaviour of different cell types during wound healing. 
This behaviour appears to be biomaterial specific depending on which cell type interacts with the 
biomaterial. As such, the biomaterial will influence tissue regeneration.
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INTRODUCTION
Biomaterials are often used in regenerative medicine. After implantation of a biomaterial, the body 
reacts with inflammation followed by a wound-healing reaction. The extent of this reaction depends 
on the type of biomaterial. Different cells are involved in this reaction and macrophages are believed 
to be key players in orchestration of this reaction [1].
 Another cell type important in the foreign body reaction is the mesenchymal stem cell (MSC). 
These cells are recently discovered as candidates for the production of extracellular matrix in wound 
healing [1-3]. Adipose tissue-derived MSCs (ASCs) also have this capacity and are likely to rapidly 
migrate to the wound site accelerating wound healing by enhancing angiogenesis, stimulating 
extracellular matrix remodelling and synthesis [4,5] as well as differentiating into different cell types 
to replace the damaged tissue [1-3]. In addition, ASCs can be immunomodulatory and therefore are 
expected to have a great influence on the foreign body reaction [6]. ASCs stimulate macrophages 
to produce interleukin (IL)-10 and express CD206 on their surface leading to an anti-inflammatory 
subtype (M2) [7,8].
 Macrophages are likely candidates for attraction of stem cells. Macrophage products such 
as monocyte chemotactive protein-1 (MCP-1), macrophage inflammatory protein-1α, and IL-8 
enhance the migration of stem cells [9,10]. It is well known that biomaterials can influence the 
phenotype of macrophages [11-13]. We previously found that macrophages differentiated toward 
a pro-inflammatory phenotype when cultured on polyethylene terephthalate coated with collagen 
film (PET/Col), whereas when cultured on polypropylene (PP), they differentiated toward an anti-
inflammatory phenotype. These two biomaterials had the most distinguishing reaction in our 
culture model in vitro; therefore, we choose these two for the following research [12].
 In vivo, PP is a material used for many decades in reconstructive surgery. PP is known to induce 
fibrosis that leads to shrinkage of the mesh and encapsulation of nerves, leading to pain [14] PET/Col 
is a more recently developed material very often used for hernia repair and has a low complication 
rate with less adhesions and good tissue integration [15,16]. The influence of biomaterials on the 
interaction between macrophages and ASCs and the contribution of these cells to the wound-
healing process in response to biomaterials are largely unknown. We hypothesized that the cross-
talk between macrophages and ASCs is biomaterial dependent and thereby influences processes 
involved in wound healing.
 Since we found opposite reactions of macrophages to PP and PET/Col [12], we used these two 
biomaterials as model materials to evaluate the effect of macrophages in contact with the already 
mentioned biomaterials on the wound-healing responses of human ASCs as a model for in vivo 
wound healing in which macrophages and ASCs play a role. This was evaluated in experiments with 
conditioned medium (CM) of macrophages cultured on PP and PET/Col on ASCs and with a direct 
coculture of macrophages and ASCs in the presence of the same materials. We analysed proliferation 
and collagen production of ASCs.
 Expression of genes important in wound-healing processes was also examined, namely collagen 
type 1 (COL1A1) as marker for the production of collagen, matrix-metalloprotease 1 (MMP1) as 
remodelling marker, procollagen-lysine, 2-oxoglutarate 5-dioxygenase (PLOD2, a gene encoding 
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for an enzyme involved in collagen cross-linking) [17], α-smooth muscle actin (ASMA) [18] and 
transforming growth factor (TGFB1) as genes associated with fibrosis [12,19,20], and prostaglandin-
endoperoxide synthase 2 (PTGS2) as an immunomodulatory marker based on the literature [21]. 
MATERIALS AND METHODS
ASC isolation 
Subcutaneous abdominal adipose tissue was harvested as left-over material from breast 
reconstruction of six different female patients, aged 46–69 years, with approval of the local medical 
ethics committee (MEC-2011-371). The tissue was incubated overnight with collagenase type I 
(Gibco, Carlsbad, CA), bovine serum albumin (BSA; Sigma-Aldrich, St. Louis, MO), and low glucose 
(LG) Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) with 0.6% fungizone and 0.1% gentamycin 
(both Gibco) at 4 °C followed by incubation at 37 °C for 1 h on a shaker.
 The solution was then centrifuged and washed in LG DMEM. After filtration through a 100 μm filter 
(BD Pharmingen, Franklin Lakes, NJ), cells were seeded at a density of 40,000 cells/cm2 and cultured 
in LG DMEM with 10% fetal calf serum (FCS; Lonza, Verviers, Belgium), ascorbic acid (10−4 M; Sigma-
Aldrich), and 1 ng/mL fibroblast growth factor 2 (FGF2; AbD Serotec, Oxford, United Kingdom). 
This medium was changed every 3 to 4 days and cells were grown until an 80% confluence. 
Undifferentiated ASCs at passage 3 or 4 were used for experiments. In parallel, their multilineage 
differentiation capacity (i.e., osteogenic and adipogenic differentiation) was confirmed (data not 
shown).
Monocyte isolation 
Monocytes were isolated with Ficoll density gradient (Ficoll-Paque™ PLUS; GE Healthcare) from buffy 
coats of male donors, age 21–63 years, obtained from the blood bank (Sanquin, The Netherlands). 
The buffy coat was diluted (1:5 ratio with phosphate-buffered saline [PBS]/BSA 0.1%) and 30 mL 
was layered on 15 mL of Ficoll and centrifugated for 15 min at 1000 g without brake. The interphase 
band, containing the peripheral blood mononuclear cells, was collected. The cells were washed 
in PBS/BSA 0.5% of 2 mM EDTA and labeled with anti-CD14+ magnetic beads (CD14 microbeads 
human, MACS separation columns LS and MidiMACS™ separator; all Miltenyi Biotec). The monocytes 
were then isolated according to the manufacturer’s guidelines as done previously [12]. This positive 
selection of monocytes will not activate the cells [22]. After monocytes were isolated and attached 
to the biomaterial or culture well, they were referred to as macrophages.
Culture of cells on biomaterials 
To evaluate the effect of biomaterials on macrophages or ASCs, monocytes were seeded on two 
different materials immediately after isolation from the buffy coat or ASCs after expansion in 
monolayer. The following materials with a mesh architecture were chosen because they initiate a 
different reaction in vitro [12,23]: pure PP multifilament, and multifilament polyethylene terephthalate 
with an absorbable, continuous, and hydrophilic collagen film on one of its sides (PET/Col). Both 
materials were from Sofradim Production, A Medtronic Company.
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The materials were cut into pieces of 1.5 cm by 1.5 cm with a sterile scalpel. Before cell seeding to 
provide protein attachment, materials were incubated in 100% nonheat-inactivated fetal bovine 
serum (Lonza, Verviers, Belgium) for 2 h. Monocytes or ASCs were adjusted to a concentration of 
700,000/mL in a total volume of 25 mL in a 50 mL tube (Falcon, PP conical tube; Becton Dickinson, 
Franklin Lakes, NJ). Twelve samples were incubated per 25 mL for 2 h at 37 °C.
Macrophage-conditioned medium on ASCs 
Macrophages were cultured in monolayer with a seeding density of 500,000 cells/cm2 and 
stimulated to obtain a pro-inflammatory subtype by lipopolysaccharide (LPS) (100 ng/mL; Sigma-
Aldrich, St. Louis, MO) and interferon gamma (IFNγ) (10 ng/mL; PeproTech, Rocky Hill, NJ),10 from 
now on referred to as M(LPS/IFNγ) [24] or to obtain an anti-inflammatory subtype by IL-4 (10 ng/mL; 
PeproTech) [10], from now on referred to as M(IL-4) [24] in X-vivo15 medium (Lonza, Verviers, Belgium) 
with 20% FCS (Lonza). Previously, it was seen that these different stimuli indeed lead to different 
phenotypes as based on gene expression and protein production [12,25].
 Macrophages were also seeded on the biomaterials by rotational seeding for 2 h in a concentration 
of 700,000 cells/mL. After seeding, the biomaterials were transferred to a nonadherent 24-well plate 
(NUNC, nontreated multiplate, Rochester, NY) with X-vivo15 medium with 20% FCS. To generate 
CM, the medium was replaced after 2 days with LG DMEM (Gibco, Carlsbad, CA) with 10% FCS, 
the medium more suitable for ASC culture. After 24 h, this CM was harvested, spun down, and 
supernatant was stored at -80 °C until further use.
 ASCs from three donors were seeded at a seeding density of 50,000 cells/cm2 in six-well plates 
in triplicate per condition in LG DMEM with 10% FCS and ascorbic acid (25 μg/mL). The medium 
containing 10% pooled macrophage-conditioned medium (MCM) was added 24 h after seeding. 
To account for the number of cells by which the MCM was produced, the average DNA contents 
of all macrophage phenotypes or macrophages cultured on biomaterials was defined as 10%. The 
percentage CM used in culture was adjusted for the DNA content per macrophage phenotype as 
described previously [25].
 The control condition also received 10% medium that was treated in the same way as the CM, but 
without being in contact with cells. The end concentration of FCS in this condition was also 10%. The 
medium was refreshed at day 3 and day 6, and at day 7 the ASC monolayers were harvested in 500 μL 
PBS by scraping and stored at -20 °C for later measurement of DNA and collagen.
Hydroxyproline assay 
To determine the amount of collagen, samples of ASC monolayers without medium in PBS were 
digested with papain (250 μg/mL; Sigma) overnight at 56 °C. Half of this papain-digested sample 
was hydrolyzed overnight with hydrochloric acid (final concentration HCl, 6 N). The next day, HCl 
was removed from the samples by use of a centrifugal evaporator. The dried samples were dissolved 
in 150 μL Milli-Q water and subsequently a hydroxyproline assay was performed. The samples were 
incubated for a period of 20 min at room temperature in a solution of assay buffer (0.24 M C6H8O7, 
0.88 M NaAc ·3H2O, 0.85 M NaOH) with chloramine-T (0.07 g/reaction; Merck, Darmstadt, Germany).
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This was followed by an incubation of 25 min at 60°C with a solution of PBS and 7,12-dimethylbenz(a)
anthracene (DMBA) (Fluka; Sigma-Aldrich). Hydroxyproline (Merck) was used as a standard curve. 
The extinction was measured at 570 nm with a spectrophotometer.
DNA 
The other half of the papain-digested sample consisting of ASC monolayers was used to determine 
the amount of DNA. The samples were treated with heparine (8.3 IU/mL; Leo pharmaceutical) and 
RNAse (0.05 mg/mL; Sigma). After 30 min of incubation at 37 °C, ethidium bromide (25 μg/mL; Gibco) 
was added. Calf thymus DNA (Sigma) was used as a standard curve up to 25 μg/mL. The samples 
were analyzed by a spectrophotometer at excitation 340 nm and emission 590 nm.
 The monolayer of macrophages and the macrophages on biomaterials were harvested in 
0.1%Triton/PBS (Sigma-Aldrich) and analyzed with CyQUANT© cell proliferation assay kit (Invitrogen, 
Carlsbad, CA) to measure the amount of DNA according to the manufacturer’s recommendation.
Transwell setup, reciprocal paracrine signalling 
To investigate the influence of macrophages on ASCs in reciprocal paracrine signalling, a transwell 
system was used (Greiner bio-one; ThinCerts). ASCs were placed in the lower compartment in 
monolayer or as seeded on a biomaterial. Macrophages were placed in the upper compartment 
on a biomaterial. We choose to culture the macrophages always on a biomaterial since these cells 
in vivo are one of the first cells to react to the biomaterial. The experiment was performed with 
three different ASC donors and three different macrophage donors in triplicate for each donor. 
The cells were cultured for 3 days in 50:50 LG DMEM: X-vivo medium with a final concentration of 
10% FCS. At day 3, both compartments were harvested in 175 μL RLT (Qiagen) lysis buffer with 1% 
β-mercaptoethanol (Sigma-Aldrich) for gene expression.
Gene expression (mRNA isolation, cDNA, qPCR) 
mRNA was isolated from the RLT buffer containing cell lysate using Qiagen RNeasy microkit (Qiagen) 
according to manufacturer’s protocol. The synthesis of cDNA was performed with the RevertAid 
First Strand cDNA Synthesis Kit (MBI Fermentas, Germany). Primers in case of Sybr green assays 
and primers with probe sequences in case of Taqman assays to analyze gene expression are shown 
in Table 1 (all Eurogentec, Seraing, Belgium). For analysis of phenotype of macrophages, we used 
IL-6 as genes encoding pro-inflammatory proteins and IL-10, CCL18, and CD206 as genes encoding 
anti-inflammatory proteins since we have shown earlier that these genes discriminate between 
phenotypes [26]. Either Taqman Universal PCR mastermix (Applied Biosystems) or SybrGreen 
(Eurogentec) was used in the quantitative polymerase chain reaction. Relative gene expression was 
calculated using the 2−ΔCT method.
512290-L-sub01-bw-Nienke
Processed on: 31-7-2017 PDF page: 97
97Biomaterials Influence Macrophage-Mesenchymal Stem Cell Interaction In Vitro | 
6
Table 1 | Genes Used for Gene Expression. List of primers in case of Sybr green assays and primers with 
probe sequences in case of Taqman assays to analyse gene expression are shown in this table (all Eurogentec, 
Seraing, Belgium).
Gene Fw Rev Probe
Reverence gene: 
Glyceraldehyde 
3-phosphate 
dehydrogenase (GAPDH)
GTCAACGGATTTGGTC 
GTATTGGG
TGCCATGGGTGGAATC
ATATTGG
FAM-CGCCCAATACGACCAAATCCGTT
GAC-TAMRA
procollagen-Lysine, 
2-Oxoglutarate 
5-Dioxygenase (PLOD2)
CCCTCCGATCAGAGAT 
GATT
AATGTTTCCGGAGTAG 
GGGAGTCTTTTT
FAM-CGTGCGCGTGATAAACTGGATCCT
GATATGGCTTCTTCGCACG-Dabcyl
α-smooth muscle actin 
(ASMA)
CGTTGCCCCTGAAGAG 
CAT
CCGCCTGGATAGCCAC 
ATACA
Collagen type 1  
(COL1A1)
CAGCCGCTTCACCTAC 
AGC
TTTTGTATTCAATCACT 
GTCTTGCC
Prostaglandin-
Endoperoxide Synthase 2 
(PTGS2)
AATGGGGTGATGAGCA 
G TTGTTC
GGATGCCAGTGATAGA 
GGGTGTTA
matrix metalloprotease 
(MMP1)
CTCAATTTCACTTCTGT 
TTTCTG
CATCTCTGTCGGCAAA
TTCGT
FAM-CGTGCCAAAGCCTTTCAACTCTGG 
AGCAATGTCACGGCACG-Dabcyl
transforming growth 
factor 1 (TGFB1)
GTGACAGCAGGGATAA 
CATACTG
CATGAATGGTGGCCAG 
GTC
Interleukin-6 (IL-6) TCGAGCCCACCGGGA 
ACGAA
GCAGGGAAGGCAGCA 
GGCAA
Interleukin-10 (IL-10) CCTGGAGGAGGTGAT 
GCCCCA
GACAGCGCCGTAGCCT 
CAGC
Chemokine Ligand 18 
(CCL18)
GCACCATGGCCCTCT 
GCTCC
GGGCACTGGGGGCTG 
GTTTC
Mannose receptor  
(CD206)
TGGCCGTATGCCGGTC 
ACTGTTA
ACTTGTGAGGTCACCG 
CCTTCCT
Data analysis 
Data are presented as scatter dot plots with each dot representing an individual sample. All 
experiments were performed with three different ASC donors, in triplicate. The mean of these donors 
is indicated by a line in the graphs. All samples were normalized to the unstimulated monolayer of 
ASCs. We compared the groups in SPSS (IBM Corp. IBM SPSS for Windows, Version 21.0. Armonk, 
NY: IBM Corp.). The data were not normally distributed; therefore, the groups were compared by a 
Kruskal–Wallis test (independent samples median test) and a Mann–Whitney test. Bonferroni was 
used to correct for multiple testing, P < 0.05 was considered statistically significant.
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RESULTS
To first evaluate in a one-way direction how factors secreted by macrophages on biomaterials 
influence regeneration by ASCs, we measured the amount of collagen and DNA in the ASC monolayer 
after stimulation with MCM (Figure 1A). MCM stimulated the collagen deposition and the amount 
of DNA of ASCs (Figure 1B, C). No differences were found between ASCs exposed to medium from 
macrophages cultured on PP or on PET/Col, even though macrophages were differently influenced 
by the biomaterials in accordance with our earlier results where PET/Col stimulated macrophages to 
a predominant pro-inflammatory reaction and PP stimulated macrophages to a predominant anti-
inflammatory reaction (data not shown, [12].
Figure 1 | Collagen production and proliferation of ASCs. A | Schematic representation of the culture setup 
in which ASCs in monolayer were stimulated with MCM for 7 days. B | Amount of collagen in microgram per 
monolayer of ASCs stimulated with or without MCM. C | Microgram of DNA per monolayer of ASCs stimulated 
with or without MCM. Values were normalized to their own control condition without pooled MCM within 
each separate experiment. Experiments were performed in triplicate for three ASC donors. 
ASC = adipose tissue-derived mesenchymal stem cells; MCM = macrophage-conditioned medium; PET/Col = Parietex™ composite; 
PP = polypropylene.
In addition to proliferation and collagen deposition, we analysed the expression of genes involved 
in collagen modification and immune modulation in the ASC monolayers. Macrophage-secreted 
factors stimulated remodelling of the extracellular matrix by increasing the gene expression of 
MMP1 in a monolayer of ASCs. PTGS2 and PLOD2, encoding for procollagen-lysine, 2-oxoglutarate 
5-dioxygenase, an enzyme involved in collagen cross-linking, were also increased when ASCs in the 
monolayer were stimulated by medium conditioned by macrophages on biomaterials.
 Again, no differences were seen between the conditioned media made from macrophages 
cultured on the two different materials. ASMA, transforming growth factor (TGFB1), and collagen 
type 1 (COL1A1) gene expression were unaffected by the MCM (Figure 2).
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6Figure 2 | Gene expression by ASCs stimulated with CM. Gene expression of ASCs cultured in monolayer 
with or without MCM of macrophages cultured on biomaterials (PP and PET/Col). The gene expression was 
normalized to the average of the control condition without MCM within each separate ASC experiment. 
Experiments were performed in triplicate for three ASC donors.
To investigate the direct interaction between ASCs and macrophages in the presence of a biomaterial, 
we cocultured macrophages on a biomaterial with ASCs in monolayer in a transwell system (Figure 
3). The effects were similar to the effects of medium conditioned by macrophages on biomaterials. 
In addition to a similar effect found for MMP1, PTGS2, and PLOD2, we found a decrease in gene 
expression for COL1A1 and TGFB1 when ASCs were cocultured with macrophages regardless of the 
biomaterial on which macrophages were cultured. The ASMA gene expression of ASCs in monolayer 
was also decreased when cocultured with macrophages on biomaterials, although only statistically 
significantly lower when macrophages were on PET/Col (Figure 3).
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Figure 3 | Gene expression of ASCs in monolayer cocultured with macrophages. Gene expression of ASCs 
in monolayer cocultured with macrophages on biomaterials (PP and PET/Col) in a transwell system. The 
average gene expression of ASCs without macrophages was set to 1 for each ASC donor. Experiments were 
performed in triplicate for three ASC donors.
The experiments thus far describe the effects of factors secreted by macrophages on biomaterials 
on ASCs in monolayer. However, after being attracted by the macrophages, ASCs will also interact 
with the biomaterial. We therefore investigated the response when ASCs were seeded on PP and 
PET/Col with and without the presence of macrophages. Without macrophages, ASCs on PET/Col 
expressed less COL1A1, PLOD2, and ASMA and more PTGS2 than ASCs on PP (Figure 4). The presence 
of macrophages on the same material lowered COL1A1 and increased MMP1 gene expression by 
ASCs. 
 Moreover, when ASCs and macrophages were cultured on PP, COL1A1 and MMP1 gene expression 
was higher than when both cells were cultured on PET/Col. Differences between biomaterials 
were not detectable anymore for PTGS2, ASMA, and PLOD2 when ASCs were cocultured with 
macrophages, both cultured on the same material. TGFB in ASCs on biomaterials was unaffected by 
the type of biomaterial and the presence of macrophages on the same material (Figure 4).
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Figure 4 | The influence of biomaterials on ASCs. The effect of biomaterials on the gene expression of MMP1, 
COL1A1, PTGS2, ASMA, TGFB1, and PLOD2 by ASCs with or without the presence of macrophages on the 
same biomaterial. 
ASC PP = ASCs alone on PP; PET/Col = ASCs alone on PET/Col; PP+mφ = ASCs on PP and macrophages on PP in a transwell system; 
PET/Col+mφ = ASCs on PET/Col and macrophages on PET/Col in a transwell system (PP, PET/Col). Experiments were performed in 
triplicate for three ASC donors.
To investigate the effect of ASCs on macrophages, we analysed the macrophage gene expression 
of CCL18, IL-6, IL-10, and CD206 when the macrophages on the biomaterials were cocultured with 
ASCs on the same biomaterials or as monolayer. No statistically significant effects were seen in gene 
expression of macrophages on biomaterials in response to the presence of ASCs in monolayer or on 
the same biomaterial (Supplementary Figure S1). 
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Supplementory Figure | Gene expression of macrophages on biomaterials co-cultured with ASCs in 
monolayer or on the same biomaterials. Gene expression of macrophages on biomaterials (polypropylene: 
PP and ParietexTM Composite: PET/Col) in a transwell system. The average gene expression of macrophages 
was set to 1 for each monocyte donor. Experiments were performed in triplicate for 3 monocyte-donors. ASC: 
adipose-derived mesenchymal stem cells.
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To further understand the influence of macrophage phenotype on the interaction between 
macrophages and ASCs, we cultured ASCs in the presence of M(LPS/IFNγ) and M(IL-4) MCM. Both 
M(LPS/IFNγ) and M(IL-4)-CM increased PLOD2, MMP1, and PTGS2 in ASCs; however, M(LPS/IFNγ)-CM 
increased the gene expression more than M(IL-4)-CM. TGFB1 gene expression was lower in ASCs 
in monolayer stimulated with M(LPS/IFNγ)-CM than in ASCs in monolayer not exposed to MCM 
(Figure 5).
Figure 5 | Gene expression of ASCs with MCM. Gene expression of ASCs in monolayer stimulated with or 
without M(LPS/IFNγ) or M(IL-4)-CM. The average gene expression of ASCs without MCM was set to 1 for each 
ASC donor. Experiments were performed in triplicate for three ASC donors.
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DISCUSSION
Macrophages and MSCs can influence wound healing and tissue regeneration and the interplay 
between these cell types is important for the healing process [27]. Biomaterials influence the 
behaviour of macrophages [12] and might also influence the cross-talk between macrophages and 
MSCs. Which processes are activated in each cell in this interaction is, however, not fully understood. 
Using a coculture model of macrophages and ASCs with biomaterials, our data indicate a biomaterial-
dependent wound-healing reaction that is orchestrated by macrophages. We found indeed that 
macrophages on biomaterials induce a reaction in ASCs. Differences between the materials became 
obvious when the ASCs were in direct contact with the biomaterial.
 MSCs are found to contribute to wound healing by migrating to the wound site and differentiate 
into different cell types, inclu ding extracellular matrix producers [5]. Direct contact with biomaterials 
influenced the behaviour of ASCs, suggesting that the wound-healing process might not solely 
be directed by macrophages. In fact, MSCs are known to influence other cells such as T cells [28], 
macrophages [29], and fibroblasts [30] by producing many cytokines and growth factors and thereby 
coordinate the wound-healing process [30]. This implicates a pivotal role for MSCs in wound healing 
and, therefore, MSCs isolated from adipose tissue (ASCs) were used in our culture models.
 To investigate the role of each cell type in the cross-talk in reaction to biomaterials, several culture 
setups were used, starting with using CM from macrophages cultured on biomaterials for the culture 
of ASCs in monolayer. MCM increased collagen deposition by the ASCs, ASC proliferation, and the 
gene expression of MMP1, PLOD2, and PTGS2. This effect was independent of the biomaterial on 
which the macrophages were cultured.
 Having the macrophages on the biomaterial and the ASCs in monolayer in a transwell coculture 
induced the same effects on MMP1, PLOD2, and PTGS2, with additional decrease of COL1A1, ASMA, 
and TGFB1. This means that biomaterials have a great influence on the reaction between ASCs and 
macrophages and thereby the wound healing, mainly influencing remodelling since the presence 
of biomaterials increased PLOD2 and MMP1. PTGS2 was increased in the ASCs, in monolayer, and on 
biomaterials, when influenced by macrophages, indicating an immunomodulatory effect of ASCs, 
this immunomodulatory capacity is known from the literature [6].
 Interestingly, biomaterials also influenced ASCs without the presence of macrophages. The 
genes COL1A1, PTGS2, ASMA, and PLOD2 were differentially expressed between the biomaterials. 
This could suggest that material differences in vivo regarding markers for fibrosis are less due to 
macrophage responses, but instead are due to MSCs that are recruited to the site. Material screening 
when focusing on fibrotic processes might be done using ASCs rather than macrophages.
 Taken together, macrophages in general influence the behaviour of ASCs, especially processes 
related to wound healing, and when macrophages are cultured on different biomaterials in a coculture 
with ASCs, they also elicit biomaterial-specific reactions in the ASCs. Biomaterials themselves also 
elicit specific reactions in the ASCs, however, on other parameters related to collagen modification 
and immune regulation.
 MCM and macrophages in coculture with ASCs stimulated the expression of PTGS2, the gene 
encoding the enzyme cyclooxygenase 2 (COX2). PTGS2 was also differentially expressed in the ASCs 
512290-L-sub01-bw-Nienke
Processed on: 31-7-2017 PDF page: 105
105Biomaterials Influence Macrophage-Mesenchymal Stem Cell Interaction In Vitro | 
6
in response to the two different biomaterials. COX2 can stimulate cell proliferation and vasodilation 
[20,21], important factors in wound healing. Thus, this shows that biomaterials influence the reaction 
of ASCs and that macrophages can influence this reaction. The literature indicates that non-steroid 
anti-inflammatory drugs might have a negative influence on wound healing [21,31]. These drugs 
inhibit the COX2 enzyme. Since these drugs are commonly used after surgery for analgesia, this 
might also have implications for biomaterial-specific wound healing.
 Macrophages are key players in wound healing [32]. Macrophage subtype can determine the 
wound-healing reaction, and the presence of biomaterials was demonstrated by us and others to 
have an effect on macrophage subtype [12,13,33]. After the acute reaction, a predominant anti-
inflammatory reaction is associated with a better wound healing [32,33]. 
 Previously, we compared the effect of the used biomaterials on macrophages to the gene expression 
and protein production profile of M(LPS/IFNγ) and M(IL-4) [12]. There, we found that IL-1RA, regulated 
on activation, normal T-cell expressed and secreted, IL-6, CCL18, and macrophage-derived cytokine 
were differentially produced between M(LPS/IFNγ) and M(IL-4). When looking at the materials, again 
CCL18 was differentially produced between the materials, but also IL-1β, TNFα, and MCP-3. In this 
study, we questioned whether the effect of macrophages cultured on biomaterials on ASCs was 
comparable with that of pro-inflammatory macrophages or anti-inflammatory macrophages.
 Our data indicate that the response of ASCs in monolayer to macrophages on both PET/Col and PP 
is similar to the response of ASCs to medium conditioned by M(LPS/IFNγ), since the macrophages 
on the materials induced MMP1, PTGS2, and PLOD2 and reduced COL1A1 and TGFB in ASCs. These 
effects were also seen after adding M(LPS/IFNγ)-CM to ASCs in monolayer. This suggests that the first 
reaction of ASCs in response to macrophages on biomaterials is predominantly pro-inflammatory, 
which is expected since pro-inflammatory macrophages are the first type of macrophages in the 
wound-healing cascade [32,33]. Most likely, factors such as IL-6, IL-1β, or TNFα among many others 
have contributed to these effects since these factors were highly produced by M(LPS/IFNγ) [12,25] or 
by macrophages on PET/Col or PP [12].
 Next, to an effect of macrophages on ASCs, ASCs are known to influence macrophage phenotype. 
Macrophages have been reported to produce more IL-10 and less IL-6, IL-12, and TNFα when they 
interact with stem cells, the so-called stem cell-educated macrophage [29]. We found, however, 
no effect of the ASCs cultured in monolayer or on biomaterials on macrophages. This might be 
explained by the fact that the macrophages were already present on a biomaterial, which might be 
a stronger stimulus than the factors produced by ASCs.
 Several culture setups were used to investigate the reaction between biomaterials, ASCs, and 
macrophages: experiments with CM to investigate the effect of one cell type on the other and 
cocultures to examine the interaction between ASCs and macrophages. Many different cytokines 
are produced by ASCs and macrophages, but it is unclear which cytokine is responsible for which 
reaction seen in our cultures. 
 More research is needed to investigate these reactions in more detail and to find out which 
soluble factor is responsible for which process, for instance with neutralizing antibodies. It is likely 
that cell–cell contact also contributes to the interaction between ASCs and macrophages. However, 
we did not include a culture setup in which we cultured macrophages and ASCs together on the 
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material to allow cell–cell contact. Such a culture would not allow us to analyse the cells separately 
for gene expression or protein production and, therefore, we focused on different cells in different 
compartments.
 The in vitro culture of macrophages and ASCs with biomaterials can be used as a model to 
investigate the wound healing in response to the implantation of a biomaterial. Thus making in vitro 
research an easy way to investigate this reaction that can lead to new hypotheses and ideas and 
maybe even predict what is happening in vivo, as we have seen earlier with our macrophage culture 
model [12]. Future research might aim to show that our coculture system indeed can predict the in 
vivo situation.
 Our culture systems contained FCS as prerequisite for the macrophage culture. FCS is a source 
of cytokines and growth factors, thereby having the possibility to interfere in our culture system. 
However, the presence of FCS does not prevent macrophages from polarizing to different phenotypes 
as we have seen before [18,26,34]. In this study, even though FCS was present in the same amount 
for every culture and condition, we still see biomaterial-dependent reactions of macrophages and 
ASCs.
 Although we found some donor variation (some donors had a higher overall gene expression 
than others), the results were very reproducible. Variation is not unexpected and comparable with 
the in vivo situation where each patient responds differently. Using different human macrophage 
and ASC donors represents the variety of patients. We did not use ASCs and macrophages from 
the same donor. Since we found clear differences between conditions, we assume that no immune 
reaction took place in our culture model. For this study, we have used monocytes and ASCs isolated 
from healthy donors. It is well known from the literature that in some patient groups comorbidities 
such as diabetes or obesity impair wound healing. Macrophage subtype in obesity and diabetes is 
mainly pro-inflammatory [33] which will likely influence the wound healing [32,33]. Therefore, more 
research is needed with non-healthy donors.
CONCLUSIONS
Biomaterials influence tissue regeneration by influencing interaction between macrophages and 
ASCs but also by influencing the cell types separately as shown in this article. This article gives more 
insight into the behaviour of two different cell types during wound healing after implantation of a 
biomaterial. This behaviour appears to be biomaterial specific. As such, for the tissue-engineering 
field, the choice of a biomaterial can influence the wound-healing response.
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THE QUEST FOR TAILOR-MADE SELECTION OF BIOMATERIALS 
Wound healing is a complex cascade of processes, especially when biomaterials are involved. In this 
reaction, also called the foreign body reaction, the type and consistency of biomaterials will alter the 
immune response [1,2]. Much research has been performed to investigate the differences between 
biomaterials and for instance it is found that lightweight mesh is preferable over heavyweight mesh 
for abdominal wall hernia surgery in terms of scarring and patient complaints [3,4]. However since 
there are hundreds of different biomaterials, it is difficult to state which biomaterial is the best. Besides 
the consistency of the biomaterial and the type of tissue it is implanted in, another important factor 
is the patient. Until now we do not fully understand why some patients have complications after 
implantation of a biomaterial and others have none with the same biomaterial. Some risk factors for 
impaired wound healing are found such as smoking, aging, obesity and diabetes [5]. For diabetes 
and obesity literature shows that macrophages are mainly of a pro-inflammatory subtype, known 
to negatively influence wound healing [1,6]. For clinical practice, it would be a great benefit to have 
a tailor-made model with patients own cells to test which biomaterial is best thereby reducing 
complication rates.
New in vitro models 
In this thesis, the first steps are described for this tailor-made treatment. Since macrophages are the 
conductors of the immune system after implantation of a biomaterial, in our research these cells 
were used to investigate the wound healing process when biomaterials are involved. In Chapter 2 
many different studies with many different biomaterials were reviewed. Since the biomaterials were 
studied in different culture settings, it was difficult to compare the effect of different biomaterials. 
Therefore a culture model was developed in which macrophages on four different biomaterials 
were cultured. As such, distinguishing differences between the reaction of macrophages to these 
biomaterials were found (Chapter 3). An in vitro model is a simplification of the foreign body reaction. 
However when the knowledge of what is known from these biomaterials in vivo is integrated, this 
model can predict the foreign body reaction. A big advantage of this new culture model is the short 
time of culture. In 3 days culture and a few days to analyse the results, the answer to the question: 
‘Which biomaterial is best for this patient’ might already be given. For a complete comparison it 
would be very interesting to use macrophages from patients scheduled for surgery and culture 
these in our culture model. Also cells of patients with complications can be compared with patients 
without complications to see whether a difference in our culture model can be found. Previously 
we used buffy coats (prepared from 500 mL of blood) to isolate monocytes, however, this amount 
of blood is probably too much asked for of patients. The first goal was to downscale the protocol in 
which our lab recently succeeded by Boersema et al. [7]. They used only 30mL of peripheral blood 
instead and was still able to isolate sufficient monocytes to test biomaterials. 
 Since contamination cannot be completely prevented in all surgical fields, our model was also 
adapted to predict the reaction of the body to biomaterials in a field with a high risk of contamination 
(Chapter 4). Contamination was mimicked by the use of interferon (IFN)γ and lipopolysaccharide 
(LPS). LPS is a main component of the membrane of gram negative bacteria like Escherichia coli, 
512290-L-sub01-bw-Nienke
Processed on: 31-7-2017 PDF page: 111
111General discussion | 
7
Salmonella and Pseudomonas. In bowel surgery, most pathogens are gram negative. In nose surgery, 
some of the postoperative infections are gram negative (E. coli, Klebsiella), some are gram positive 
(Staphylococcus aureus) [8]. For the future it would be interesting to culture with ‘real’ bacteria, gram 
positive and gram negative like S. aureus and E. coli. These two bacteria are known from literature 
to induce a strong M1 polarisation [9]. It would be possible then to compare if these bacteria induce 
the same reactions in macrophages in combination with biomaterials, as in our inflammatory model. 
To have more insight in the wound healing process, cells that can produce matrix which is necessary 
to close the wound were added to our culture model. For this purpose adipose-derived stem 
cells (ASCs) were added, since these cells are known to migrate to the wound site and are either 
able to accelerate wound healing by secretion of factors or by differentiation into fibroblasts and 
produce matrix to repair the defect [10,11]. We found distinguishing differences between the effects 
of biomaterials on gene expression and cytokine production of macrophages and ASCs. Some 
biomaterials induced a predominantly pro-inflammatory and others induced a predominantly anti-
inflammatory reaction. The question arose: which type or balance between M1 and M2 macrophages 
is optimal? 
M1 or M2, that’s the question (12)
From literature, it is known that every foreign body reaction will start with a solemnly M1 i.e. 
pro-inflammatory reaction, since these macrophages start with cleaning up the wound site by 
phagocytosis. By production of pro-inflammatory cytokines and chemokines, many different cell 
types are attracted to the wound site [1,6,13]. After the first inflammation reaction the macrophages 
change to an anti-inflammatory subtype to conduct the wound healing [6]. When this reaction 
is out of balance device failure or complication does occur. When macrophages stay at the M1 
polarisation, poor incorporation of the biomaterial and impaired wound repair will be the result 
[6,14]. This reaction is often found in chronic ulcers in diabetic patients and in patients with chronic 
inflammatory diseases such as rheumatoid arthritis, Crohn’s disease and asthma [6,14]. However, 
when M1 macrophages are depleted and the reaction is of a solemnly M2 type, wound healing will 
have delayed granulation tissue formation and delayed wound closing [6,14]. This means that both 
types of macrophages are necessary and a good balance is needed. To make it even more complex, 
M2 macrophages can also induce fibrosis by myofibroblast differentiation and by producing TGFβ 
leading to an increased collagen production [14]. M1 macrophages sometimes help organizing scar 
tissue, and therefore reduce fibrosis [14]. In our own co-culture (Chapter 6) it was indeed apparent 
that cytokines from M2 macrophages induced gene-expression of TGFβ1 and ASMA (alpha smooth 
muscle actin) in ASCs, both associated with fibrosis [15,16]. This means that the answer to the 
question: “M1 or M2” is not black and white and indeed a balance of these two subtypes is needed to 
conduct the wound healing cascade, starting with a balance more towards M1 and after a few days 
the balance must shift towards M2. In our culture model cells were cultured for 3 days; the wound 
healing cascade, however, can take sometimes several weeks. Still we found differences compatible 
with the in vivo outcome. Macrophages normally arrive at day 2 or 3 at the wound site. Macrophages 
were used in our culture model, so our starting point in the wound healing cascade is not at time 
point zero. Furthermore, in culture there might be less cell debris than at the wound site, since only 
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living cells were attached to the biomaterial. This is might accelerate the M2 transition. Therefore in 
only 3 days the foreign body reaction can already be predicted. 
Modulation of macrophages to interfere with the wound healing 
A potential way to improve wound healing might be modulation of macrophages when influenced 
by biomaterials. All synthetic (non-degradable) biomaterials induce mainly a M1 reaction since 
macrophages are constantly triggered by the foreign body, trying to engulf the biomaterial. During 
the last decades, synthetic biomaterials are altered to help transit this reaction. For instance small 
pores will induce more M2 macrophages, than with a non-porous biomaterial [1,6]. 
 Another possibility is the addition of stem cells, these cells being known to induce a more M2 
subtype of macrophages when co-cultured [17]. Also in pre-clinical studies, it is described that stem 
cells will promote the M1 to M2 transition in for instance brain and cardiac injury [6,18,19]. However, 
the use of stem cells in clinical medicine is still controversial since we do not know the long term 
effects and possible carcinogenic differentiation. 
 In vitro, macrophages can be forced into an anti-inflammatory type by adding for instance IL-4 
(Chapter 2). This is not directly applicable for systemic administration, since this can enhance an 
inflammation reaction and IL-4 is described to be important in the pathogenesis of asthma and 
metastasis [20,21]. Interference with other cytokines can alter wound healing, like blockages of 
cytokines IL-1β, IL-17 and TNFα in diabetic mice accelerate skin wound healing [13]. However since 
we do not know all the effects of these cytokines in the human body, it is difficult to use it in a clinical 
setting.
 Another possibility to modulate macrophage behaviour is the use of drugs, already used in patients 
(for other purposes) such as Haloperidol and Risperidone which are used for mental disorders. 
They are described in literature to stimulate macrophages to produce pro-inflammatory cytokines, 
which can be useful to promote ingrowth of the biomaterial, since a solemnly M2 reaction can 
delay wound closure [6,13,22]. Some drugs can also suppress the inflammation reaction. Recently 
our group published an article on the reaction of macrophages to dexamethasone, rapamycine 
and pravastatin [23]. With dexamethasone suppression of the inflammation reaction was found. In 
vivo it is also described to influence wound healing, by suppression of the inflammation reaction 
[24], so in clinical practise dexamethasone can maybe be used to supress a chronic inflammation 
reaction. Rapamycine is commonly used to prevent rejection of transplanted organs, meaning a 
very strong drug suppressing the immune system, so this is also not favourable to use in healthy 
patients. Pravastatin, a relatively save drug to reduce cholesterol enhanced the production of IL-10 
and is therefore likely to promote M2 macrophages. It would be interesting to investigate this in a 
clinical setting since many patients use statins. Every drug, however, has side-effects. Our group 
also investigated the possibility of modulation of macrophages when attached to a biomaterial [25] 
and found that some drugs did modulate macrophages on all different types of biomaterials, and 
some only effected one or two different types. This means that the type of biomaterial is of strong 
influence, which we also find in our culture models. Therefore more and more research is performed 
to investigate the possibility for local administration or even incorporate it in a biomaterial such as 
the addition of antibiotics or for instance diclofenac [26,27].
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The use of biomaterials in otorhinolaryngology 
In otorhinolaryngology different biomaterials are being used. In ear surgery, titanium prostheses 
are used to reconstruct the ossicular chain. Most of these biomaterials perform well and only a few 
complications are found. Failure of these implants is sometimes due to the formation of fibrous 
tissue, preventing the prosthesis to move freely and thereby limiting the transfer of sound vibration 
in 2%–37% of patients [28]. In rhinoplasty almost no biomaterials are used due to a high risk of 
complications like infection, extrusion and movement [29]. The nose is not a sterile working field 
because it has direct connections to air. Most of the time cartilage (septum, ear of rib) is used in 
rhinoplasty, however due to donor site morbidity and lengthening of the surgery sometimes 
biomaterials are used. In Asia biomaterials are more frequently used than in Europe. Mostly used 
are silicone, expanded polytetrafluoroethylene (ePTFE) , porous high-density polyethylene (pHDPE) 
and sometimes acellular human dermis [29]. After silicone implantation, a high complication rate up 
to 36% is described [30]. In the case report in the Introduction such a complication was described, 
which resulted in extensive fibrous tissue formation and chronic inflammation, even years after 
implantation. ePTFE is described with a low complication rate (2–3.7%, 0,38% infection) [30,31]. In 
Chapter 4 using ePTFE (Dualmesh®) in a rat peritonitis model, we found, however, infection rates as 
high as 50%. Rhinoplasty is a surgical field with a risk of contamination and therefore not completely 
comparable with our peritonitis model where contamination is always present, but still this biomaterial 
had a higher percentage of infection than other biomaterials used in this study. Histologically we 
found more T-cells and macrophages, indicative for a chronic inflammation reaction [12,32]. Based 
on our research, this biomaterial would not be a good candidate for rhinoplasty. Acellular human 
dermis is sometimes used in rhinoplasty, even though it can give bulkiness and it is not as stable as 
cartilage [30]. In our culture model with simulated inflammation (Chapter 5), we found the lowest 
production of pro- and anti-inflammatory cytokines than with the other biomaterials, indicative for 
a mild foreign body reaction against acellular dermis. In hernia surgery, biologic biomaterials seem 
not to perform better than synthetic biomaterials and infection rates of 15.9% are found [33,34]. 
Taken all together, this means that there is still much research to do to find the best biomaterial 
for each application like for instance rhinoplasty. Maybe biomaterials can be improved by coating 
with extracellular matrix components to improve incorporation of the biomaterial, like is done with 
ParietexTM Composite. This material, also used in our in vitro model, is never used in rhinoplasty. 
Biomaterials with antibodies to polarise the macrophages or drugs to prevent infections or reduce 
inflammation might also be a topic to focus on in future research [27,35]. Our culture model with 
simulated inflammatory can help testing newly developed biomaterials.
 The search of the best tailor-made biomaterial has just started and we have made the first steps 
in this quest by developing an in vitro model with human macrophages in which we can measure 
biomaterial-dependent differences. Already in the near future, it is pivotal to investigate which 
M1/M2 ratio and which reaction of adipose-derived stem cells is needed to get the best outcome 
in vivo. Furthermore, since biomaterial research is performed by many different groups, it would 
be beneficial to coordinate all surgeons working in the biomaterial field to register complications 
leading to a research databank. This will provide much knowledge helping to develop better 
materials and preventing complications. 
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Biomaterials are often used in many fields of medicine to restore or replace tissue. These biomaterials 
always elicit a reaction of the immune system, called the foreign body reaction, which can lead to 
complications in patients and failure of the device. Macrophages are key players in this reaction [1]. 
Because the foreign body reaction depends on the type and consistency of biomaterials [2-4] but 
also on the patient itself, a tailor-made model will be of great help to assess the best treatment. 
Therefore the ultimate aim of our research was to develop a tailor-made model. 
 Much research has already been performed on macrophages and biomaterials, therefore we 
started with a literature research of what is already known. First a systematic review of in vitro 
models describing the macrophage polarisation (pro- (M1) or anti-inflammatory (M2)) in response to 
different biomaterials was performed (Chapter 2). It was found that many factors are influencing this 
polarisation such as chemistry, pore size and surface topography. Also sterilisation and chemically 
crosslinking will alter the macrophage polarisation. However, since many different culture conditions 
were used, it was difficult to compare the biomaterials. 
 Since we eventually aimed for a tailor-made model, the development of an in vitro model with 
human isolated macrophages from blood was initiated (Chapter 3). First, distinguishing genes and 
cytokines for polarisation were determined. These read-out parameters were used for investigating 
the influence of four different biomaterials on macrophage polarisation; the model showed 
biomaterial-dependent differences. Macrophages on polypropylene had a phenotype comparable 
to M2, while macrophages on polyethylene terephthalate and on a combined biomaterial Parietex™ 
Composite (polyethylene terephthalate and collagen) had a phenotype similar to M1. Macrophages 
on a collagen biomaterial (Permacol™) produced a low amount of proteins and therefore did not 
have a clear phenotype. This model can be useful in the future to predict the in vivo outcome of 
biomaterials.
 Most research is performed in a sterile environment. However some anatomical locations in the 
human body are not sterile, like in bowel surgery or rhinoplasty as described in the case report in the 
introduction. The use of biomaterials in these fields has an increased risk of complications, such as 
infection [5]. In Chapter 4a an in vivo animal model was used in which a contaminated environment 
was created by puncture of the bowel, creating a peritonitis to compare the performance of different 
biomaterials. Six different synthetic and one biological biomaterial were implanted in the abdominal 
wall. Significant differences in infection rate and incorporation between materials were found. Most 
infections occurred in C-QurTM and Dualmesh®. The incorporation of the biological mesh (Strattice®) 
was less than the other synthetic biomaterials, however this mesh was never infected. Dualmesh® 
showed the most shrinkage. In Chapter 4b samples of the previous study were used to analyse 
the subtype of macrophages. Parietene CompositeTM and SeprameshTM induced more iNOS-positive 
cells (M1 polarisation) and C-QurTM and Dualmesh® were surrounded by more CD206-positive cells 
(M2 polarisation), finding biomaterial-dependent differences in this in vivo rat model.
 The biomaterial-dependent polarisation of macrophages in a contaminated environment in the 
rat study inspired to modify the culture model developed in Chapter 3. Inflammatory cytokines (LPS 
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and IFNγ) were added to our in vitro model in Chapter 5, to mimic an inflammatory environment. 
Polypropylene again stimulated M2 polarisation and Parietex™ Composite and polyethylene 
terephthalate stimulated an M1 reaction. Despite inflammation, macrophages still behaved 
biomaterial-dependent. 
 Another important factor in tissue regeneration is the production of matrix, our in vitro model in 
Chapter 6 was extended to a co-culture with adipose tissue derived stem cells (ASCs). The cytokines 
produced by macrophages when cultured on biomaterials, increased proliferation of ASCs and 
collagen deposition. Co-culture of macrophages and ASCs demonstrated biomaterial-dependent 
differences in gene-expression of wound healing genes.
In conclusion, this thesis describes the development of three in vitro models with human 
macrophages in different conditions where biomaterial-dependent differences can be found. This 
confirms that the type of biomaterial is very important in the foreign body reaction and for patient 
outcome. These models can be useful to study the biological mechanisms of foreign body reactions 
as well as to evaluate newly developed, modified or functionalized biomaterials. Moreover, this 
work represents the first step to a tailor-made model that in the future can preoperatively predict 
the foreign body reaction in a specific patient and therefore help to select the best biomaterial per 
patient. 
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Biomaterialen worden in verschillende medische specialismen gebruikt om weefseldefecten te 
herstellen. Omdat deze materialen lichaamsvreemd zijn, reageert het lichaam met een afweerreactie, 
ook wel vreemdlichaamreactie genoemd. Deze reactie kan complicaties bij patiënten veroorzaken 
en ervoor zorgen dat het biomateriaal niet goed functioneert. Macrofagen zijn de dirigenten in 
deze reactie, zij regelen het wondgenezingsproces. Biomaterialen zijn al jaren op de markt en er 
is dan ook al veel onderzoek naar gedaan. Omdat de reactie tussen patiënten en de reactie per 
biomateriaal verschillend is, zou het helpen over een patiënt-specifiek model te beschikken om per 
patiënt te kunnen testen wat het beste biomateriaal is. 
 In Hoofdstuk 2 wordt een literatuurstudie van de bestaande in vitro modellen gepresenteerd. 
Omdat macrofagen de dirigenten zijn van de vreemdlichaamreactie is gekeken naar in vitro 
modellen, die de invloed van biomaterialen op de polarisatie van macrofagen (pro-(M1) of anti-
inflammatoir (M2)) beschrijven. Veel factoren zijn van invloed op deze polarisatie zoals poriegrootte, 
oppervlaktekarakteristieken en materiaaltype. Ook de manier van steriliseren en versterken van het 
materiaal blijken van grote invloed. Omdat elk model andere kweekomstandigheden kent, bleek 
het lastig de materialen met elkaar te vergelijken. 
 Daarom werd er een in vitro model opgezet met humane macrofagen geoogst uit bloed. 
In Hoofdstuk 3 wordt dit model beschreven waarin specifieke genen en eiwitten gevonden 
werden om te differentiëren tussen M1 en M2 macrofagen. Deze “markers” werden gebruikt om 
de reactie van macrofagen op biomaterialen te onderzoeken. In ons model zijn vier verschillende 
materialen gebruikt: polypropyleen, polyethyleentereftalaat, een gecombineerd biomateriaal: 
polyethyleentereftalaat met collageen (Parietex™ Composite ) en een puur collageen biomateriaal 
(Permacol™). Op basis van onze markers, hadden macrofagen op polypropyleen een M2 profiel, de 
macrofagen op polyethyleentereftalaat een M1 profiel. PermacolTM toonde slechts een beperkte 
reactie van de macrofagen en polariseerden niet duidelijk. 
 Het meeste onderzoek, tot op heden, is in een steriel milieu uitgevoerd. Echter niet alle anatomische 
onderdelen van het menselijk lichaam zijn steriel, zoals bijvoorbeeld de darm- en de neuschirurgie. 
Hoe hier de vreemdlichaamreactie verloopt is nog niet helemaal duidelijk. Wel worden er meer 
complicaties gezien waarvan een voorbeeld is gegeven in het case-report in de introductie. In 
Hoofdstuk 4a is een in vivo model beschreven, waarin in ratten een gecontamineerd milieu werd 
gecreëerd door een darmlekkage en buikvliesontsteking te veroorzaken. Vervolgens werden zeven 
verschillende biomaterialen geïmplanteerd. Na 28 en 90 dagen werd onderzocht hoe vaak infectie 
voorkwam en hoe de biomaterialen waren ingegroeid en/of gekrompen. Ook werd gekeken naar 
verklevingen in de buikholte door het biomateriaal. Hierbij werden duidelijke verschillen tussen 
de biomaterialen gevonden. Het doel van het onderzoek beschreven in Hoofdstuk 4b was om 
te onderzoeken of er in deze ratstudie verschillen te vinden zouden zijn met betrekking tot de 
macrofaagpolarisatie. Om die reden zijn in de biopten, genomen van de geïmplanteerde materialen, 
algemene macrofagen (CD68) en de subtypes: iNOS (M1) en CD206 (M2) aangetoond. In dit in vivo 
model werd een biomateriaal-afhankelijke reactie van macrofagen gevonden. 
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Omdat het ratmodel een duidelijk biomateriaal-afhankelijk verschil liet zien met betrekking 
tot polarisatie van macrofagen, is in Hoofdstuk 5 het in vitro model aangepast om materialen 
in een gecontamineerd/inflammatoir milieu te kunnen onderzoeken. Door het toevoegen van 
inflammatoire cytokines (lipopolysacharide en interferon gamma) werd een inflammatoir milieu 
nagebootst. Zelfs in een inflammatoir milieu werd gevonden dat de biomaterialen een biomateriaal-
afhankelijke polarisatie van de macrofagen induceren. 
 Omdat bindweefsel-producerende cellen ook heel belangrijk zijn in de reparatie van weefsels, is 
in Hoofdstuk 6 het in vitro model gemodificeerd, waarbij naast macrofagen ook stamcellen werden 
gekweekt. Ook hier waren duidelijke verschillen in stimulatie door een biomateriaal waarneembaar. 
Met dit model is het mogelijk om de interactie tussen macrofagen en stamcellen te onderzoeken. 
Hierbij bleken biomaterialen op beide soorten cellen een grote invloed hebben, waarbij bovendien 
biomateriaal-afhankelijk effecten werden gezien. 
Concluderend werden in alle beschreven kweekmodellen biomateriaal-afhankelijke polarisaties van 
macrofagen gezien. Dit bewijst dat de keuze voor een bepaald type biomateriaal erg belangrijk is 
voor de patiënt. Dit model helpt bij de keuze en kan ook nieuw ontwikkelde materialen evalueren. 
Hiermee zet dit onderzoek de eerste stappen naar een preoperatief toe te passen model om te 
bepalen welk biomateriaal het beste is voor welke patiënt.
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List of abbreviations
ACS adipose-derived mesenchymal stem cells
ASMA α-smooth muscle actin
BDEDTC poly(styrene-co-benzyl N,N-diethyldithiocarbamate
CCL-18 chemokine ligand 18
CD(x) cluster of differentiation
CLP caecal ligation and puncture model
CM conditioned medium
COL collagen
COX cyclo-oxygenase 
DMAPAAmMel methyl iodide of poly[3-(dimethylamino)propyl]acrylamide
FCS fetal calf serum
FGF fibroblast growth factor
GAPDH glyceraldehyde 3-phosphate dehydrogenase
GM-CSF granulocyte-macrophage colony-stimulating factor
IL-(x)(RA) interleukin-(x) (receptor antagonist)
IFNγ interferon gamma
iNOS inducible nitric oxide synthase
LPS lipopolysaccharide
M1 pro-inflammatory macrophage
M2 anti-inflammatory macrophage
MCP monocyte chemotactic protein
MDC  macrophage-derived chemokine
MIP macrophage inflammatory protein
MMP matrix metalloproteinase 
MSC mesenchymal stem cells
PAAm polyacrylamide
PAANa poly(acrylic acid)
PAH poly(allylamine hydrochloride)
PCL-(U4U) poly-e-caprolactone bisurea
PDGF platelet-derived growth factor
PDO polydioxanone
PDL poly-d-lysine
PE polyethylene
PEG-g-PA perfluoropolyether with large fibers
PET polyethylene terephthalate
pHEMA 2-hydroxyethyl methacrylate
(m)PP (multifilament)polypropylene
PFPE perfluoropolyether
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PLA polylactic acid
PLGA poly(D,L-lactide-co-glycolide)
PLOD2 procollagen-lysine,2-oxoglutarate 5-dioxygenase 2
PMN polymorphonuclear leukocytes
(e)PTFE (expanded) polytetrafluorethylene
PTGS2 prostaglandin-endoperoxide synthase 2
PU polyurethane
RANTES regulated and normal T-cell expressed and secreted
SIS small intestine submucosa (biological mesh)
THP-1 monocyte cell line
TGFβ transforming growth factor beta
Th2 T-helper 2
TNFα tumor necrosis factor alpha
VEGF vascular endothelial growth factor
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Summary of PhD training and teaching
Name PhD student: Nienke Schmidt-Grotenhuis
Erasmus MC Department: Otorhinolaryngology  
and General Surgery
Research School: Molecular Medicine
PhD period: 2010-2017
Promotor(s): GJVM van Osch, JF Lange
Supervisor: YM Bastiaansen-Jenniskens
1 | PhD training
Year Workload 
(ECTS)
Courses 
 – Biomedical Scientific English writing course (Molmed)
 – Introduction to Data Analysis (NIHES)
2011 
2010
4
2
Presentations
 – Science day Otorhinolaryngology
 – Science day (Stafdag) Surgery
 – Research group meeting Orthopaedics/Otorhinolaryngology (multiple 
times)
 – CTCR research group (multiple times)
 – Otorhinolaryngology department research meeting (multiple times)
 – Molmed PhD-day (2 times, poster presentation)
 – Scientific meeting of Dutch society for ENT
 – Journal club meeting
2014
2011 & 2012
2010-2013
2010-2013
2010-2016
2011 & 2012
2012, 2014
2010-2013
2
(Inter)national conferences-poster presentation
 – COST-Nambio: Biomaterial-dependent reaction of macrophages in 
conditions stimulating an inflammatory environment
2012 5
(Inter)national conferences-podium presentation
 – TERMIS Granada, Spain: Differentiation of macrophages into pro-or 
anti-inflammatory/repair subtype in culture
 – NBTE Lunteren, the Netherlands: A culture model to analyse the acute 
biomaterial-dependent reaction of macrophages
 – TERMIS Vienna, Austria: Biomaterial-dependent reaction of 
macrophages in conditions simulating an inflammatory environment
 – NBTE Lunteren, the Netherlands: The reaction of macrophages to 
biomaterials in an inflammatory environment
 – European Hernia Society congress, Rotterdam, the Netherlands: The 
acute response of macrophages to biomaterials, as a predictor for late 
outcome. 
 – Inflammaday, Covidien, Lyon, France: Biomaterial dependent reaction of 
macrophages in conditions simulating an inflammatory environment
2011
2011
2012
2012
2012
2012
5
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Other
 – Heidelberg visit/workshop culturing and isolation of monocytes with 
podium presentation, 3 days visit
2012 1
2 | Teaching
Year Workload 
(Hours/
ECTS)
Lecturing
 – Basic ENT for interns (multiple times) 
 – Cancer in ENT for interns (multiple times)
 – Acute ENT for ER-nurses (multiple times) 
 – Cancer in ENT for nurses 
 – ENT surgery for anaesthesiology nurses
2016
2015-2016
2012-2016
2015
2016
5
Supervising Master’s theses
 – Hylke vd Toom, medical student, the inflammatory in vitro model,  
20 weeks
 – Samantha de Witte, stem cells and macrophages, 40 weeks
 – Jovita Schoffelmeer, technical medicine student, 10 weeks
2011-2012
2013
2013
4
8
2
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List of publications
1) N.Grotenhuis, S.F. de Witte, G.J. van Osch, Y. Bayon, J.F. Lange, Y.M. Bastiaansen-Jenniskens. 
Biomaterials Influence Macrophage-Mesenchymal Stem Cell Interaction In Vitro. Tissue Eng Part 
A. 2016 Sep;22(17-18):1098-107. doi: 10.1089/ten.TEA.2016.0162.
2) N. Grotenhuis, J.P. Koopman, J.M. Kruyt, L.K. Rothuizen, R. Knevel, H. Blom. Implementation of the 
hyaluronic acid fat graft myringoplasty technique, pitfalls and lessons learned. Acta Otolaryngol. 
2017 May 29:1-4. doi: 10.1080/00016489.2017.1330556. 
3) G.S. Boersema, N. Grotenhuis, Y. Bayon, J.F. Lange, Y.M. Bastiaansen-Jenniskens. The Effect of 
Biomaterials Used for Tissue Regeneration Purposes on Polarization of Macrophages. Biores 
Open Access. 2016 Jan 1;5(1):6-14. doi: 10.1089/biores.2015.0041. 
4) N. Fay, M.L. de Vries-van Melle, J. Lehmann, W. Wei, N. Grotenhuis, E. Farell, P.M. van der Kraan, 
J.M. Murphy, Y.M. Bastiaansen-Jenniskens. G.J.V.M. van Osch. Human osteoarthritic synovium 
impacts chondrogenic differentiation of mesenchymal stem cells via macrophage polarisation 
state. Osteoarthritis Cartilage. 2014 Aug;22(8):1167-75. doi: 10.1016/j.joca.2014.05.021. Epub 
2014 Jun 7.
5) N. Grotenhuis, H.F. van den Toom, N. Kops, Y. Bayon, E.B. Deerenbert, I.M. Mulder, G.J.V.M van 
Osch, J.F. Lange, Y.M. Bastiaansen-Jenniskens. In vitro model to study the biomaterial-dependent 
reaction of macrophages in an inflammatory environment. Br J Surg. 2014 Jul;101(8):983-92. doi: 
10.1002/bjs.9523. Epub 2014 May 19.
6) M.Ditzel, E.B. Deerenber, N. Grotenhuis, J.J. Harlaar, K. Monkhorst, Y.M. Bastiaansen-Jenniskens, J. 
Jeekel, J.F.Lange. Biologic meshes are not superior to synthetic meshes in ventral hernia repair: 
an experimental study with long-term follow-up evaluation. Surg Endosc. 2013 Oct;27(10):3654-
62. doi: 10.1007/s00464-013-2939-y. Epub 2013 Apr 3.
7) N.Grotenhuis, Y. Bayon, J.F. Lange, G.J.V.M. van Osch, Y. M. Bastiaansen-Jenniskens. A culture 
model to analyze the acute biomaterial-dependent reaction of human primary macrophages. 
Biochem Biophys Res Commun. 2013 Mar 29;433(1):115-20. doi: 10.1016/j.bbrc.2013.02.054. 
Epub 2013 Feb 26.
8) E.B. Deerenberg, I.M. Mulder, N. Grotenhuis, M.Ditzel, J. Jeekel, J. F. Lange. Experimental study 
on synthetic and biological mesh implantation in a contaminated environment. Br J Surg. 2012 
Dec;99(12):1734-41. doi: 10.1002/bjs.8954.
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Nienke Grotenhuis werd geboren op 2 februari 1985 in Enter, 
Overijssel. Ze groeide op in Maarssenbroek en verhuisde op 
zesjarige leeftijd naar Drenthe waar zij op Protestantse Basisschool 
‘de Bron’ te Nijensleek haar basisonderwijs volgde. Nadien doorliep 
ze het gymnasium op de Regionale Scholen Gemeenschap te 
Steenwijk en behaalde in 1997 haar diploma. Ze begon aansluitend 
met Geneeskunde bij de Rijksuniversiteit te Leiden. Tijdens haar 
studie was Nienke actief binnen studentenverening LSKO ‘Collegium 
Musicum’ als praeses. In haar tweede jaar begon ze met onderzoek 
binnen de afdeling neonatologie naar pulsoximeters. In het vierde 
jaar na afronding van haar vakken ging ze voor een wetenschappelijke 
stage voor 9 maanden naar Yokohama, Japan, onder Prof.dr. H. Kawamato en Prof.dr. W. van Ewijk, 
waar ze onderzoek deed naar het afweersysteem. Na deze stage doorliep ze haar co-schappen en 
ontving ze in maart 2010 haar artsexamen. Tijdens een extra coschap KNO in Zwolle raakte Nienke 
geïnteresseerd in de KNO en na haar semi-arts stage in het LUMC wist ze zeker dat ze KNO-arts wilde 
worden. In mei 2010 startte ze onder leiding van Prof. dr. G.J.V.M. Van Osch, Prof. dr. J.F. Lange en dr. 
Y.M. Bastiaansen-Jenniskens haar promotietraject in het Erasmus MC te Rotterdam, wat resulteerde 
in dit proefschrift. In september 2013 startte ze als AIOS KNO in het Erasmus MC bij Prof. dr. R.J. 
Baatenburg de Jong, dr. R.M.L. Poublon en dr. R.M. Metselaar. Haar perifere opleiding doorliep ze in 
het HAGA ziekenhuis bij dr. H.M. Blom en drs. J.P. Koopman en in het Reinier de Graaf Gasthuis te 
Delft bij drs. F.A.W. Peek en dr. H.C. Hafkamp. 
Nienke is in 2014 getrouwd met Marc Schmidt en op 5 januari 2017 werd hun dochter Lilian geboren. 
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Het is af! 
 Dat was echter niet mogelijk geweest zonder hulp van velen. Ik wil een aantal mensen specifiek in 
het zonnetje zetten.
 Allereerst dank aan alle bloeddonoren en patiënten die hun bloed en weefsel ter beschikking 
stelden aan de wetenschap en zo mijn onderzoek mogelijk maakten.
 Lieve professor Gerjo, allereerst dank dat je deze medicus met (Japanse) lab-ervaring aannam voor 
een uitdagend fundamenteel onderzoek met macrofagen. Dat er nog geen ervaring op het lab was, 
heeft ons nooit tegengehouden. In de laatste jaren zijn er veel onderzoekers meegenomen in de 
wondere wereld van de macrofaag en is hij uit het CTCR lab niet meer weg te denken. Je was altijd 
bizar snel met nakijken, dacht ik dat een stuk even van mijn bordje was, had ik het dezelfde avond 
met commentaar al weer terug! 
 Lieve Yvonne, de aanhouder wint past ons beide, de ‘diva’-cellen hebben ons veel kopzorgen 
gekost, maar uiteindelijk hebben we een prachtig kweeksysteem opgezet. Dank voor ons wekelijks 
beraad waarna ik altijd vol goede moed weer aan de slag kon. En die IFNy/INFy!
 Lieve professor Johan, dank voor de begeleiding en gezellige gesprekken over macrofagen en 
meshes. Jij zorgde voor de klinische blik op ons fundamenteel onderzoek en hield me bij de les. 
De vraag wat heb je nou precies nodig, hoeveel M1 en M2, dat blijft ook na al die jaren lastig te 
beantwoorden en is alleen maar complexer geworden. 
 Hooggeachte promotiecommissie, dank voor uw tijd, discussies en aanbevelingen voor mijn 
proefschrift.
 Beste professor Rob, dank voor het doorsturen van mijn sollicitatie naar Gerjo en het aannemen 
van mij als AIOS KNO. Een mooier vak kan ik me niet indenken!
 Alle co-auteurs, zonder jullie was het niet gelukt!
 Dear Yves, many thanks for our lively discussions about culturing macrophages and meshes. I 
enjoyed attending the ‘Inflammaday’ and visiting Lyon, eating frog legs and snails! 
 Lieve collega A(N)IOS, dank voor al jullie gezellige koffietjes, praatjes, borrels en steun, je zit toch 
allemaal in hetzelfde schuitje, dat boekje moet toch eens af!
 Lieve Hylke en Sam, jullie hebben je sufgepipeteerd als ‘mijn’ studenten, maar dat heeft dan toch 
mooi geleid tot 2 prachtige artikelen. Dank!
 Kamer 1618, lieve Rintje, Jasper, Mairead, Mieke en Marloes, wat een heerlijke onderzoekstijd! 
Kabouter Wesley-imitaties: ‘Zeg, ik moet wel naar de zee hè’ en ‘wat is daar het praktisch nut van’, 
oh, wat hebben wij gelachen! Maar ook tips en trucs, Graphpad, lay-out en SPSS, daar hebben we 
veel van elkaar geleerd. Lieve analisten, Wendy, Nicole, dank voor jullie geduld en hulp met kweken, 
eindeloos coupes snijden en kleuren en puntjes vullen. Maar toch vooral ook voor de gezellige 
gesprekken tijdens het isoleren van macrofagen. Sandra, dank voor al je hulp! Overige labcollega’s, 
dank voor alle samenwerking en gezelligheid.
 REPAIR groep, dank voor alle gezellige discussies, Eva en Irene, dank voor de leuke samenwerking, 
we hebben elkaar veel geleerd!
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 Lieve paranimfen, Marloes en Jorke, dank dat jullie aan mij zijde willen staan!
 Lieve Marloes, ik ben heel blij dat ik je dankzij dit onderzoek heb leren kennen als overbuurvrouw 
en dat je mijn beste vriendin bent geworden, je stond en staat altijd voor mij klaar met een luisterend 
oor. Dank voor al je steun en wijze woorden. 
 Lieve (schoon)familie, dank voor jullie interesse in mijn onderzoek en meevieren van hoogtepunten, 
fijn dat jullie er bij zijn op zo’n bijzonder moment.
 Lieve papa en mama, dank voor al jullie steun en liefde en dat jullie me van kinds af aan hebben 
meegegeven niet te klagen maar door te gaan en niet op te geven. Als je het heel graag wilt, dan 
gebeurt het ook!
 Lieve Marc, door jouw geweldige steun en meedenken is het toch maar mooi gelukt! Ik kan me 
geen betere man wensen! Lieve Lilian, je bent mijn zonnestraal! Jullie maken me zo gelukkig!
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